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To assess the antibacterial properties of novel dental composite formulations containing 
the antibacterial polylysine and varying type or amounts of monomer/glass/calcium 
phosphate.  
Methods 
Minimum inhibitory/bactericidal concentrations of polylysine against Streptococcus 
mutans UA159 were determined. The antibacterial activity of composite discs with 
polylysine was determined by immersing the discs into a suspension of S. mutans and 
carrying out bacterial counts. All the results were compared with commercial materials. 
Mass and volume change of the material as well as polylysine release were determined 
over time and compared for multiple formulations containing polylysine. Bacterial growth 
was visualised on the discs using LIVE/DEAD staining with confocal microscopy and 
using scanning electron microscopy. 
Results 
The addition of a minimum 1% polylysine to the novel formulations inhibited bacterial 
growth at low inoculum density and the addition of a minimum 2% polylysine inhibited 
bacterial growth at all inoculum densities in air. In an atmosphere of air enriched with 5% 
carbon dioxide and in the presence of sucrose there was a bacteriostatic effect with 5% 
polylysine addition. None of the commercial materials showed any antibacterial 
properties. Increasing the amount of polylysine in the novel composite formulations 
increased mass change over two months and increased polylysine release over three 
weeks. Volume was not significantly affected. Using SEM, bacterial growth was seen on 
composite discs after 4 days incubation in a suspension of S. mutans at 37oC in air with 
5% carbon dioxide. It appeared that a biofilm was formed under these conditions for all 
formulations and commercial materials whereas in air, there was minimal growth. Using 
confocal microscopy an increase in dead bacteria was seen as the polylysine 
concentration increased in both air and in air with 5% CO2. 
Conclusion 
Novel composites with added polylysine are capable of reducing the load of 
Streptococcus mutans. These above experimental composites have novel 
characteristics that make them more suitable for minimally invasive tooth restorations.  
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Dental caries is caused by the demineralisation of hydroxyapatite by acids coming from 
bacterial fermentation of sugars. These bacteria reside in the dental plaque on the tooth 
surface (Loesche, 1996). 
Dental caries is one of the most common diseases in the world. It is estimated to affect 
31% of adults in the United Kingdom and the National Health Service spends 
approximately 5.8 billion pounds per year on restoring teeth at the dentist (Steele & O 
’Sullivan, 2009). 
 
1.1.2 Epidemiology  
Oral health has significantly improved since the 1970s. Generally, this is due to the 
availability of fluoride in toothpaste but also in water, mouthwash, tablets and other. 
However, almost a third (31%) of 5 years old children in the UK still have caries on their 
primary teeth and the ones who are affected will have at least three decayed teeth. 
Dental caries is the most common reason for a young child to have a general anaesthetic, 
and caries is a disease that can be prevented through oral hygiene and tooth brushing 
(Reena, 2012). One of the most recent epidemiological studies in the UK was done in 
2013. Nearly half (42%) of 15 year olds and a third of 12 year olds has had previous 
caries experience in the permanent dentition (Pitts & Chadwick, 2013). This has been 
reduced by approximately 10 percent since 2003 when the previous survey was done. 
Also in 2013, and in the younger population, a third of 5 year old and almost half of 8 
year olds has had previous decay in the primary dentition. Socioeconomic level also 
plays a role and children from lower income families are more likely to have dental caries 
(Pitts & Chadwick, 2013). Although the above numbers seem significant, if these are 
compared with 1973, when the first children dental health survey was done, it is clear 
that the reduction is huge. Since 1973 approximately 70,000 children between five to 
fifteen years old have been involved in the child dental health survey. In the UK, caries 
prevalence has been reduced from 72% to 41% in 5 year olds and from 97% to 46% in 
15 years olds (Murray et al., 2015). The table below shows the reduction of dental caries 





Figure 1-1: DMFT and proportion with caries in 15 (Left) and 5 (Right) year old children in UK (Murray et 
al., 2015), with permission from Nature Publishing Group. 
 
The latest adult dental health survey was done in 2009 (Pitts & Chadwick, 2009). Again, 
there is a decrease over the years with only 6 percent of the population being edentulous 
compared to 22 percent in 1978. The mean number of teeth in dentate adults was 25.7. 
Interestingly only 17 percent of dentate adults had healthy periodontal status and 10 
percent had excellent oral health. For those under 45, there is now a high chance that 
they will retain a large number of their permanent teeth for their whole life. This may lead 
to a higher percentage of decayed teeth as these are retained for longer. About one third 
of dentate adults had obvious decay, and for those who had decay, the affected teeth 
were 2.7 on average. The prevalence of decay has fallen from 46 per cent in 1998 to 28 
percent in 2009 (Pitts & Chadwick, 2009).  
Data from the World Health Organization (WHO) in 2000 compare mean Decayed, 
Missing, Filled Teeth (DMFT) in Europe for 12 years old children. England is amongst 
the lowest prevalence of DMFT in Europe at 0.7 along with Germany, Denmark and 
Cyprus. On the other hand Lithuania, Poland and Romania are among those with the 




1.1.3 Aetiology  
There are three theories that attempt to explain the aetiology of dental caries: the specific 
plaque hypothesis, the non-specific plaque hypothesis and the ecological plaque 
hypothesis (Takahashi & Nyvad, 2011). According to the specific plaque hypothesis, only 
a few different bacteria, such as Streptococcus mutans and Lactobacillus spp., are active 
during the disease process. In the non-specific theory, dental caries is the outcome of 
the activity of many species within the plaque microflora. The ecological plaque 
hypothesis suggests that caries is a process where demineralisation and 
remineralisation exist in an equilibrium and a shift in the balance will result in dental 
caries (Aas et al., 2008). In this process bacteria other than S. mutans play an important 
role in maintaining ecological stability. This process can be described as ‘net mineral 
gain’ and ‘net mineral loss’. Once an acidic environment has been established, aciduric 
(acid tolerant) bacteria tend to increase and promote an environment where a ‘net 
mineral loss’ happens (Takahashi & Nyvad, 2011). Microbes produce acids upon 
hydrolysis of carbohydrates present in the oral cavity. Acids released by bacteria drop 
the pH below 5.5 and cause demineralisation of tooth tissue. Remineralisation induced 
by precipitation of phosphate, calcium and fluoride which are present in saliva, 
toothpaste, mouthwashes counters the above. Erosion of the enamel is followed by 
infection and demineralisation of the dentine. Dental caries will eventually reach the pulp 
chamber where it will cause inflammation and subsequent necrosis of the pulp tissue 
(Loesche, 1996, Takahashi & Nyvad, 2011). 
 
1.1.4 Pathogenesis 
Culture-based studies from plaque samples have been able to identify specific bacteria 
that are associated with dental caries (Becker et al., 2002, Chhour et al., 2005, Munson 
et al., 2004). These studies have helped with developing the above three hypotheses. S. 
mutans and Streptococcus sobrinus as well as Lactobacillus spp. have been previously 
identified as major bacterial agents. In dental caries S. sobrinus is more aciduric and 
acidogenic than S. mutans, meaning it can survive and grow in an acidic environment 
and produce acids respectively. However, it is in most cases outnumbered by S. mutans 
in an active carious lesion. The reason may be that S. sobrinus is unable to catabolize 
N-acetylglucosamine, a sugar present in the plaque biofilm, which in turn doesn’t allow 
the organism to proliferate (Beighton, 2005). Only in rare cases where carbohydrate 
levels may be very high, for example in bulimic patients, can S. sobrinus proliferate in 
caries (Beighton, 2005). Additionally, the presence of S. sobrinus has been associated 
with high caries experience. Studies have shown that children that carried both S. 
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sobrinus and S. mutans had higher caries rate that children carrying only S. mutans 
(Okada et al., 2005). 
In a study done in 2008 bacterial growth on teeth was analysed using a reverse capture 
DNA hybridization assay (Aas et al., 2008). This makes use of the polymerase chain 
reaction technique to rapidly detect and enumerate bacterial species. Using this 
technique is more sensitive than bacterial culture techniques, however it can sometimes 
suffer from inadequate specificity (Paster et al., 1998). Fifteen young children with 
primary teeth and twenty five adults were investigated in this study as well as forty 
controls. Plaque was removed from teeth from 4 different areas, intact enamel, white 
spot lesions, dentin lesions, and deep dentin lesions. The analysis presented 197 
different bacterial species present in plaque. S. mutans was present in 90% of cases in 
dentin lesions. Caries also developed in the absence of S. mutans and individuals with 
high levels of S. mutans don’t necessarily develop caries. S. mutans has a more 
dominant role in dentine lesions in primary teeth compared to permanent teeth. In early 
carious lesions, Streptococcus parasanguinis and Streptococcus salivarius were 
observed in high levels. On top of that Corynebacterium spp. and Actinomyces 
gerencseriae were detected in primary teeth and Leptotrichia spp, Campylobacter 
gracilis and Selenomoas spp. in permanent dentition. This microbial composition was 
completely different in deep carious lesions. The microflora was dominated by S. mutans, 
Lactobacillus spp., Propionibacterium spp. In primary teeth deep lesions, 
Bifidobacterium spp. and in permanent teeth Atopobium Genomospecies C1 were also 
identified (Aas et al., 2008). Other studies have also confirmed that S. mutans and 
Lactobacillus spp. are the most dominant species in deep carious cavities (Chhour et al., 
2005; Fragkou et al., 2016; Corby et al., 2005).  
Based on the ecological hypothesis, previous studies have shown that in a newly cleaned 
tooth surface S. mutans will only constitute 2% of the total streptococcal population 
(Nyvad & Kilian, 1990). In cavitated lesions, S. mutans will comprise 30% of the total 
microbial flora. In the actual advancing front S. mutans is seen less frequently and there, 
lactobacilli, Prevotellae and Bifidobacterium are encountered more often (Takahashi & 
Nyvad, 2011). 
Looking more closely at the ecological hypothesis during the dynamic stability change, 
small changes to the pH by occasional sugary foods can be restored through 
homeostatic mechanisms in the saliva. As stated before, in this stage, Actinomyces and 
non-mutans streptococci are mostly present in plaque. When sugar is supplied more 
frequently the pH in plaque decreases. In this sugar-rich environment non mutans 
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streptococci increase their acidogenicity (acid production) and ‘low-pH’ aciduric non-
mutans bacteria will increase selectively. This can lead to initiation or progression of 
dental caries. Upon exposure to a pH of 4.0 or less, non-mutans streptococci and 
Actinomyces lose their viability, while S. mutans and Lactobacilli are able to survive. This 
leads to the next stage where aciduric (acid resistant) bacteria are dominant. Under 
these condition the latter proliferate and lead to a pronounced net mineral loss and lesion 
progression. Similar to S. mutans, Bifidobacterium is also very acidogenic and aciduric, 
and this bacterium can also overcome the competition under the aciduric stage and 
increase its population (Takahashi & Nyvad, 2011). 
It is also important to mention the role of S. mutans in Early Childhood Caries (ECC). A 
systematic review in 2006 concluded that the presence of S. mutans, both in plaque and 
saliva of young children without caries can be associated with a considerable increase 
in caries risk (Thenisch, et al. 2006). Similarly, the detection of Lactobacillus spp. and 
Bifidobacterium spp. in ECC is very common and agrees with the ecological hypothesis 
as these bacteria are very aciduric and acidogenic (Aas et al., 2008). 
The yeast, Candida albicans has high cariogenic potential and previous studies have 
shown that there is an association between ECC and C. albicans (de Carvalho et al., 
2006; Fragkou et al., 2016). 
Finally, in the table below a list of the man bacteria implicated in dental caries has been 
made to summarise the above review. 
 Early  Deep  










Permanent teeth S. mutans 
S. salivarius 










Table 1-1: Bacteria involved in dental caries as discussed in chapter 1.1.4 
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1.1.5 Streptococcus mutans 
Streptococcus mutans is a facultatively anaerobic, Gram-positive coccus mainly found 
in the oral cavity. It is closely related to Streptococcus sobrinus, with which it cohabits 
the oral cavity. Its main virulence factors associated with cariogenicity include adhesion, 
acidogenicity and acid tolerance. It was first isolated and described by JK Clarke in 1924 
(Clarke, 1924).  
Biofilms are three dimensional structures in which the bacteria are embedded in an 
exopolysaccharide matrix on surfaces such as enamel. The extracellular 
polysaccharides (EPS), as well as other polymers such as DNA and proteins, also affect 
the physical and biochemical properties of the biofilm. The biofilm starts with formation 
of the salivary pellicle. This is formed from salivary components (such as mucin, 
lysozyme, proteins and other) adsorbing to the acquired enamel pellicle (AEP). AEP is 
the base for biofilm formation. Streptococcus species can adhere to the pellicle together 
with hundreds of other bacterial species. These species are able to ferment 
carbohydrates and produce acid as a by-product (Wan et al., 2003). Bacteria such as S. 
mutans adhere to the pellicle via two mechanisms; sucrose-dependent and sucrose-
independent.  The sucrose independent path may initiate the process of adhesion but 
colonisation of tooth surface is mediated by sucrose dependent pathway. In the sucrose 
independent mechanism an interaction between particles of S. mutans and the acquired 
enamel pellicle is seen. Agglutinins found in the saliva aid the adhesion of S. mutans, 
based on the interaction with the I/II antigen, which is a multifunctional P1 adhesin 
anchored in the bacterial cell wall.  Ag I/II interact with glycoprotein-340 which is found 
in saliva and adsorbs on the surface of teeth. Experiments have been done in rats to test 
whether there will be less adhesion if the P1 is removed genetically in S. mutans. Results 
from multiple studies arrive at mixed conclusions (Bowen et al., 1991; Crowley et al., 
1999).The sucrose dependant mechanism is understood to be through the action of 
glucosyltransferases (GTFs) in the synthesis of glucans. GTFs are able to split sucrose 
into glucose and fructose. GTFs are also responsible for formation of glucans from 
sucrose. Glucans enable bacterial adhesion to enamel as well as bacteria to each other. 
After this has happened microcolonies are formed and this enables the formation of a 
biofilm (Krzyściak et al., 2014; Banas, 2004). 
S. mutans contains a glycolytic pathway through which it can produce acids such as 
lactate and formate as fermentation by-products. When glucose is abundant lactate is 
the major fermentation product. It is understood that the acidogenicity of S. mutans leads 
to the ecological changes in the plaque flora and, in caries involving S. mutans, is 
consistent with the ecological hypothesis described above. Together with the 
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acidogenicity S. mutans is aciduric or acid-tolerant. It retains its glycolytic abilities at pH 
as low as 4.4 (Bender GR, 1985). Also the formation of a biofilm allows S. mutans to 
survive, whereas planktonically grown bacteria may not survive such low pH (Banas, 
2004). 
 
1.1.6 Management   
The dramatic reduction in the DMFT in the past 20 years is evidence that prevention 
works. Prevention is based on four pillars, tooth brushing and plaque control, diet advice, 
fluoride and fissure sealants. 
It is evident that diet advice, although very regularly given may not be as effective as 
once thought, and is currently thought to be only valuable for children under 5 years old 
(Kay et al., 2016). An example of effective diet advice may be the stopping of bottle 
feeding/breast feeding at night after the primary teeth have erupted. Similarly tooth 
brushing instructions can produce short term gains in plaque control. 
In 2007 the Department of Health released a document called ‘Delivering better oral 
health: an evidence based toolkit for prevention’. This incorporates the 4 pillars of 
prevention as well as advice for adults such as smoking and alcohol cessation advice 
(Public Health England, 2014). Importantly for paediatric dentistry it gives 
recommendations for the application of fluoride varnish, instructions for effective tooth 
brushing and correct concentrations of sodium fluoride in the toothpaste to be used. 
Research suggests that toothpaste containing at least 1000 μg/ml fluoride has a 23% 
increased preventive effect against caries compared to placebo, whereas a toothpaste 
with 500 μg/ml fluoride showed no difference in caries prevention compared to the 
placebo (Walsh et al., 2010). Fluoride varnish also has a significant effect on caries 
development and has been shown that applying varnish twice yearly may reduce caries 
by 37% in primary teeth and 43% in permanent teeth (Marinho et al., 2013). Fissure 
sealants are a preventive intervention which is particularly important for first molars which 
erupt at the age of 6-7 and are susceptible to occlusal caries. Applying a resin based 
fissure sealant to these teeth will reduce the chances of caries developing by 33-51% 
which is significant (Ahovuo-Saloranta et al., 2013). When caries has progressed, it is 
dealt with by surgical interventions. 
Traditionally dental caries has been managed with complete caries removal and 
restoration of the cavity with amalgam or similar restoration. This is a very effective way 
of dealing with dental caries and is well evidenced (Ricketts et al., 2013). Complete caries 
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removal however may be demanding for young children as it will involve the use of local 
anaesthesia and high speed handpieces. In more recent years the focus has been on 
prevention as well as partial or no caries removal. With the development of new dental 
materials, mainly dental composites with or without antibacterial properties as well as 
improvements in bonding have led to less need for full caries removal and the concept 
of ‘sealing’ caries in is now well evidenced (Tellez et al., 2013). One of the strongest 
advocates for no caries removal is the ‘Hall crown’ technique which led to a large amount 
of interest when the results of the 5 years randomized controlled trial in 2009 by N. Innes 
showed that sealing caries in the tooth with a preformed metal crown significantly 
outperformed conventional restorations (Innes et al., 2011). Since then partial caries 
removal or no caries removal has become very popular and sealing caries is often 
preferred to removing it. This is of course why dental composites with antibacterial and 
remineralizing properties have become the centre of interest. When caries is left behind 
it is vital that the marginal seal is effective to prevent caries progression. Importantly it 
should be mentioned that on a similar principle, non cavitated carious lesions (NCCl) can 
be simply sealed with a fissure sealant (Tellez et al., 2013). 
 
1.2 Dental Materials 
1.2.1 Amalgam  
Amalgam has been used for over 150 years. An amalgam is formed when mercury is 
mixed with an alloy. The alloy used consists of a mixture of silver, tin, copper and zinc. 
Silver is the main component and together with tin they form Ag3Sn, known also as the 
γ- phase. The γ phase reacts with mercury to form amalgam. Copper is added to increase 
strength. In terms of properties, amalgam has very high strength, it flows and creeps and 
it corrodes. Corrosion can affect the restoration in a positive and negative way; the 
corrosion products help to produce a good marginal seal, however it can also cause a 
deterioration of the properties of amalgam. The main limitations of amalgam include poor 
aesthetics, lack of adhesion and concerns of amalgam toxicity. The most serious 
potential hazard is that of mercury vapour, during placement and removal of the 
restoration.  Dental staff are more at risk from contamination and the threshold is 50 
μg/m3. Also there have been reports of delayed hypersensitivity reactions to mercury in 
patients following placement of the restoration (Noort, 2007). 
In January 2013 the Minamata convention was published (Mackey et al., 2014). This is 
an international treaty designed to protect human health and the environment from 
emissions and releases of mercury and mercury compounds. Dental amalgam was part 
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of the discussion as it accounts of approximately 3% of all mercury use in the world. The 
recommendation for dental amalgam is that a reduction in its use, rather than a ban, 
should be implemented and a greater focus on dental prevention and health promotion, 
increased research and development of alternatives, and best management techniques 
for amalgam waste should be encouraged (Mackey, Contreras and Liang, 2014). 
European legislation has aligned with the Minamata convention which in summary will 
prohibit the use of dental amalgam in under 15 years old children and in pregnant or 
breastfeeding women by 2018 and phase out dental amalgam by 2030 (Bourguignon, 
2017). 
 
1.2.2 Glass Ionomer Cement 
Glass Ionomer Cements (GICs) are restorative materials consisting of a powder and 
liquid, which when mixed together produce a fluid mass which quickly becomes solid. 
They are mainly used in dentistry as temporary restorations, class V restorations, as 
luting cements and also as permanent fillings in the primary dentition. They were first 
described in 1971 by Wilson and Kent and they were an extension of zinc 
polycarboxylate cements that were available since the 1960s. The replacement of 
phosphoric acid with polyacrylic acid meant less irritation to the tissues and stronger 
restoration (Wilson & Kent, 2007). The two main advantages of GICs are the ability to 
bond to enamel and dentine and the ability to release fluoride over time. A further 
advance in GICs is the addition of a resin component, allowing the material to set by light 
activation. This is known as resin-modified GIC (RMGIC) (Noort, 2007). GICs are a 
mixture of glass, a polyacid and water. The glass comprises silica (SiO2) and alumina 
(Al2O3) mixed with calcium fluoride (CaF2). The polyacid can be made from copolymers 
of acrylic and itaconic acid or acrylic and maleic acid. Also a copolymer of vinyl, 
phosphoric acid is a stronger acid that has been used in more recent GICs, and gives 
better strength and moisture resistance. RMGICs can include polyacrylic acid, tartaric 
acid, a photo initiator and a hydrophilic monomer such as Hydroxyethyl methacrylate 








The setting reaction is with an acid-base reaction: 
MO∙SiO2 + H2A 
 
→ MA + SiO2 + H20 
Glass  Acid  Salt  Silica gel   
Table 1-2: Setting reaction of glass ionomer cement (Noort, 2007) 
There are three phases in the setting process of glass ionomer cement; dissolution, 
gelation and hardening. In dissolution, when the water is mixed with the powder, the acid 
goes into solution and reacts with the outer layer of the glass. This layer then becomes 
exhausted of aluminium, calcium, sodium and fluoride ions and only the silica gel is left. 
The hydrogen ions are released from the carboxyl groups on the polyacid diffuse on the 
glass and make up for the lost ions above. Although the majority of the setting reaction 
takes only a few minutes the GIC will continue to set for up to one month. The gelation 
phase happens when the calcium ions react with the carboxyl groups of the acid. Finally, 
the hardening phase can last up to seven days. This provides the strength to the GIC by 
up taking of aluminium and the introduction of crosslinks. 
In the case of RMGIC the acid base reaction is similar, but much slower, enabling a 
longer working time. These materials may instead set rapidly upon light activation.  This 
causes polymerization of the monomer. After 150s of the application of light source, 
polymerisation is almost complete (Noort, 2007; Young, 2004). 
 
1.2.3 Biodentine 
Biodentine is a calcium silicate based material which was made available by Septodont 
in 2011. It is important to mention it here as it is a biocompatible material with good 
mechanical properties. Septodont claimed that it can be used as a ‘’dentine replacement 
material whenever original dentine is damaged’’. It is used for crown and root dentin 
repair treatment, repair of perforations and resorptions, apexification and root end filling. 
More importantly for our research it can be used as a permanent dentine substitute in 
large carious lesions (Malkondu Ö et al., 2014). 
Biodentine induces mineralization after its application. It increases TGF-β1 secretion 
from pulp cells which increases mineralization. As part of the setting process calcium 
hydroxide is released and due to its high pH this causes irritation, hence it induces 
deposition of reactionary and reparative dentine. Finally its high alkalinity causes some 





Compomers are similar to composites but they also contain a monomer/polymer with an 
acidic chemical group and fluoride releasing silicate glasses. They generally consist of 
hydrophobic monomers such as urethane dimethacrylate (UDMA) and triethyleneglycol 
dimethacrylate (TEGMDA) with fluoroalumino silicate glass particles. Once in contact 
with water an acid base reaction occurs as the compomer absorbs water, which facilities 
fluoride release (Meyer et al., 1998).  
Polymerization shrinkage is a concern in compomers, however water sorption may 
compensate for the shrinkage. The water sorption doesn’t initiate the glass/acid reaction 
significantly enough, which is a requirement to promote fluoride release (Young, 2004). 
Compomers have been used as a substitute for glass ionomer cements especially in 
paediatric dentistry. A study has shown superior longevity compared to glass ionomers 
in primary teeth (Welbury et al., 2000). However the reduction in mechanical properties, 
especially strength of up to 40% compared to composites as well as increased 




Dental composite consists, as the name implies, of a mixture of two or more materials. 
They generally consist of three different components, the organic resin matrix, the 
inorganic filler and the coupling agent. As we will see later however, more components 
may be added such as antibacterial agents and remineralising agents. The resin forms 
the matrix of the composite and binds to the filler particles through the coupling agent.  
Composite materials are limited by polymerization shrinkage, limited toughness, the 
presence of unreacted monomer and other factors. Eventually these drawbacks reduce 
the restoration’s lifetime. In recent years dental composites have been the centre of 
interest for researchers and dentists with a goal of improving performance.  
The resin is initially a fluid monomer and is then converted into solid through a 
polymerisation reaction. The most common used monomer is produced from bisphenol-
A and glycidylmethacrlylate (Bis-GMA). The other monomers that is common is Urethane 
Dimethacrylate resin (UDMA). Bis-GMA and UDMA are highly viscous fluids because of 
their high molecular weights. To overcome this drawback, low viscosity monomers are 
also available such as triethylene glycol dimethacrylate (TEGDMA). To have a long shelf-
life, inhibitors, for example camphorquinone (CQ), is included to initiate polymerization. 
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Currently methacrylate resin formulations are included in the majority of dental 
composites. These are typically BisGMA and UDMA as well as BisEMA (ethoxylated 
bisphenol-A dimethacrylate). However, while many dimethacrylate derivatives have 
shown some promise, improvements relative to BisGMA/UDMA are generally modest 
(Noort, 2007).The filler has traditionally been Quartz. Fillers reduce polymerization 
shrinkage, reduce the coefficient of thermal expansion, improve mechanical properties, 
provide radiopacity and control colour and translucency. Finally the coupling agent 
ensures that the resin and the filler are bonded together strongly (Noort, 2007). 
A recognised drawback of composites is polymerization shrinkage. As traditional 
composites do not have any intrinsic defence mechanisms against caries, once a gap is 
formed then microleakage will occur. The ideal composite should have as low as possible 
shrinkage so that it can enhance marginal adaptation, reduce chances of bond 
breakdown and inhibit development of recurrent caries. Typical polymerization shrinkage 
values range between 1.5-2.5% for conventional composites and 4-5% for flowable 
composites. To overcome this problem, techniques such as incremental placement or 
using small amounts of flowable composite in the base of boxes have been introduced 
(Noort, 2007). The setting reaction involves light initiated photopolymerisation of the 
monomers to form a highly crosslinked polymer. The polymerisation involves three 
separate phases, initiation, propagation and termination (Cramer et al., 2011). 
 
1.2.5.1 Types of composites 
Dental composites are generally categorized by the particle size of the filler. Traditional 
composites contain glass filler particles with a mean size of 10-20 μm with the largest 
particles reaching 40 μm. These composites had poor aesthetics and finish. Microfilled 
resins were introduced in the late 1970s. The particle size of 0.02 μm meant that these 
composites could be polished to a very smooth surface. However having such small 
particles means that a high resin concentration is required to cover all the surface area 
of the small particles. Hybrid composites overcome this by containing large particles of 
15-20 μm and also a small amount of colloidal silica with a particle size of 0.01-0.05 μm. 
Most recent dental composites are hybrid. Finally hybrid composites with even smaller 
particles (average less than 1 μm) have also been developed and provide excellent 
aesthetics due to the high polishability (Noort, 2007). However it should also be accepted 
that, due to poor mechanical properties, these materials should not be used in areas of 
stress such as large restorations in contact with opposing tooth or to replace cusps 
(Fujishima et al., 1995). 
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1.2.5.2 Physical properties 
Dental composites restorations have always been technique sensitive, require more time 
to place than amalgam and also require acid etching with phosphoric acid and use of a 
dentine bonding agent. The ideal viscosity of a composite should be a balance between 
how well it can be condensed in large cavities but also flow in inaccessible spaces. By 
reducing the filler loading a flowable composite can be produced. A more packable 
composite can be produced for posterior restorations by increasing filler loading. 
However increased filler may lead to inferior surface finish (Noort, 2007). 
Biocompatibility is very important in any dental material. Dental composites release 
products after they set. These may include UV stabilizers, initiators and more. There 
have been reports of changes in oestrogen-sensitive organs and cells, mainly caused by 
Bis-GMA. Also allergic reactions are not uncommon. Resin based materials account for 
12% of reactions to materials according to the national survey of adverse reactions to 
dental materials (Moharamzadeh et al., 2009). 
The coefficient of thermal expansion needs to be close to that of the tooth tissue to 
minimize the possibility of stress developed in the tooth-composite interface when 
temperature changes. 
Finally the aesthetic qualities of dental composite have always been well recognised. 
Marginal discoloration is an issue when debris penetrates in the composite-tooth 
interface. A good marginal seal may overcome this. Composites with large filler particles 
may get surface discoloration due to the increased surface roughness.  
 
1.2.5.3 Mechanical properties 
Compressive strength is easy to measure but difficult to interpret as it is a poor indicator 
of a materials resistance to failure (Noort, 2007). Tensile strength is a more accurate 
predictor of whether a material may fail, however it is a lot more difficult to measure as it 
is almost impossible to eliminate internal flaws or small cracks in the surface. However 
the diametral tensile test is an alternative which gives reproducible results and is 
relatively easy to measure. Hence it is often quoted in measurements of mechanical 
properties (Noort, 2007).  
Finally wear is the process of which material is displaced by the forces generated as two 
surfaces rub together. A high filler loading, smooth surface finish and a strong bond 
between filler and resin are desirable properties on a posterior composite. Again it is 
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difficult to measure wear on a composite and most in vitro methods do not predict in vivo 
results with certainty (Noort, 2007). 
 
1.2.5.4 Failure of composites 
Dental restorations have a limited lifespan. Restorations fail due to fracture or secondary 
caries. Dental composites have an annual rate of failure of 3-8% and up to 70% of dental 
composites fail due to secondary caries or recurrent infection (Kopperud et al., 2012; 
Laske et al., 2016). One of the main reasons of failure is polymerisation shrinkage. As 
stated above dental composites may exhibit 1.5-5% shrinkage after polymerisation 
(Noort, 2007). This shrinkage leads to voids in the tooth tissue - composite interface 
which may lead to bacterial microleakage. Voids can also be created by errors in the 
placement of the composite such as inadequate packing (Nedeljkovic et al., 2015; 
Demarco et al., 2012). Finally natural degradation over time may occur due to breakdown 
of the resin matrix and or the interface between the filler and resin matrix (Drummond, 
2008). 














Property  Amalgam (RM)GIC Compomer Composite  
Strength  Excellent Poor Satisfactory Good 
Aesthetics Poor Satisfactory  Good Excellent  
Longevity  Excellent  Poor  Satisfactory Good  
Anti-bacterial Yes  No  No No  
Remineralisation  No  Yes  Yes No  
Table 1-3: Properties of dental materials 
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1.3 Antibacterials in dental composites 
1.3.1 History 
Dental composites have been used in dentistry for many years to restore decayed teeth. 
They offer excellent aesthetics and strength. Dental composites last for an average  of 7 
years with the main causes of failure being fracture or secondary caries (Zhang et al., 
2014). Secondary caries is caused by the ingress of bacteria into the gaps between the 
composite and tooth. Dental composites are 3.5 times more likely to fail than amalgam 
restorations due to secondary caries (Bernardo et al., 2007). 
Incorporating antibacterial compounds into a dental composite may reduce the risk of 
failure due to secondary caries.  Therefore, composites with antibacterial agents 
incorporated that can kill bacteria in a biofilm are highly desirable. The antibacterial effect 
should preferably be long term and the addition of the agent should not affect the 
mechanical properties (Leung et al., 2005). 
The antibacterial properties of dental materials have been investigated from as early as 
the nineteenth century where it was noted that bacteria such as Staphylococcus aureus 
and Lactobacillus acidophilus were killed when placed in water in contact with copper 
(Shay et al., 1956; Sheppard, 1935). The antibacterial properties of dental materials were 
first measured by Shay et al in 1951 and 1956 (Shay et al., 1956).  
 
1.3.2 Fluoride 
Fluoride works by inhibiting demineralisation and promoting remineralisation of tooth 
structure by forming fluoroapatite crystals. There is also an antibacterial role, however 
that may not be as important as the concentrations required to have an antibacterial 
effect are high (ten Cate & van Loveren, 1999). 
Traditionally conventional glass ionomer cements have incorporated fluoride and are 
very effective at reducing secondary caries formation around restorations. However, 
compared to dental composites they are weaker. To overcome this, hybrid materials 
have been developed such as resin-modified glass ionomer cements and compomers. 
The advantage of GICs and compomers is their ability to release, absorb and re-release 
fluoride (Syafiuddin et al., 1997).  
There are different ways to develop fluoride releasing composites. These include 
addition of inorganic or organic water soluble salts, addition to glass fillers and bonding 
to a resin component (Dionysopoulos et al., 2013). 
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It has also been reported that fluoride releasing filer systems, such as strontium fluoride 
(SrF2) and ytterbium trifluoride (YbF3) have an antibacterial effect (Beyth et al., 2014). 
Fluoride is released by an exchange reaction of water diffusion into the composite and 
fluoride release from the particles. On the downside however most of the fluoride is 
released by the time the setting reaction is complete and the release of fluoride in the 
oral cavity actually creates voids in the matrix (Beyth et al., 2014). 
Antibacterial monomers containing quaternary ammonium fluoride salts are 
biocompatible and antibacterial against S. mutans. Fluoride releasing composite 
containing 3% of the above  can inhibit bacterial growth and at the same time maintain 
mechanical properties similar to the control (Xu et al., 2012).  
Fluoride releasing dimethacrylate monomers together with ternary zirconium fluoride 
chelate were investigated in 2009. The study’s conclusion suggested that a composite 
with sustained fluoride release as well as good mechanical properties is difficult to 
implement, and further work is needed to improve the mechanical and physical 
properties (Ling et al., 2009).  
In summary dental composites with sustained fluoride release achieve considerably less 
percentage release of fluoride when compared with glass ionomer cements (Boeckh et 
al., 2002; Itota et al., 2002). 
 
1.3.3 Chlorhexidine  
Chlorhexidine is a broad spectrum antibacterial agent with low cytotoxicity which has 
been used widely to reduce bacterial load in the oral cavity through means like 
mouthwash and toothpaste (Basrani, 2005). 
The mechanism of action of chlorhexidine is well known. It is effective against Gram-
positive and Gram-negative bacteria. The positively-charged chlorhexidine molecule is 
attracted to the negatively-charged sites of the bacterial cell wall. This changes the 
integrity of the cell membrane and chlorhexidine penetrates into the cell. This causes 
precipitation of the cytoplasm and prevents repair of the cell membrane. This is the 
bacteriostatic effect which is reversible. Greater damage to the cell membrane can be 
caused by increasing the concentration. Leakage of low-molecular-weight components 
falls and this reflects the coagulation and precipitation of the cytoplasm by formation of 




In 1983 Jedryschowski et al studied chlorhexidine added to dental composite and its 
effect on bacteria of the oral cavity like S. mutans and viridans streptococci.  His study 
showed that even the addition of 1% chlorhexidine dihydrochloride would triple the 
antibacterial effect compared to a conventional glass ionomer. Furthermore 
chlorhexidine dihydrochloride can be added to composite without affecting its 
mechanical properties. On the other hand chlorhexidine gluconate reduces its 
mechanical properties (Jedrychowski et al., 1983). 
Experimental dental composites containing chlorhexidine diacetate (CHXA) have also 
been formulated. Chlorhexidine releasing HEMA based composites with added UDMA 
and TEGDMA can achieve polymerization rates suitable for clinical application.  
Chlorhexidine release was shown to prevent bacterial microleakage in vitro (Leung et 
al., 2005). 
However the addition of chlorhexidine to dental composites decreases strength, 
increases water sorption and make the surface more porous. Simply mixing 
chlorhexidine with a dental composite will not meet the requirements for dental 
application (Deligeorgi et al., 2001). 
More recently a new type of dental composite containing mesoporous silica 
nanoparticles (MSN), which enables recharging and sustainable release of antimicrobial 
agents such as CHX have been shown to be useful. The addiction of MSN to a dental 
composite does not affect strength, aesthetics or surface integrity of the material. In a 
study by Zhang et al 5%CHX and MSN addition to dental composite results in similar 
surface roughness and few visible voids on the surface compared to CHX alone which 
had rough surface and deep voids. Furthermore the CXH with MSN composite had a 
greater antibacterial effect than the control composite (Zhang et al., 2014). 
Due to the increasing events of chlorhexidine allergy and even the death of 2 people in 
the UK in 2009 and 2011 from administration of chlorhexidine raises a question as to 




Polylysine (EPL) (Poly-ε-lysine) (ε-PL) is an antibacterial agent which is widely used due 
to its broad antimicrobial spectrum (Shima & Sakai, 1977). There are several types of 
lysine polymers which may differ in chemistry and link position. Lysine’s chemical formula 
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is C6H14N2O2 and it has a molar mass of 146.2g/mol. It is typically produced as a 
homopolypeptide of approximately 25–30 L-lysine residues (Shima & Sakai,1977). 
 
Figure 1-2: Polylysine chemical formula 
Polylysine has been increasingly used as a food preservative due to its potent 
antimicrobial activity and safety. Its activity targets both Gram-negative and Gram-
positive bacteria, yeasts and moulds (Ye et al., 2013). Polylysine is also biodegradable, 
water soluble, edible and non-toxic to humans. It has been approved by the US FDA 
(Food and Drug Administration) as safe at levels of up to 50 mg/kg in food as well as by 
the Ministry of Health in Japan. 
Polylysine is produced for commercial and scientific purposes by Streptomyces albulus. 
It is a secondary metabolite and can be detected when the fermentation broth has an 
acidic pH during the stationary growth phase. Polylysine is an unusual cationic, naturally 
occurring homopolyamide and consists of 25 to 35 L-lysine residues with linkages 
between α-carboxyl groups and ε-amino groups (Yamanaka et al., 2010; Shih et al., 
2006).  
The mechanism against pathogens is not fully clear, however there are a few 
publications which confirm that polylysine has antibacterial properties (Ye et al., 2013; 
Shima et al., 1984). A possible mechanism could be the electrostatic adsorption of 
polylysine to the cell surface and abnormal distribution of the cytoplasm, which may lead 
to cell damage. This was suggested following the investigation of E. coli treated with 
polylysine and examined using electron microscopy. In the same article the author 
concluded that polylysine with more than 10 L-lysine residues have antibacterial abilities 
and 25-30 residues is optimum (Shima et al., 1984).  
Polylysine has been used for many years. It has been given to  rats in doses of 
20000μg/ml with no adverse effects (Hiraki et al., 2003). Polylysine didn’t cause any 
toxicity in reproduction, neurological and immunological functions, growth and 
development of embryos for two generations in rats (K. Neda, T. Sakurai, M. Stakahashi, 
M. Shiychi, 1999). It has a history of safe use in Japan in foods such as sushi and 
noodles. For example it is sprayed or dipped on the fish at levels of 1000-5000 μg/ml 
(Hiraki et al., 2003). It has also been used as an emulsifying agent and a dietary agent. 
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In medicine it has been used as an interferon inducer, drug delivery carrier and gene 
delivery carrier as well as coating materials for biochip and bioelectronics (Shih et al., 
2006) 
Polylysine has already been shown to have good antibacterial properties. In bone 
infections, the minimum inhibitory concentration (MIC) is 12 μg/ml against 
Staphylococcus aureus (NI Qing-Yan, LI Yan, 2008). In a different study which was done 
according to the National Committee for Clinical Laboratory Standards the MIC of EPL 
for S. mutans was 20 μg/ml when the initial S. mutans bacterial density was 5x105 
CFU/ml (Badaoui Najjar et al., 2009). This bacterial cell density is similar to an infected 
oral cavity (Pannu et al., 2013; Deo & Deshmukh, 2015). 
Polylysine is considered to be a stable material under basic and acidic conditions at high 
temperatures. When heated to 100oC or autoclaved to 121oC it was stable (Hiraki, 2000). 
All the above give evidence that polylysine is a safe, stable, non-toxic molecule with good 
antibacterial properties. 
As of June 2017 there is currently one published paper investigating the use of polylysine 
incorporated in a dental composite and multiple doctorate thesis (Panpisut et al., 2016; 
Khan, 2015; Liaqat, 2015). A patent is in effect for the use of polylysine in dental 
composites with the inventor, Prof Anne Young, supervising this thesis. 
 
1.3.5 Quaternary Ammonium Methacrylate and Dimethylaminohexadyl 
Methacrylate 
In 2015 a study from Zhang et al. showed that the incorporation of a protein repellent 
and an antibacterial in a dental composite has a beneficial effect. Their in vitro study 
combined a protein repellent 2-methacryloyloxyethyl phosphorylcholine (MPC) with a 
quaternary ammonium methacrylate with increased alkyl chain length (CL) of the 
ammonium group. Dimethylaminohexadecyl methacrylate (DMAHDM) with CL of 16 was 
used as it had the best antibacterial effects. Their experiment tested 3% MPC and 1.5% 
against a control. These were added to BisGMA (bisphenol A glycidyl dimethacrylate) 
and TEGDMA (triethylene glycol dimethacrylate) (Zhang et al., 2015). 
The in vitro results were promising. There was a small change in the mechanical 
properties, however there was a 1/10 reduction in protein adsorption and three orders of 
magnitude reduction in the S. mutans counts compared to the control composite. 
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In different study an antibacterial, self-healing and remineralizing composite containing 
DMAHDM, as well as nanoparticles of amorphous calcium phosphate (NACP) and 
microcapsules with poly(urea-formaldehyde) (PUF) shells, also contained triethylene 
glycol dimethacrylate (TEGDMA) and N,N-dihydroxyethyl-p-toluidine (DHEPT) as 
healing liquid. The initiator used was benzoyl peroxide. By adding up to 7.5% of self-
healing microcapsules the mechanical properties of the composite were not adversely 
affected and self-healing was achieved with 65-81% recovery in fracture toughness, 
which is enough to recover the capability of a cracked composite. Additionally, this 
composite proved to have a strong antibacterial effect by reducing bacterial numbers in 
an in vitro biofilm by 3-4 logs compared to control. The inoculum used was human saliva 
diluted in glycerol to a concentration of 70% and then further diluted by 1:50. The two 
day biofilm was removed by sonicating and vortexing the discs before viable counts were 
done. The authors suggested that further study is needed to see if the DMAHDM has 
long-term antibacterial effects. Remineralizing effects were not tested in this study, 
although the authors concluded that the addition of NACP and DMAHDM did not affect 
the self-healing properties suggesting that the three components can be added to a 
composite without affecting its mechanical properties (Wu et al., 2015). However what is 
not mentioned is the cytotoxicity of some of the components of the formulations such as 
TEGDMA and DHEPT (Walters et al. (b), 2016; Paschalidis et al., 2014). 
 
1.3.6 Triclosan 
Triclosan (2,4,4-thrichloro-2-hydroxidiphenilethen) is an antibacterial agent which is 
known to be able to inhibit bacterial growth by interrupting the enzymatic activity of 
bacteria, specifically by inhibiting fatty acid synthesis (Kolenbrander, 2000; Wierzbicka 
et al., 1987; Heath et al., 1999). It is widely used in toothpastes, cosmetic products, 
soaps and detergents. 
Triclosan has initially been used as an antibacterial agent in toothpastes, with the most 
common UK toothpaste with triclosan being ‘Colgate Total’. In recent years it has been 
introduced to dental composites. Studies previously done have had mixed results. One 
study showed that 1% triclosan added to a composite had a significant inhibition in 
bacterial growth, but another study showed that 0.3% triclosan had no antibacterial 
effect. It was suggested that as triclosan has limited solubility in water its release was 





Silver has been added to dental composites due its antibacterial effect as well as its 
biocompatibility (Ryu et al., 2012; Kang et al., 2009). Silver inhibits bacterial growth by 
interfering with bacterial enzymatic activities. Silver ions affect DNA molecules and 
interact with thiol groups in protein which induces the inactivation of the bacterial 
proteins.  (Liu et al., 2013; Kawashita et al., 2000). 
In one study 1% silver nanoparticles were added to a flowable composite resin. 
Composites discs with silver particles and a control were incubated in a suspension of 
S. Mutans and Lactobacillus sp. of 1x105 CFU/ml for 12 hours. The suspension was then 
diluted and spread on agar plates. After 12 hours, there were 126 and 3.8 colonies of S. 
mutans and Lactobacillus sp. respectively on the control, and 0.93 and 1.2 on the 
composites with silver particles (Kasraei et al., 2014). In another study, the addition of 
0.1 silver nanoparticles as well as amorphous calcium phosphate to a dental adhesive 
reduced bacterial growth by one order of magnitude after incubation for 2 days in diluted 
human saliva (Melo et al., 2013). A disadvantage of using silver may be the colour 
stability (van der Burgt & Plasschaert, 1985). 
 
Cochrane review 
The Cochrane Collaboration did a review of literature in 2013 regarding antibacterial 
agents in composite restorations. As always only randomized control trials were included 
in the review. Unfortunately, the authors concluded that at the time of writing no 
randomized controlled trials on resin composite containing antibacterial agent compared 
to a control group were available. The review also raised the important point that most 
of the in vitro studies to date report on bacterial load reduction rather than dental caries 







1.4 Calcium Phosphates in Dental Composites 
1.4.1 History 
The term remineralisation has been used before to describe the process by which 
calcium and phosphate ions supplied from an external source promote ion deposition in 
demineralized enamel crystals to result in a net mineral gain (Cochrane et al., 2010). 
Saliva alone has a great well documented remineralisation potential, due to its ability to 
supply calcium and phosphate ions. However, it is usually not enough to work on its own 
so additional extrinsic calcium, phosphate and fluoride ions are required to induce natural 
remineralisation (Larsen & Pearce, 2003).  
Calcium phosphate is the name given to a family of minerals containing Calcium ions 
(Ca2+) and phosphate ions (PO4). Dental enamel consists of 90% hydroxyapatite, a 
calcium phosphate mineral. 
 
Name Abbreviation Formula Ca/P ratio 
Hydroxyapatite HA Ca5(PO4)3(OH) 1.67 
Amorphous calcium phosphate ACP Ca3(PO4)2·nH2O 1.5 
Tricalcium phosphate TCP Ca3(PO4)2 1.5 
Dicalcium phosphate DCP CaHPO4 1 
Monocalcium phosphate  MCPM Ca(H2PO4)2 0.5 
Table 1-4: Summary of calcium phosphates discussed in this thesis 
 
1.4.2 Hydroxyapatite 
Hydroxyapatite (HA) is the second most stable and least soluble calcium phosphate after 
fluoroapatite. Its chemical formula is Ca5(PO4)3(OH). The Ca/P ratio of HA  is 1.67. HA 
has a similar composition to bone minerals, and for that reason it has gained a lot of 
attention as a biomaterial component (Shi, 2004). 
To prepare hydroxyapatite two types of methods are used, either solid state reactions or 
wet methods. The wet method consists of precipitation of calcium phosphates. In order 
to precipitate HA the reactant has to contain salts of calcium and phosphate (El Briak-
BenAbdeslam et al., 2008). For the solid state reaction method materials are mixed to 
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create HA, for example calcium carbonate (CaCO3) and calcium pyrophosphate 
(Ca2P2O7) can be mixed at 1100oC for 1 hour or potassium dihydrogenphosphate 
(KH2PO4) and calcium hydroxide Ca(OH)2 at 50oC for 24 hours and then at 650oC for 1 
hour (Rhee, 2002). 
 
Figure 1-3: Chemical structure of hydroxyapatite 
 
1.4.3 Amorphous Calcium Phosphate 
Amorphous calcium phosphate (ACP) is a glassy precipitate of variable composition with 
a chemical formula of CaxHy(PO4)z· nH2O where n can be between 3 and 4.5 depending 
on the pH during production. The Ca/P ration can range from 0.67 to 1.50 (Habraken et 
al., 2016). 
Unstabilised amorphous calcium phosphate can be produced as a calcium salt and a 
phosphate salt that could be delivered separately intraorally. This then mixes with saliva 
and releases calcium and phosphate ions. This unstable mixture rapidly transforms to a 
more stable crystalline phase, i.e. hydroxyapatite/fluorohydroxyapatite. Commercially 
available products with unstabilised ACP are not yet available (Cochrane et al., 2010). 
Casein, which is a protein derived from milk, can stabilize calcium and phosphate ions. 
This has led to a remineralising technology based on casein phosphopeptide-stabilized 
amorphous calcium phosphate complexes (CPP-ACP). These complexes have become 
commercially available through chewing gums in the USA (Trident Extra Care) and 
dental cream (tooth mousse). Amorphous calcium phosphate (ACP) complexes are 
readily soluble in saliva, and create a diffusion gradient that allows them to be deposited 
in plaque. CPP-ACP in plaque then enters as an intact fluid and diffuses in the lesion. 
Formation of mineral, similar to fluoroapatite or hydroxyapatite will consume phosphate 
and calcium thus maintaining the gradient (Cochrane & Reynolds, 2012). 
The authors of the above review concluded that there is a growing body of scientific 
evidence to support the use of CPP-ACP to help fluoride in inhibiting demineralization 




1.4.4 Tricalcium Phosphate  
Tricalcium phosphate is a calcium salt of phosphoric acid and has the chemical formula 
Ca3(PO4)2. Its Ca/P ration is 3:2. It is derived from inorganic sources such as mineral 
rocks. It is found in two different forms α-TCP and β-TCP. β-TCP may be prepared 
chemically by calcium deficient hydroxyapatite thermal decomposition at temperatures 
above 8000C or by interactions of acidic calcium phosphates in a solid state phase. Also 
the process of calcining bones can form ion substitutes β-TCP (Dorozhkin, 2009). α-TCP 
may be formed by a phase transformation of β-TCP and is stable at temperatures ranging 
between 1125 and 1430oC. The β-TCP phase is stable up to 1125oC (Yin et al., 2003). 
β-TPC has been used as calcium phosphate cement, the development of multivitamins 
and as an ingredient in toothpastes. α-TCP is mostly used in calcium phosphate cements 
(Mirtchi et al., 1990). 
 
Figure 1-4: Chemical structure of tricalcium phosphate 
 
1.4.5 Dicalcium Phosphate 
Dicalcium phosphate exists in two states, dicalcium phosphate dihydrate (DCPD) also 
known as mineral brushite and dicalcium phosphate anhydrous (DCPA), also known as 
mineral monetite (Oliveira et al., 2007). DCPDs chemical formula is CaHPO4·H2O and 
DCPAs formula is CaHPO4. Its Ca/P ratio is 1. 
DCPD is used in medicine in calcium orthophosphate cements and for tooth 
remineralisation (Bermudez et al., 1994). It is also added to toothpaste for caries 
protection when coupled with fluoride and as a polishing agent (Crall & Bjerga, 1987). 
DCPA is less soluble that DCPD due to the absence of water. It is mainly used in calcium 
phosphate cements as well as polishing agent, toothpaste component and a source of 
calcium and phosphate in nutritional supplements (Takagi et al., 1998). 
In dental composites dicalcium phosphate dihydrate (brushite) is not added directly to 
the components, instead it is formed by breakdown of monocalcium phosphate to 
phosphoric acid and dicalcium phosphate in contact with water, usually after the reaction 
with tricalcium phosphate (Mehdawi et al., 2013). As DCPA is less soluble than 
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monocalcium phosphate (MCP) if used in composites it will increase strength but calcium 
phosphate release is drastically reduced (Xu et al., 2007). This is the reason it is not 
used in composites, instead it is a bioproduct of the release of other calcium phosphates. 
 
Figure 1-5: Chemical formula of Dicalcium Phosphate 
 
1.4.6 Monocalcium Phosphate 
Monocalcium phosphate is an inorganic compound commonly found as monohydrate 
(MCPM) or anhydrous salt (MCPA). The chemical formula of MCPM is Ca(H2PO4)2·H2O 
and for MCPA is Ca(H2PO4)2. Its Ca/P ratio is 1:2. 
MCPM is the most acidic and most soluble CaP. Because of its high solubility it is 
possible to generate solutions that can kill eukaryotic cells. It is commonly used in 
medicine as an element in self-hardening calcium phosphate cements (Bermudez et al., 
1994). It can also be used in combination with basic CaP such as TCP or CaO (calcium 
orthophosphate) (Huan & Chang, 2007). MCPM is added to dental composites as it is 
hydrophilic and upon release in solution and contact with water will form brushite and 
phosphoric acid. Brushite will aid remineralisation of tooth tissue and the phosphoric acid 
will act as etchant to enhance bonding of the material to the toot structure. MCPM has 
been used as buffer, hardener, leavening agent, yeast food and as a nutrient.  
MCPM is produced by a reaction called ‘triple superphosphate’ for fertilizer production. 
Here the reaction of concentrated phosphoric acid with powdered phosphate rock 
produces MCPM. If the temperature is raised above 100oC then a molecule of water is 
released and MCPA is produced (Becker, 1989). 
 





1.5.1 Bulk monomers 
1.5.1.1 Bis-GMA 
Bisphenol A Glycidyl Methacrylate (Bis-GMA) is a high viscosity resin that has been part 
of dental composites for a long time. It is an aromatic ester of methacrylate. It is used as 
a bulk monomer on its own or together with a diluent monomer such as Triethylene glycol 
dimethacrylate (TEGDMA). Its formula is C29H36O8 and the molecular weight is 512.59 
(Chemfinder). Its structure includes two aromatic rings with a pendant hydroxyl group 
(OH). It has strong inter-molecular hydrogen bonding which arises from the hydroxyl 
groups and the double aromatic rings. (Asmussen & Peutzfeldt, 1998). The two pendant 
hydroxyl groups give Bis-GMA its hydrophilic nature.  Bis-GMA has a final conversion at 
body temperature of 50-65% (Khatri et al., 2003).  
 
Figure 1-7: Chemical formula of Bis-GMA 
Bis-GMA is the reaction product of bisphenol A (BPA) and Glycidyl Methacrylate. In 
recent years there has been a lot of controversy on Bisphenol-A (BPA) products. These 
have the ability to bind to oestrogen as well as mimic oestradiol, a hormone produced by 
a variety of tissues such as the ovaries and testes. While BPA is not part of any dental 
composite, it can be a residual impurity in composites containing Bis-GMA and it can 
also be released through the action of salivary esterases. However it has been shown 
that exposure to BPA from dental composites is minimal, at least 2000 times below the 
minimum daily accepted limits set by the US Environmental Protection Agency and the 
European Food Safety Authority (American Dental Association Council on Scientific 
Affairs., 2014; Kingman et al., 2012). 
 
1.5.1.2 UDMA 
Urethane dimethacrylate (UDMA) was developed by Foster and Walter in 1974. UDMA 
has a chemical formula of C23H38N2O8 with a molecular weight of 470.563.  UDMA is an 
aliphatic high molecular weight monomer consisting of two amino groups (-NH-). These 
form intermolecular hydrogen bonds which increases its viscosity. However the aliphatic 
molecule gives it greater mobility (Filho et al., 2008). UDMA is a smaller molecule than 
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Bis-GMA and as a result it has a higher double bond concentration (Walters et al.(b), 
2016). Composites containing UDMA instead of Bis-GMA show improve conversion, 
increased biaxial flexural strength and depth of cure, due to the greater flexibility (Nick J 
Walters et al. (b), 2016). UDMA has a significant lower viscosity and hence higher 
mobility than Bis-GMA. For this reason UDMA has can be used with or as an alternative 
to Bis-GMA in many commercial composites. Still its viscosity may be quite high, 
therefore more often than not a diluent monomer may be added, such as polypropylene 
glycol (PPGDMA) or TEGDMA. However, it can be used with a minimum amount of 
diluent monomer. The urethane linkage (-NHCOO-) of UDMA forms hydrogen bonds with 
water molecules and gives it its hydrophilic nature. These bonds are however weaker 
than the hydroxyl groups of Bis-GMA. This may lead to a lower hydrophilic nature than 
Bis-GMA (Palin et al., 2005). 
 UDMA has been extensively used in coatings, adhesives, pultrusion processes and 
dental materials. All the above are a class of materials with two methacrylate end groups, 
and this allows them to be cured thermally via polymerization. One of their drawbacks 
(common with all composites) is polymerization shrinkage which may result in marginal 
gaps and secondary caries (Atai et al., 2007). Dental composites containing UDMA have 
significantly higher monomer conversion and also better cytocompatibility compared to 
composites containing Bis-GMA. The use of UDMA with PPGDMA has no negative effect 
on the shrinkage or depth of cure and also the handling properties are better compared 
to Bis-GMA (Walters et al. (b), 2016).  
 
Figure 1-8: Chemical formula of UDMA 
 
1.5.2 Diluent monomers 
1.5.2.1 TEGDMA 
Triethylene glycol dimethacrylate (TEGDMA) is the most commonly used diluent 
monomer in dentistry. It is an aliphatic hydrophilic monomer characterized by presence 
of ester linkages (C-O-C). It is used together with a bulk monomer such as Bis-GMA at 
a ratio ranging between 20-50%. It has a low molecular weight at 286g/mol and a low 
viscosity of 0.05 Pa∙s.  These can reduce the viscosity of the mixture and hence can 
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increase the conversion.  However the increased conversion may lead to an increase in 
polymerization shrinkage (Floyd & Dickens, 2006; Gonçalves et al., 2009). 
Concerns over TEGDMA cytocompatibility have been raised. TEGDMA has been found 
to be cytotoxic on pulp fibroblasts and dental pulp stem cells. Cytotoxicity can occur 
through apoptosis, oxidative stress or cell cycle delays (Paschalidis et al., 2014; About 
et al., 2002).  
 
Figure 1-9: Chemical formula of TEGMDA 
 
1.5.2.2 PPGDMA 
Polypropylene glycol (PPG) is a polymer of propylene glycol which chemically is a 
polyether. It is used as a diluent monomer in dentistry. PPG dimethacrylate (PPGDMA) 
has a much higher molecular mass than TEGDMA and hence it has greater flexibility 
and lower double bond concentration. As a result it enables improved conversion when 
cured (Walters et al. (b), 2016). Furthermore it has shown reduced toxicity compared to 
TEGDMA (Khan et al., 2014). 
An extensive search of the literature showed that PPGDMA is not a monomer commonly 
used in dental materials. 
 
Figure 1-10: Chemical formula of PPGDMA 
 
1.5.3 Adhesion promoting monomers 
1.5.3.1 4-META 
4-methacryloxyethyl trimellitic anhydride (4-META) is an acidic monomer. It has a 
molecular weight of 304.25 and the molecular formula is C15H12O7. 4-META was 
discovered in 1978 and it marked a new level in bonding as it significantly improved 
adhesion to tooth structure compared to previously used adhesives (Atsuta et al., 1982; 
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Van Landuyt et al., 2007; Chang et al., 2002). It also has demineralizing properties (Van 
Landuyt et al., 2007). 4-META is a crystalline powder. After it has been added to water, 
a rapid hydrolysis reaction will happen and this will form 4-MET. Two carboxylic groups 
are produced and are attached to the aromatic group. These groups release acid and 
hence can cause demineralisation. The acidic and aromatic group counteract each other 
as one is hydrophilic and the other hydrophobic. 4-META still remains partially 
hydrophilic, which increases its wetting properties (Unemori et al., 2003). 
 
Figure 1-11: Chemical formula of 4-META 
 
1.5.3.2 HEMA 
2-Hydroxyl ethyl methacrylate (HEMA) is a monomethacrylate which is commonly used 
in dentistry. It is an aliphatic monomer with a molecular weight of 130.14 and a molecular 
formula of C6H10O3. It is often added to improve the ability of the monomer to be mixed 
in a homogeneous solution (Van Landuyt et al., 2005). It is hydrophilic and hence it 
improves the wetting properties of the monomer as well as increases the penetration 
efficacy into the tooth structure (Nakabayashi et al., 1982; Toledano et al., 2004). The 
presence of hydroxyl groups (OH) allows HEMA to promote high water sorption in 
composites. Its hydrophilic nature allows the polymerised form to easily release 
components such as antibacterial agents in aqueous environments (Mehdawi et al., 
2009). HEMA has also been shown to increase bond strength to tooth structure (Nakaoki 
et al., 2000). 
 
Figure 1-12: Chemical structure of HEMA 
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1.5.4 Initiators and Activators 
1.5.4.1 DMAEMA 
2-(N,N-dimethylamino)ethyl methacrylate (DMAEMA) is a co-initiator. Its chemical 
formula is C11H18N2O2. Along with N,N-dimethyl-p-toluidine (DMTP) they are the most 
commonly used co-initiators. They are used in conjunction with type II photoinitiators 
such as CQ as they have the ability to donate protons to the excited initiator molecules 
and form free radicals. The use of these materials, has declined due to concerns of their 
cytotoxicity. Materials with UDMA and PPGDMA can polymerise without the need of a 
co-initiator (Dunnick et al., 2014; Walters et al. (b), 2016). 
 
Figure 1-13: Chemical sturcture of DMAEMA 
 
1.5.4.2 Camphorquinone 
Camphorquinone (4,7,7- trimethylbicyclo[2.2.1]heptane-2,3-dione)(CQ) is an aliphatic α-
diketone and is used as a photoinitiator. It has a molecular weight of 166.22 and its 
formula is C10H14O2. The chemical formula is seen below. A photoinitiator is added to all 
composites to enable the polymerization reaction through light activation. 
Photopolymerization uses light to dissociate initiator molecules into free radicals. These 
then react with double bonds in the monomers and then crosslinking occurs. It is usually 
used alongside an amine for example DMAEMA, which acts as a reducing agent or as 
an electron and proton donor, and hence makes this an effective photoinitiating system. 
CQ absorbs light in the ultraviolet region at 200-300nm and in the visible region at 
467nm. This is responsible for its yellow colour (Kamoun et al., 2014). Previously UV 
light was used to cure dental composites, however as this provided limited depth of cure, 
it has been replaced with high intensity visible light sources, such as light emitting diodes 
(LED) or halogen light (Bala et al., 2005). Absorption of light by CQ leads to two excited 
states, 1CQ* and 3CQ*. Electron transfer between the two states and an amine forms an 
exciplex. This generates free amine radicals, which initiate polymerization of 
dimethacrylates by hydrogen abstraction (Shi & Nie, 2007). Recent studies in this group 
have shown that amines such as DMAEMA can be cytotoxic, so they are not used 
anymore as CQ can also be used on its own without an amine (Walters et al. (b), 2016). 
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However CQ/amine complex can be more efficient than CQ alone (Taira et al., 1988). 
Benzoyl peroxide (BPO) is an alternative to CQ and used in chemical cured composites. 
Resins containing polymer and BPO and a liquid monomer are mixed releasing 
polymerized polymer chains. When the mixture reaches 60oC, BPO undergoes homolytic 
decomposition of the peroxy bond. This thermolylsis releases radicals which initiate the 
polymerization reaction (Kwon et al., 2012).      
      
Figure 1-14: Chemical formula of CQ 
 
1.6 Summary 
Dental caries is one of the most common diseases affecting humans. Millions of pounds 
are spent yearly in the UK to treat it, while a large proportion of the population still has 
untreated dental caries. 
Having dental caries can have a detrimental effect on a person. It can lead to pain, 
swelling, loss of teeth and difficulty eating and drinking. There is evidence showing that 
invasive dentistry can create anxiety and young 5 year old children who have had 
pain/invasive dental treatment are more likely to be dentally anxious at the age of 10 
(Oosterink et al., 2008; Raadal et al. 2002). This can lead to avoidance of dentists and 
further problems. This avoidance can usually be associated with high caries rate (Arnrup 
et al., 2003). 
In recent years the concept of ‘’Drill and Fill’’ has changed remarkably and dentistry is 
now focused in prevention, early diagnosis of caries and non-invasive treatments. 
Carious teeth are in many cases not fully cleaned from caries before being restored. This 
is mainly due to the evolution of dental materials, primarily GIC’s and RMGIC’s, which 
has allowed for less invasive dentistry. Such materials may be able to arrest the 
development of caries, remineralise dental hard tissue and inhibit the remaining bacteria 
that may have been left in the cavity. The lack of strength has however proved 
problematic. There have been multiple attempts to create composites with antibacterial 
as well as remineralising properties, however there are currently no published clinical 
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trials with any such composites. These have been tested in vitro. Novel dental 
composites containing antibacterial polylysine are currently under development at the 
Eastman Dental Institute and are the focus of this study. It is anticipated that the release 
























2. Chapter Two: Aims and Objectives 
2.1 Hypothesis 
The addition of a small amount of polylysine into a novel composite will increase the 
antibacterial properties of this composite when compared to control. 
2.2 Aims 
The aim is to produce a dental composite that has the potential to inhibit the growth of 
S. mutans. 
2.3 Objectives 
1. Determine the minimum inhibitory and minimum bactericidal concentration of 
polylysine against S. mutans and compare it with chlorhexidine, a known potent 
antibacterial agent. 
2. Assess antibacterial properties of 
a. UDMA / TEGDMA based composite discs with fixed MCPM / TCP and 4 
different concentrations of polylysine (EPL). 
b. Z250, UDMA and UDMA / PPGDMA based composite discs with varying 
concentrations of MCPM and EPL.  
c. Z250, FUJI II, FUJI IX, UDMA / PPGDMA based composites discs with 
varying concentrations of MCPM and EPL tested in air and air enriched 
with 5% CO2 and 1% sucrose. 
d. Z250, FUJI II, UDMA / PPGDMA based composite discs with varying 
concentration MCPM and EPL in different inoculum concentrations. 
3. Visualise bacterial growth on UDMA / PPGDMA based composite discs 
containing MCPM and polylysine and compare it with commercial materials. 
4. Determine how different concentration of polylysine in UDMA / PPGDMA based 
composite discs affect the mass and volume over time. 
5. Determine the amount of polylysine released from UDMA / PPGDMA based 








3. Chapter Three: Materials 
3.1 Components 
Below are tables of all components used to create the novel composite formulations that 
were used in this thesis. 






Aerosil OX-50, Evonik Industries 
AG, Essen, Germany 
153022145 All  
0.7μm glass DMG, Hamburg, Germany DMG 021110 
Batch: 706366 
1 
7.0μm glass DMG, Hamburg, Germany DMG 020684 
Batch: 680326 
1  
0.7μm glass DMG, Hamburg, Germany DMG 021100 
Batch: 746375 
2, 3 and 4 
7.0 μm glass DMG, Hamburg, Germany DMG 020684 
Batch: 711591 
2, 3 and 4 
Polylysine (EpolytmP) Handary, Belgium 0204 1 and 2 
Polylysine (EpolytmP) Handary, Belgium 0201 3 and 4 
MCPM (53μm) Himed, Hitemco medical 
applications, USA 
MCP-B26 All  
TCP (16.9μm) Plasma Biotal Limited, UK P 292 S 1 
CQ DMG, Hamburg, Germany DMG 100134 
Batch: 90339 
All  









Material  Brand  Lot/batch 
number 













470.6 All  









600.0 All  




304.2 All  







 Activator  157.21 1 
Table 3-2: Liquid components 
 
3.2 Novel composite formulations with added polylysine 
Composites pastes were prepared in four different sets of formulations (see tables 5-14). 
The liquid phase was prepared by mixing the components and stirring for twenty-four 
hours at room temperature on a magnetic stirrer hot plate (Jeo Tech) until a clear liquid 
was achieved.  
Powder and liquids were mixed for 45 seconds at 3500rpm using the centrifugal mixer 
(Speedmixer, Hauschild Engineering, Germany) to produce pastes. This method 
minimises air present in the paste and ensures full wetting of all the particles. The glass 
used remained constant in all formulations and was composed of 7.0μm, 0.7μm and 
40nm fillers mixed at a ratio of 6:3:1. There were three different monomers prepared, two 
different calcium phosphates used and all pastes contained polylysine apart from the 
controls. Disc shaped specimens were formed by applying the composite pastes to metal 
circlips with internal diameter 10mm and thickness of 1mm and pressing the between 
two sheets of acetate. This not only prevented oxygen inhibition during polymerization 
but also expelled excess paste, ensuring an even distribution of the same thickness. The 
specimens were then photopolymerized using a blue light emitting diode curing unit with 
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a wavelength of 450-470nm and power of 1100-1300 mW/cm2 (Demi Plus, Kerr Dental). 
The curing duration was 40 seconds on each side of the disc. A circular motion was used 
while curing to ensure fully polymerised disks, as the width of the curing unit beam was 
7mm and the discs 10mm. The curing unit was kept approximately 5mm away from the 
specimen. The disks were then removed from the circlip and any excess on edges 
removed and polished. They were then stored at room temperature away from light until 
the day of the experiment. 
Below a schematic of the steps for preparation of composites discs is shown. 
 











3.2.1 Series 1 - UDMA/TEGDMA composites with MCPM/TCP and varying EPL 
The first series included 4 composites with constant monomer and glass but different 
concentrations of polylysine. These were 0%, 2%, 5% and 10%. The powder to liquid 
ratio (PLR) was 4:1 and the same monomer was used in all composites. 
Below is a table showing the 4 composites that were prepared.  


















A2 49.8 24.9 8.3 2 
A3 48 24 8 5 
A4 45 22.5 7.5 10 











UDMA/TEGDMA 3:1 2 5 0.75 1 
Table 3-4: Table of liquid phase of series 1 
3.2.2 Series 2 - UDMA and UDMA/PPGDMA composites with varying 
MCPM/EPL 
The second series included a combination of different composites. The glass used 
remained constant but was different to the 1st set as the distributor provided us with an 
updated batch. The powder to liquid ratio was 5. 
Below is a table that shows the 5 composites that were prepared as well as the 
commercial composite, Z250. Z250 (3M) is a popular dental composite, the successor 
of Z100, first released in 1992. It consists of 2 monomers, a blend of UDMA and Bis-
EMA. Both monomers have high molecular weight. The filler has a particle size of 0.01μm 








Composite  Monomer Glass 7μm, 0.7μm,  







Average particle size of 0.6μm 0 0 
B1 
(control) 
UDMA/PPG 60 30 10 0 0 
B2  UDMA/PPG 52.8 26.4 8.8 10 2 
B3 UDMA/PPG 55.8 27.9 9.3 5 2 
B4 UDMA/PPG 54 27 9 5 5 
B5 UDMA 54 27 9 5 5 
Table 3-5: Powder phase of series 2 
Monomer UDMA:PPG (wt:wt) 4META (wt%) CQ (wt%) 
UDMA/PPG 3:1 3 1 
Table 3-6: Liquid phase of series 2 
 
3.2.3 Series 3 - UDMA/PPGDMA composites with varying MCPM/EPL and PLR  
In the third series there were no new components introduced. Instead the powder to 
liquid ratios was changed to assess if it would have any effect in the antibacterial 
properties. Two formulations from the 2nd set of composites were used, B2 and B4 with 
the only difference that the PLR was changed to three. The polylysine was changed to 
an updated batch which was the same brand and chemical formula as with the 2nd batch 
of composites (Epolytm P) (Handary, Belgium).   
Two more commercial materials were also used, GC FUJI II LC and GC FUJI IX (GC 
America). FUJI IX is a glass ionomer restorative cement which has the ability to release 
fluoride and sets through an acid / base reaction as described previously. FUJI II LC is 
a resin modified glass ionomer restorative cement which again releases fluoride and sets 
initially by HEMA free radical polymerisation through light activation. This is followed by 
a water catalysed acid / glass reaction. They both have a PLR of about 3:1 making them 
quite flowable. They release fluoride as described in chapter 1.2.2. The commercial 
composite Z250 was also used. 
Below is the table that shows the 5 composites that were prepared. Two formulations 
were prepared in PLR 5 and 3, whilst the control was PLR 5 only. 
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10 2 3 







5 5 3 
C5  5 5 5 
Table 3-7: Powder phase of series 3 
Monomer UDMA:PPG (wt:wt) 4META (wt%) CQ (wt%) 
UDMA/PPG 3:1 3 1 
Table 3-8: Liquid phase of series 3 
3.2.4 Series 4 - UDMA/PPGDMA composites with varying MCPM/EPL 
In the fourth series all the components remained constant apart from calcium phosphate 
and polylysine. This batch had a constant monomer which included UDMA and PPG for 
all formulations including the control. The powder to monomer ratio was 5:1, same as on 
the previous sets of composites. 
Below is a table that shows the seven composites that were prepared. For the 
microscopy, mass/volume change and polylysine release these were named differently 
for clarity. 
Composite  Also 
named 







D1 (control) 0M 0P UDMA/PPG 60 30 10 0 0 
D2 10M 0P UDMA/PPG 54 27 9 10 0 
D3 10M 0.5P UDMA/PPG 53.7 26.9 8.9 10 0.5 
D4 10M 1P UDMA/PPG 53.4 26.7 8.9 10 1 
D5 10M 2P UDMA/PPG 52.8 26.4 8.8 10 2 
D6 5M 5P UDMA/PPG 54 27 9 5 5 
D7* 0M 2P UDMA/PPG 58.8 29.4 9.8 0 2 
Table 3-9: Powder phase of series 4 (* D7 only used in polylysine release) 
Monomer UDMA:PPG (wt:wt) 4META (wt%) CQ (wt%) 
UDMA/PPG 3:1 3 1 
Table 3-10: Liquid phase of series 4 
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3.3 Confocal microscopy 
Composite formulations from series 4 were used for this experiment. The formulations 
used were D1-D6 and they were named according to their MCPM and EPL 
concentrations. 
 
3.4 Scanning Electron Microscopy 
Composite formulations from series 4 were used for this experiment. The formulations 
used were D1, D2, D4, D5 and D6 and they were named according to their MCPM and 
EPL concentrations. 
 
3.5 Mass and Volume  
Composite formulations from series 4 were used for this experiment. The formulations 
used were D3-D6 and they were named according to their MCPM and EPL 
concentrations. 
 
3.6 Polylysine release 
Composite formulations from series 4 were used for this experiment. The formulations 














4. Chapter Four: Methods 
4.1 Minimum Inhibitory Concentration and Minimum Bactericidal 
Concentrations  
The aim was to establish the minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) of polylysine for S. mutans (Objective 1). In these 
experiments, chlorhexidine was tested as a control since it has been tested extensively 
in composites before. 
Although there is no Clinical Laboratory Standards method for determining MIC/MBC for 
S. mutans, we used bacterial densities from 5x105-8 CFU/ml as these are common 
concentrations used in antibiotic susceptibility testing. 
MIC and MBC determination 
Polylysine (EPL) (EpolytmP Handary, Belgium, Batch:0201) and Chlorhexidine diacetate 
salt hydrate (CHX) (Sigma-Aldrich, UK batch: 083K0014V) were prepared to 1wt% 
(10000μg/ml) concentrations by adding 0.1 g of each to 10 ml of distilled water (DW). 
S. mutans UA159 (domestic strain) was stored at -80C in brain heart infusion broth 
(BHI) (CM1135 brain heart infusion, Oxoid and CM1136 brain heart infusion agar, Oxoid) 
containing 10% (v/v) glycerol. It was cultured in an atmosphere of air enriched with 5% 
CO2 on BHI agar or in BHI broth. To prepare the inoculum for determination of polylysine 
MICs and MBCs, a single colony was removed from a 72 h BHI agar culture and 
inoculated to BHI broth which was incubated in air enriched with 5% CO2 at 37C for 16 
hours. It was assumed that a single colony is derived from a single bacterium. The culture 
was diluted 1 in 3 with BHI and then the Optical Density (OD600) measured to 
approximately 0.40-0.50 using a spectrophotometer (Biochrom WPA CO8000). This 
culture has a density of approximately 5x108 CFU/ml. The culture was then diluted 
accordingly depending on the density of inoculum required. To determine accurately the 
inoculum density, a ten fold dilution series was prepared and plated on agar. The number 
of colonies that grew following three days of incubation in air enriched with 5% CO2 were 
counted and used to calculate the number of viable bacteria in the inoculum after 
consideration of the dilution factor. 
The MIC of EPL and CHX were determined using 96 well tissue culture plates as follows: 
These were prepared to contain 100μl of Brain heart infusion broth (BHI) and the 
antibacterial agent at different concentrations. Two-fold serial dilutions were then done 
from 5000 μg/ml to 100 μg/ml for EPL and from 100 μg/ml to 1μg/ml for CHX. The first 
56 
 
column was used as control. 100μl of the inoculum was then added to all wells for a total 
of 200μl per well. The well plate was incubated in air enriched with 5% CO2 for 24 hours. 
In some occasions, different serial dilutions were done to obtain more accurate results. 
After 24 hours, there was growth in the wells where the antibacterial was not enough to 
inhibit the bacteria and wells without growth were clear. The MIC was the lowest 
concentration of antibacterial that resulted in a clear well.  
To set up the MBC a 96- well inoculator was sterilised with 70% ethanol and then dipped 
into the wells once and immediately transferred onto a 12cm agar plate until contact was 
made with the agar and then withdrawn. Any live bacteria will grow to form colonies and 
can be counted by assuming that each single colony arises from a single bacterium. The 
agar plate was incubated in air enriched with 5% CO2 for three days to allow for bacterial 
growth. After 72 hours the results of MBC were obtained. MBC will always be 
higher/equal to MIC.  
 
4.2 Novel composite formulations with added polylysine   
The aim was to find how different components added to the composite formulations 
inhibits the growth of S. mutans or reduces the viable counts (Objectives 2 - a, b, c, d). 
The composite formulations used can be found in the materials section. 
The suspension of S. mutans was prepared to different concentrations with the same 
method as the MIC/MBC experiment. 
Below the method of investigating the antibacterial properties of the novel composites is 
described in detail. 
Sixteen hours before the experiment the BHI broth was inoculated with S. mutans for 
overnight growth. This was then diluted as required for the inoculum concentration 
needed as described before. On the day of each experiment the discs were irradiated 
with ultraviolet light for 30 minutes on each side to ensure bacterial decontamination. 
This was done by first placing the composite discs in a 24-well plate where the 
experiment would be carried out and placing the well plate in a custom-made UV box. 
The well plate was flipped at 30 minutes to ensure full decontamination. 
The composite discs were placed into a 24 well plate as seen in figure 4-1. Then 1ml of 
the inoculum was added to the well plates and the plates are placed on a shaking tray at 
200 rpm in air at 37oC or in air enriched with 5% CO2 non shaken at 37oC. 
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At 6 hours, the viable bacterial counts were calculated by preparing a 10-fold dilution 
series of each suspension and plating 100 μl aliquots on BHI agar plates. A 100 μl 
volume of the undiluted suspension was also plated when the bacteria remaining were 
expected to be very few. In some occasions where complete kill was expected, the whole 
1 ml suspension was centrifuged (Jouan C412, Fischer Scientific) for 15 minutes at 
3000rpm to recover the bacteria which were resuspended in 100 μl of broth and plated 
in agar. The number of colonies that grew following three days of incubation of all the 
agar plates in air enriched with 5% CO2 was counted and along with the dilution factor 
used to calculate the bacterial counts for each composite disc. 
At 24 hours viable counts were repeated in the same way as above. Bacterial colonies 
were visible on the agar plates after 3 days of incubation in 5% CO2. 
The results are based on 3 composite discs per experiment and the experiment was 
repeated on 3 different occasions to further increase confidence. 
 
 






4.2.1 Series 1 - UDMA/TEGDMA composites with MCPM/TCP and varying EPL 
The aim was to determine the minimum concentration of polylysine that will inhibit 
bacterial growth (objective 2a). The first series of composites was tested in air while 
shaken with an inoculum density of 6x104 CFU/ml. 
 
4.2.2 Series 2 - UDMA and UDMA/PPGDMA composites with varying 
MCPM/EPL 
The aim was to see if calcium phosphate and diluent monomer would affect the 
antibacterial properties (objective 2b). Additionally a higher inoculum density was used, 
1x105 CFU/ml. 
4.2.3 Series 3 - UDMA/PPGDMA composites with varying MCPM/EPL and PLR  
The aim was to test the antibacterial properties of composite formulations under different 
conditions, air and air enriched with 5% carbon dioxide, at an inoculum density of 
approximately 6x106 CFU/ml (objective 2c). 
 
4.2.4 Series 4 - UDMA/PPGDMA composites with varying MCPM/EPL 
The aim was to test the antibacterial properties of composite formulations under different 
inoculum concentrations, 8x105 CFU/ml and 8x106 CFU/ml (objective 2d) 
 
4.3 Confocal microscopy 
4.3.1 Technique 
Confocal microscopy is an optical imaging technique, which provides increased optical 
resolution and contrast by adding a spatial pinhole at the confocal plane of the lens to 
eliminate out of focus light. It is able to collect different images of the specimen at 
different depths and thus able to create a three dimensional image. Its difference 
compared to a conventional microscope is that it can ‘see’ images at deeper levels, 




Confocal (Radiance 2100, Biorad) was used in this thesis to visualise alive and dead 
bacteria on the composites discs after 3 day exposure to a suspension of S. mutans 
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(objective 3). In our experiments composite discs, which were previously prepared and 
immersed in a suspension of S. mutans for 96 hours, were stained using the LIVE/DEAD 
Viability kit (Thermofischer Scientific, UK). The LIVE/DEAD kit contains calcein and 
ethidium homodimer-1 (EthD-1) in the presence of DNA. Our aim was to visualise live 
and dead bacteria on the discs. Live cells are identified by the presence of ubiquitous 
intracellular esterase activity, which is determined by the enzymatic conversion of the 
nonfluorescent cell-permeant calcein AM to the intensely fluorescent calcein. Calcein 
produces a uniform green fluorescence in live cells. EthD-1 enters the cells that have 
damaged membranes and undergoes a 40-fold enhancement of fluorescence upon 
binding to nucleic acids, which then produces a bright red fluorescence in dead cells. 
Background fluorescence is very low as the dyes are virtually non-fluorescent before 
coming into contact with the cells. 
After the discs were removed from the suspension of S. mutans they were gently 
immersed in fresh Brain Heart Infusion broth before placed in a clean well plate. The 
LIVE/DEAD assay was prepared by mixing 1μL of each of the two liquids with 1ml 
sterilized deionized water. The solution was kept out of sunlight and was stored at <-
20oC between experiments. Using a pipette 20μl of the assay was placed on the surface 
of the disc. The assay reacts very quickly so the working time is no more than two hours.   
When composite discs from the viable counts experiments were used the conditions 
were slightly different. The discs were incubated in air or air enriched with 5% CO2 for 3 
days. Sucrose was added to the suspension of S. mutans at a concentration of 10mg/ml. 
The initial bacterial density was 5x106 CFU/ml. 
An objective lens of 10x-20x magnification was used to visualize dead or alive colonies 
of S. mutans under the Confocal. These were processed and saved using Lasersharp 
2000 application. The images saved were separate for alive and dead colonies. These 
were then stacked to show both alive and dead colonies together. This was done using 
ImageJ (ImageJ Developers). 
 
4.4 Scanning Electron Microscopy  
4.4.1 Technique  
Scanning Electron Microscopy (SEM) uses a focused beam of electrons targeted on the 
surface of the specimen to generate the images. The electrons in the beam interact with 
the specimen and produce signals which can be used to obtain information on the 
surface topography and composition. A beam of electrons is generated by the electron 
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gun. This travels through an electromagnetic field and hits the sample. A set of 
electromagnetic coils pull the beam back and forth scanning it across the specimen’s 
surface. The electrons which are emitted by atoms excited by the electron beam, known 
as secondary electrons, are gathered and converted into the signal which produces the 
final image on the screen. Whereas conventional microscopes which use light have a 
maximum magnification of about 1000x, the SEM which uses electrons can magnify 
specimens up to 30000x.  
 
4.4.2 Method 
SEM (Phillip XL-30, Eindhoven, The Netherlands) was used in this study for the 
visualisation of bacterial growth on the composite discs after exposure to a suspension 
of S. mutans (objective 3). The same discs that were used for viable counts at 24 hours 
were left in the suspension of S. mutans until 96 hours in air enriched with 5% CO2 to 
allow for a biofilm to form. These were then removed from the suspension and were 
fixed in 3% glutaraldehyde (Agar Scientific, UK) in 0.1M sodium cacodylate buffer for a 
minimum of 24 hours. Before using the SEM the discs were dehydrated in a series of 
different concentrations of ethyl alcohol for 10 minutes each. Following that, the discs 
were immersed in hexamethyldisilazane (TAAB Ltd, UK) for 2 minutes and then coated 
with platinum in a sputter coating machine (Polaron E5000, East Sussex, UK) for 1 
minute and 30 seconds at 20 mA. After that they were mounted on aluminium stubs 
with an adhesive. The discs were then loaded into the SEM and images were taken. 
Different magnifications were used to visualise bacterial growth. Individual bacteria can 
be seen at a magnification of approximately 2500x-5000x. A similar technique to 
prepare and visualise S. mutans has been used before (Asahi et al., 2015). 
 
4.5 Mass and Volume  
Mass and volume change of different composite formulations were evaluated using a 
digital balance with a density kit (AG204, Mettler, Toledo) (objective 4). 
Composite discs were prepared in seven different formulations. The discs were prepared 
in 10mm diameter by 1mm thickness. Three composites discs were used per formulation. 
The discs were immersed in 1ml of deionised water (DW) in a sterile tube. At different 
time points (1, 3, 6, 24, 48, 120, 168, 336, 672 and 1344 hours) the discs were removed 
from the solution, dried in absorbent paper, weighted in air and in the buoyancy medium 
and placed into new tubes. The medium used to measure the body volume was 1% 
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Sodium dodecyl sulphate in DW. The temperature of the medium was recorded at each 
time point as the density of the medium changes at different temperatures. The 
specimens were kept at room temperature in between experiments at 23 degrees 
Celsius. The mass (m), volume change (v) and density (ρ) were determined using the 
equations below and according to the ISO 17304:2013.  
• The mass is measured in grams using the density kit.  






v is the volume in cubic centimeters 
m is the mass in g 
ρ is the density in g/ml 






 ρ = the density of the specimen in g/ml. 
mc1= the mass of the specimen in air and  
mc2 = the mass of the specimen in the buoyancy medium, both measured in grams 
ρ0 = the density of the buoyancy medium at the measuring temperature in g/ml 
 
• Mass and volume change percentage can be calculated at each time point using 
the below equations: 








m0 is the sample mass initially and v0 is the sample volume initially. 
mt is the sample mass at a given time and vt is the sample volume at a given time. 
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Means and standard deviations of the samples were calculated and plotted against the 
square root of time (SQRT). 
 
4.6 Polylysine release 
4.6.1 Technique  
High-performance liquid chromatography (HPLC) is an analytical technique, generally 
used for separation, identification and quantification of different components in a mixture. 
HPLC is commonly used to separate and quantify hydrophilic drugs. In this thesis, HPLC 
was used for the determination of polylysine concentration. HPLC operates by passing 
pressurized liquids containing the sample through columns filled with the adsorbent 
material. The components interact differently and lead to their separation as they flow 
out of the column. Several techniques have been suggested before for the determination 
of polylysine release in solution with the most common one being the use of trypan blue 
(TB) assay (Grotzky et al., 2010). The advantage of HPLC is that it is less sensitive to 
release of additional components and can show differences arising through changes in 
polylysine molecular weight.  
 
4.6.2 Method 
HPLC was used to measure polylysine release from composite discs (objective 5). The 
composite discs were prepared in 10mm diameter x 1mm thickness. Three samples were 
prepared for each different formulation. The samples were initially weighed and then 
immersed in 1ml deionized water (DW). The discs were removed from the DW, weighted 
and placed in the next tube at certain time points. They were evaluated for three weeks. 
The specific time points were 1, 3, 6, 24 hours, 2, 5, 7 days and 3 weeks. 
To prepare the solutions for HPLC, 300μl of the DW were transferred to the HPLC vials. 
These were then inserted in the HPLC.   
A normal phase column in hydrophilic interaction liquid chromatography (HILIC) mode 
was used for the experiment. HILIC mode us a HPLC technique used to analyse polar 
compounds, charged substances, carbohydrates and peptides. This mode employs 
polar stationary phase such as silica and acetonitrile (ACN) is commonly the mobile 
phase (Venkatasami & Sowa, 2010). The benefits of using ACN are its miscibility in 
water, low absorbance at short wavelength (<280nm), high elution strength and low 
pressure applied to the column (Buszewski & Noga, 2012). Analysis of solutions were 
performed using Shimadzu HPLC system (Shimadzu corporation, Kyoto, Japan). The 
63 
 
mobile phase was made of 1l of acetonitrile with 1ml of added 97% phosphoric acid and 
1l of DW with 1ml of added 97% phosphoric acid. The flow rate was set to 1.0 ml/minute 
and each sample had an average run time of 43 minutes. The experiment was run at 
30oC. Spectroscopic detection was used to detect polylysine in the solution through 
ultraviolet (UV) absorption. Absorbance was recorded at 210 nm. Polylysine 
chromatographic peak will be detected between 19 and 27 minutes. The values obtained 
by the HPLC are essentially absorbance of UV light and to measure this the surface area 




Figure 4-2: Example of chromatograph of EPL. The area below the peak at 18-26 minutes was measured. 
Calibration was done by preparing a polylysine stock solution and then diluted to 100, 
80, 60, 40, 20, 10 μg/ml. A calibration curve was made by plotting the Polylysine 
concentration (μg/ml) vs UV response (mV). 
 
 
























After the calibration is completed a value is generated for the gradient which is 0.3233 
AUmin-1ppm-1 and was used to calculate the polylysine present in the solution in μg/ml.  
 
The mass, m, of EPL in the original disc is given by 
𝑚𝐸𝑃𝐿𝑠𝑎𝑚𝑝𝑙𝑒 = 𝑃𝑥𝑚𝑡/(P+1) 
where : 
x = mass fraction of EPL in the powder 
mt = total sample mass 
P = powder/liquid ratio 
To calculate the amount of polylysine in the solution the following formula is used 
mEPLsolution= a0.3233 
where a is absorbance and is recorded in the HPLC and 0.3233 is the constant value of 
gradient. 
 
To calculate the percentage of polylysine released the following formula was used 
% EPL    =  
𝑚𝐸𝑃𝐿𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 𝑥 100
𝑚𝐸𝑃𝐿𝑠𝑎𝑚𝑝𝑙𝑒
          
4.7 Data Analysis 
Data analysis was done using SPSS with the aid of a chartered statistician. 
Data analysis was done for the bacterial viable counts, volumetric analysis and polylysine 
release. The p-value was set at 0.05. SPSS Statistics version 24 for Windows was used 
for statistical analysis.  
Analysis of variance (ANOVA) was used to test the differences between two or more 
means. To perform multiple comparisons of multiple formulations the Bonferroni 
adjustment was used. The Levene test was performed to assess the homogeneity of 





5. Chapter Five: Results 
5.1 Minimum Inhibitory Concentration and Minimum Bactericidal 
Concentrations 
Minimum Inhibitory Concentration (MIC) for polylysine and chlorhexidine were measured 
in 96 well plates (figure 5-1) and Minimum Bactericidal Concentration (MBC) using 12cm 
agar plates (figure 5-2). The objective was to determine the concentrations of polylysine 
and chlorhexidine required to inhibit growth or kill varying concentrations of S. mutans 
incubated in air enriched with 5% CO2 for 24 hours (objective 1). Figures 18 and 19 show 
examples of MIC/MBC determination experiments. 
 
Figure 5-1: Example of a 96 well plate used to determine MIC of polylysine against S. mutans. This image 
is after incubation in 5% carbon dioxide for 24 hours at 37oC with an initial bacterial count of 6x106 CFU/ml. 
multiple two fold dilutions were made from 1000μg/ml to 1μg/ml. The first column is a control with no bacteria. 






Figure 5-2: Example of an agar plate were the MBC experiment was carried out. Bacteria have grown on 
the areas were the metal prongs touched the agar after dipping them in the 96 well plate. In this example, 
the MBC of polylysine is higher than 2000μg/ml and the MBC of chlorhexidine is 8μg/mln. 
The results of the MIC/MBC experiments are presented in the table below (table 5-1). As 
the density of S. mutans increased, an increase in the amount of antibacterial required 
to inhibit/ kill bacteria was seen. There was a significant difference between the two 
antibacterials with chlorhexidine being at least 100 times more effective than polylysine 
(objective 1). 
 Polylysine Chlorhexidine 
Inoculum  
S. mutans 
MIC MBC MIC MBC 
5x108 CFU/ml 2000μg/ml 2500μg/ml 8μg/ml 16μg/ml 
6x106 CFU/ml  1000μg/ml 2000μg/ml 4μg/ml 8pμg/ml 
5x105 CFU/ml 500μg/ml 1000μg/ml 2μg/ml 2μg/ml 
Table 5-1: Results of MIC/MBC. Two fold dilutions were made to obtain these results. 96 well plates were 
kept in air enriched with 5% CO2 at 37oC for 24 hours before MIC results could be obtained. Bacteria were 
transferred to 12cm agar plates, which were kept in air enriched with 5% CO2 at 37oC for 3 days before 
results could be obtained. Note that for Polylysine in 5x108 CFU/ml a different dilution was done to obtain 






5.2 Novel composite formulations with added polylysine 
5.2.1 Series 1 - UDMA/TEGDMA composites with MCPM/TCP and varying EPL 
In the first series of composites all the components remained same apart from the 
Polylysine level in the glass phase which had different concentrations of 0, 2, 5, 10%. 
The objective was to determine the concentration of polylysine that needs to be added 
to UDMA/TEGDMA based composites to allow early killing of bacteria in the suspension 
(objective 2a).  
 
Figure 5-3: Results for Series 1. Bacterial inoculum=6x104 CFU/m of S. mutans. Four different formulations 
with increasing concentration of polylysine were tested at 6 hours and 24 hours. Plate was kept in air at 37oC 
while being shaken. Error bars = st dev n=3, *=0 
As seen in figure 5-3, after 6 hours, bacteria counts increased slightly in the well with no 
specimen from the initial density of 6x104 CFU/ml to 4x105 CFU/ml. With the composite 
discs however, all four formulations caused a decrease in bacterial counts of between 1 
and 2 logs. The level of effect increased with increasing polylysine level. At 24 hours, the 
inoculum and the well containing the disc with 0% polylysine had an increase in bacterial 
numbers of approximately 4 log, whereas the discs with 2% and 5% EPL caused a 
decrease in bacterial numbers of >2 log from the initial level. The well containing a disc 
prepared with 10% polylysine in the glass phase had no detectable bacteria at 24 hours 
(limit of detection was 10 CFU/ml). 
At 6 hours, there was no statistically significant difference in any of the results.  
At 24 hours, the A2, A3, A4 were statistically significant different from A1 (p = 0.00 for all 
samples). A2 also had a statistically significant difference with A4 (p = 0.028). 
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5.2.2 Series 2 - UDMA and UDMA/PPGDMA composites with varying 
MCPM/EPL 
The objective was to assess the antibacterial effect of removing or changing the diluent 
monomer to PPGDMA, and varying MCPM and EPL level in composites with no TCP 
(objective 2b). Additionally, to compare the antibacterial effect of a control composite 
with new monomers with those of a commercial formulation (Z250). These were tested 
in a suspension of S. mutans at an initial density of 1x105 CFU/ml.  
 
Figure 5-4: Results for Series 2. Bacterial inoculum=1x105 CFU/m of S. mutans. Five different formulations 
and a commercial composite were tested at 6 hours and 24 hours. Plate was kept in air at 37oC while being 
shaken. Error bars = st dev n=3, *=0 
As shown in Figure 5-4, the 0% EPL control and Z250 had no antibacterial effect. At 24 
hours there was an increase in viable counts of at least 3 logs which was greater that 
what was seen in the inoculum at this time point. The remaining composite formulations 
showed a reduction in viable counts of at least 3 logs. There was some difference 
between the wells with composite discs with 2% and 5% EPL but it was not statistically 
significant. 
There was no significant change in the antibacterial action upon increasing the MCPM 
concentration in the filler phase from 5% to 10% (B2 and B3). Furthermore, there was 
no significant difference when adding PPGDMA (B4 and B5) to the filler phase. 
At 6 hours B1 and Z250 had statistically significant more bacteria than B2, B3, B4, B5  
(p = 0.002, 0.002, 0.002, 0.000 and 0.011, 0.011, 0.000, 0.000 respectively). 
 At 24 hours B1 and Z250 had statistically significant more bacteria than B2, B3, B4, B5 
(p = 0.000 for all samples). 
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5.2.3 Series 3 - UDMA/PPGDMA composites with varying MCPM/EPL and PLR  
The objective was to assess the antibacterial effect of varying PLR in UDMA / PPGDMA 
based formulations with poylysine as well as to compare with commercial formulations 
(Z250, FUJI II, FUJI IX). Additionally, to assess different environment conditions, in air 
shaken and in air enriched with 5% CO2 not shaken but with 10 mg/ml sucrose added, 
and their effect on the antibacterial properties of composite discs with polylysine 
(objective 2c). The viable counts were only done at 24 hours and not at 6 hours. Figure 
5-5 shows the results in air at 37oC. 
 
 
Figure 5-5: Results for Series 3. Bacterial inoculum=5x106 CFU/m of S. mutans. Five different formulations 
and three commercial materials were tested at 24 hours. Plate was kept in air at 37oC while being shaken. 
Error bars = st dev n=3 
In figure 5-5, the initial bacterial density was 5x106 CFU/ml. After 24 hours, bacterial 
counts increased by 2 logs in the absence of EPL. All four wells containing discs with 2% 
and 5% EPL showed a reduction in bacterial numbers of 7 logs after 24 hours compared 
to the control without EPL. The control without MPCM remained similar to the inoculum. 
The three commercial materials showed a 2 log increase in bacterial counts after 24 
hours. The biggest increase was seen on Z250 and the smallest on FUJI II LC. 
All the composite discs with polylysine had statistically significant less bacterial counts 
when compared with the commercial materials and the composite without polylysine (p 





Figure 5-6: Results for Series 3. Bacterial inoculum=7x106 CFU/m of S. mutans. Five different formulations 
and two commercial materials were tested at 24 hours. Plate was kept in 5% CO2 at 37oC not shaken. Error 
bars = st dev n=3 
In figure 5-6 the initial bacterial density was 7x106 CFU/ml and the experiment was done 
in air enriched with 5% CO2 and added 10 mg/ml sucrose. At 24 hours, wells with the 
inoculum, the discs containing polylysine, the disc with no EPL and the commercial 
materials had increased bacterial counts of between 1 and 2 logs. The 2 wells with 
composite discs containing 5% polylysine (C4, C5) had a bacteriostatic effect as the 
increase in bacterial counts compared to the inoculum (day 0) was less than 1 log10. 
C4 and C5 had statistically significant less bacterial counts when compared with the 









5.2.4 Series 4 – UDMA/PPGDMA composites varying MCPM/EPL 
The objective was to determine whether a lower concentration of polylysine added to 
composite discs would still inhibit bacterial growth. Additionally, to assess what effect 
different inoculum densities have in the antibacterial properties of composite discs with 
polylysine. The experiment was done in air using different bacterial cell densities, 8x105 
CFU/ml and 8x106 CFU/ml (objective 2d). 
 
Figure 5-7: Results for Series 4. Bacterial inoculum=8x105 CFU/m of S. mutans. Six different formulations 
and a commercial composite were tested at 24 hours. Plate was kept in air at 37oC while being shaken. 
Error bars = st dev n=3 
In figure 5-7, after 24 hours, both the well with the inoculum and the well containing a 
disc with no EPL showed an increase by 3 logs as seen in the previous experiments. 
The addition of MCPM 10% to the control did not have any effect on the antibacterial 
properties and the bacterial numbers increased by 3 logs, similar to the disc with no EPL 
and no MCPM. Composite discs with 0.5% EPL were ineffective as the bacterial numbers 
also increased by 3 logs. When 1% polylysine was added to composite discs there was 
a bacteriostatic effect and an increase of 1 log was seen compared to the inoculum (day 
0). As in previous experiments wells with composite discs with 2% and 5% polylysine 
showed a significant reduction in bacterial counts of 6 to 7 logs compared with the 
inoculum at 24 hours. 
D5 and D6 had statistically significant less bacteria when compared with the remaining 
composites (p = 0.000 for all samples). D4 had no statistically significant difference to 
D2 or D1 but the p-value was low (p = 0.104 and 0.059 respectively). D5 and D6 did not 




Figure 5-8: Results for Series 4. Bacterial inoculum=8x106 CFU/m of S. mutans. Six different formulations 
and two commercial materials were tested at 24 hours. Plate was kept in air at 37oC while being shaken. 
Error bars = st dev n=3 
In figure 5-8, at 24 hours, the well with the inoculum, composite discs with no EPL, 0.5% 
and 1% EPL and the two commercial materials showed an increase of 2 logs. The 
composite disc with 2% EPL showed an increase of less than 1 log and had some 
bacteriostatic activity. The composite disc with 5% EPL showed a decrease in bacterial 
counts of 5 logs after 24 hours. 
D5 and D6 had statistically significant less bacteria when compared to the remaining 
composites (p = 0.000). Additionally D5 had statistically significant more bacteria when 










5.3 Confocal microscopy and Scanning Electron Microscopy 
For this experiment, a selection of formulations from series 4 was studied. The discs 
were visualised after being left in a suspension of 5x106 CFU/ml S. mutans for three days 
in air or in air enriched with 5% CO2 with 10 mg/ml sucrose. 
The control and 4 different formulations were used. All had PLR 5 and all had the same 
monomer and glass. The EPL concentration changed from 0%, 0.5%, 1%, 2% and 5%. 
All formulations apart from the control and D6 had 10% MCPM. These correspond to D1, 
D2, D3, D4, D5 and D6 formulations. 
In the images of the confocal studies, live and dead bacterial colonies can be visualised. 
The objective for the SEM was to assess presence of bacteria on discs and formation of 
a biofilm under different conditions (objective 3). The red stains on the confocal images 
show dead bacterial cells and the green alive. As the concentration of polylysine in the 
composite discs increases, an increase in the proportion of dead bacteria is apparent. 




Figure 5-9:From top left to bottom right formulations D1, D2, D3, D4, D5 (M=MCPM% P=EPL%). Inoculum: 
S.mutans 5x106 CFU/ml. Discs in suspension for three days in air before staining. Stained with Live/Dead 
staining. Repeats=2 
0M 0P (D1) 10M 0P (D2) 10M 0.5P (D3) 
10M 1P (D4) 10M 2P (D5) 
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In the SEM images below S. mutans is seen on the composite discs, however it appears 
as mostly individual bacteria which are not adhering to each other. The difference in 
concentration of polylysine in the different discs did not seem to affect the number of 
bacteria on the discs, however it was not clear whether these bacteria are dead or alive. 
Figures 5-10 to 5-12 show discs after incubation in a suspension of S. mutans in air for 
3 days. 
 
Figure 5-10: D2 (10% MCPM, 0% polylysine) formulation. Inoculum: S. mutans 5x106 CFU/ml. Discs in 
suspension for three days in air at 37oC. 
 
Figure 5-11: D4 formulation (10% MCPM 1% polylysine). Inoculum: S. mutans 5x106 CFU/ml. Discs in 




Figure 5-12: D5 (10% MCPM 2% polylysine) formulation. Inoculum: S. mutans 5x106 CFU/ml. Discs in 


















Figure 5-13 shows images of confocal after discs were incubated for 3 days in 5% CO2 
and 10mg/ml sucrose. The proportion of dead bacteria increased as the concentration 
of EPL increases but some live bacteria are still present even at 5% EPL. The control 
discs as well as the two commercial materials allow adhesion of bacterial colonies and 
formation of what appears to be a biofilm on the discs. Especially in the commercial 




Figures 5-14 to 5-18 show discs after suspension in S. mutans in air enriched with CO2 
and 10 mg/ml sucrose (objective 6). In the images below S. mutans was present on all 
discs. A very similar appearance was seen on all discs at 500x and 2000x magnification. 
The bacteria were adhering to each other and were forming what appeared to be a three-
dimensional biofilm. An increase in the concentration of polylysine did not seem to affect 
bacterial adherence and proliferation on the discs. The commercial materials showed 
similar bacterial growth with the novel formulations.  
 
 
Figure 5-13: From top left to bottom right formulations D1, D5, D6 (M=MCPM% P=EPL%). Fuji II, Z250. 
Inoculum: S. mutans 5x106 CFU/ml. Discs in suspension for three days in 5% CO2 and 10mg/ml sucrose 
before staining. Stained with Live/Dead staining. Repeats=2 
FII 





Figure 5-14: D1 (0% MCPM, 0% polylysine) formulation after three days in suspension of S. mutans 5x106 
CFU/ml in CO2 and 10 mg/ml sucrose at 37oC. Magnification of 500x on left and 2000x on right. 
 
Figure 5-15: D5 (10% MCPM, 2% polylysine) formulation after three days in suspension of S. mutans 5x106 
CFU/ml in CO2 and 10 mg/ml sucrose at 37oC. Magnification of 500x on left and 2000x on right. 
 
Figure 5-16 D6 (5% MCPM, 5% polylysine) formulation after three days in suspension of S. mutans 5x106 




Figure 5-17: Fuji II after three days in suspension of S. mutans 5x106 CFU/ml in CO2 and 10 mg/ml sucrose 
at 37oC. Magnification of 500x on left and 2000x on right. 
 
Figure 5-18: Z250 after three days in suspension of S. mutans 5x106 CFU/ml in CO2 and 10mg/ml sucrose 












5.4 Mass and Volume  
Mass and volume change over 8 weeks versus the square root of time as well as total 
mass and volume change are shown on graphs 5-19 to 5-23 (objective 4). The 
specimens were kept in deionised water at 23 degrees Celsius. Three samples were 
used for each formulation. In all the calculations, the 0 hour intercept has been adjusted 
by using the first three readings and extrapolating to zero.  
Figure 5-19 showed that as the amount of polylysine increased in the formulations, the 
mass change over time also increased. The formulations have 0.5, 1, 2, 5% polylysine 
and the mass change seemed to directly correlate with the polylysine concentration. 
 
 
Figure 5-19: Graph of percentage change in mass of four formulations after 2 months after adjusting for the 
zero intercept by using the first three readings and extrapolating to 0. The formulations have all components 
constant apart from EPL and MCPM (M=MCPM%, E=EPL%), error bars – st. dev. n=3 
10M 0.5P (D3) and 10M 1P (D4) had statistically significant less change when compared 
with 5M 5P (D6) (p = 0.000 and 0.001 respectively). 10M 2P (D5) did not have 
significantly more change in mass when compared to 10M 0.5P, but the p value was 
close to 0.05 (p = 0.052). 10M 2P has significantly less change in mass compared to 5M 














































Figure 5-20 showed a linear increase in mass versus the square root of time for all 
formulations. At 2 months, final mass change was greatest for the composite with 5% 
polylysine at 3.1%, while the composite disc with 0.5% polylysine had the smallest 
increase at 0.7%.  Table 5-2 shows the gradients and R2 for figure 37. An increase in the 
gradient is seen as the polylysine concentration in the composite discs increases. 
 
 
Figure 5-20: Plot of the percentage change in mass versus the SQRT of time of four after adjusting for the 
zero intercept by using the first three readings and extrapolating to 0. The formulations have all components 
constant apart from EPL and MCPM (M=MCPM%, E=EPL%), error bars - st. dev n=3 
 
Formulations Gradient %hr-0.5 R2 
10M 0.5P y = 0.0245x 0.7023 
10M 1P y = 0.0353x 0.5971 
10M 2P y = 0.0391x 0.8054 
5M 5P y = 0.0809x 0.9526 
































Figure 5-21: Mass change increases linearly with the concentration of polylysine. 
Figure 5-21 shows the relationship between percentage mass change at 2 months and 







































As seen in figure 5-22 the volume was not affected as much by the different components 
with all four formulations seeing an increase of between 2.0% and 2.5% with the 5% 
polylysine disc having the smallest change at 2.1% and the 1% polylysine discs the 
largest change at 2.5% increase. None of the results have any statistically significant 
differences. 
Figure 5-23 illustrates the initial burst change in volume before it reaches a more linear 
increase at approximately 10 SQRT. As seen below the volume change for all four 
formulations is very similar. 
 
Figure 5-22: Graph of percentage change in volume of four formulations after 2 months after adjusting for 
the zero intercept by using the first three readings and extrapolating to 0. The formulations have all 
components constant apart from EPL and MCPM (M=MCPM%, E=EPL%), error bars – st. dev. n=3 
 
Figure 5-23: Plot of the percentage change in volume versus the SQRT of time of four formulations. after 
adjusting for the zero intercept by using the first three readings and extrapolating to 0. The formulations have 















































































5.5 Polylysine release  
A total of seven different formulations were used, same as the mass and volume 
experiment with the addition of D7 (0M 2P). Polylysine release was recorded at intervals 
for three weeks (objective 5). Three different comparisons were made. The first 
comparison included the four formulations with increasing polylysine content of 0.5, 1, 2, 
5% (10M 0.5P, 10M 1P, 10M 2P, 5M 5P) with the remaining components being constant 
apart from the 5% polylysine which had 5% MCPM instead of 10%. The second 
comparison looked at whether adding MCPM to the formulations influences the release 
of polylysine. Three formulations were used, all with 2% polylysine and with 0, 5, 10% of 
MCPM (0M 2P, 5M 2P, 10M 2P). Finally, polylysine release in parts per million was 
calculated for formulations with increasing polylysine content of 0.5, 1, 2, 5% after 6, 24 
hours and after 3 weeks. 
 
 
Figure 5-24: Cumulative percentage release of Polylysine over 3 weeks at 23 degrees Celsius. The 
formulations have all components constant apart from EPL and MCPM (M=MCPM%, E=EPL%), error bars 
- st. dev n=3 
In figure 5-24 graph the cumulative release of polylysine can be seen for four 
formulations with increasing polylysine concentration. The overall percentage release is 
between 3.5 and 5.2% in these formulations after 3 weeks. There is a statistically 







































Figure 5-25: Plot of the percentage release of polylysine over the SQRT of time (3 weeks) of four 
formulations. The formulations have all components constant apart from EPL and MCPM (M=MCPM%, 
E=EPL%). error bars - st. dev n=3 
 
In figure 5-25 the percentage release over time can be seen for the same formulations 
as above. There is a burst release in the first 24 hours where between 0.8% and 2.4% 
has already been released. Following that there is far less release over time until three 
weeks. The gradient and R2 for polylysine release are presented in table 5-3. 
Formulations Gradient 7 days  R2 
10M 0.5P y = 0.0024x 0.9513 
10M 1P y = 0.0021x 0.8593 
10M 2P y = 0.0032x 0.4585 
5M 5P y = 0.0041x 0.9819 






































Figure 5-26: Cumulative release of Polylysine after 3 weeks in milligrams of 4 different formulations. The 
formulations have all components constant apart from polylysine and MCPM (M=MCPM%, E=EPL%) error 
bars - st. dev n=3 
Figure 5-26 shows the cumulative micrograms released for the same formulations as in 
figure 5-24. Although the percentage release was very similar the actual micrograms 
released were more as the concentration increased due to the initial higher percentage 
of polylysine in the formulations. All compositions were statistically significant different 
when compared with each other apart from 10M 0.5P and 10M 1P (p = 0.00 for all other 
samples when compared with each other) 
 
Figure 5-27: Cumulative percentage release of Polylysine over 3 weeks at 23 degrees Celsius. The three 
formulations have 2% polylysine and keep all components constant apart from MCPM which increases from 
0% to 10%. error bars - st. dev n=3. 
Figure 5-27 shows the increase in percentage release of three formulations with 
increasing amount of MCPM. There is a significant difference when 10% MCPM is added 
in the 10M 2P formulation as the cumulative increase in polylysine release over three 


































































Figure 5-28: Polylysine release after 6, 24 hours and 3 weeks at 23 degrees Celsius. The formulations have 
all components constant apart from EPL and MCPM formulations (M=MCPM%, E=EPL%). error bars - st. 
dev n=3 
 
Figure 5-28 shows the average polylysine release of the four formulations at 6, 24 hours 
and three weeks. The is more release of polylysine as the concentration of polylysine in 
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6. Chapter Six: Discussion 
In this thesis, the antibacterial properties of polylysine added to novel dental composite 
formulations were investigated. Initially the minimum inhibitory/bactericidal concentration 
of polylysine on S. mutans was established. The bulk of this thesis concentrated on the 
antibacterial properties of composite discs with polylysine at different environment 
conditions as well as different inoculum densities. Materials were tested under different 
conditions attempting to mimic the aerobic conditions in the oral cavity (tested in air) as 
well as the anaerobic conditions in the composite-tooth interface (tested in air enriched 
with 5% CO2). Additionally, the same composite formulations were investigated under 
microscopy (Confocal and Scanning Electron) for presence of live and dead bacteria as 
well as the formation of a biofilm under different environment conditions. Finally, 
polylysine release as well as mass and volume change of composite discs in solution 
over time was measured. 
S. mutans is one of the most prevalent cariogenic bacteria in the oral microflora. Its 
association with caries is well evidenced as discussed in chapter 1.1.3 and 1.1.4. In this 
thesis, only one strain (UA159) of S. mutans was used. As discussed in chapter 1.1.4 
dental caries is not caused by one single bacterial organism and is multifactorial, 
however S. mutans is one of the main causative bacteria and is especially involved in 
deep carious lesions. Other studies looking at antibacterial properties of dental 
composites also focus on S. mutans (Kasraei et al., 2014; Wu et al. 2015; Zhang et al., 
2015). Future work should examine more strains including fresh isolates from patients’ 
saliva rather than lab-adapted strains.  Previous research has shown that it is possible 
to isolate S. mutans from saliva. Cariogenic S. mutans is known to be resistant to 
bacitracin, an antibiotic, and this can be used as a technique to isolate the bacterium 
from the oral microflora. It is possible to count S. mutans on culture plates by adding 0.2 
units of bacitracin per ml of agar (McBain et al., 2005; Wu et al., 2015).  
 
6.1 Minimum Inhibitory Concentration and Minimum Bactericidal 
Concentrations 
The first experiment was to determine the MIC and MBC of chlorhexidine and polylysine 
on S. mutans. The reason for doing this experiment was to compare polylysine with 
chlorhexidine, a known potent antibacterial agent. Additionally, to be able to make a 
correlation between the amount required to inhibit growth as well as the amount needed 
to be incorporated in the composite discs to inhibit bacterial growth. In a previous study 
using an initial bacterial cell density of 5 x 105 CFU/ml, the MIC of EPL was reported as 
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20 μg/ml (Badaoui Najjar et al., 2009). In this work, the MIC of EPL at the same inoculum 
density was found to be 500 μg/ml. There were however differences in the techniques 
used as well as the materials that may account for the different results. The strain of S. 
mutans used was 33402 (different to the one used in this thesis), the medium used was 
trypticase soy broth with yeast extract and most importantly it is not stated whether the 
well plate was kept in air enriched with 5% CO2 or just in air. Also, the temperature was 
different at 30oC and the polylysine was from a different distributor. For such low results 
of MIC/MBC it is expected that the well plate was kept in air with no added CO2. As seen 
in results of research (A. Day, unpublished) at EDI UCL, the conditions that S. mutans is 
incubated in can have an impact on its growth. Changing from air while shaken to air 
enriched with 5% CO2 can increase the MIC/MBC by 10 times or more (Day, 
unpublished). As discussed in chapter 1.1.5, S. mutans uses two different pathways for 
adhesion with the sucrose dependent being more efficient as it allows the bacteria to 
adhere to each other. Additionally, being a facultative anaerobe, it can survive in oxygen 
but will grow more efficiently in an environment with reduced oxygen. This is the reason 
this thesis experiments show such a high MIC/MBC as air enriched with 5% CO2 was 
used. 
Chlorhexidine MIC has been previously shown to be about 1 μg/ml for 90% MIC and 
0.5μg/ml for 50% MIC (Jarvinen et al., 1993). In that study 424 clinical isolates of S. 
mutans were used and 50% and 90% stands for the number of isolates inhibited at the 
given concentration. However in the study quoted the inoculum density is not given, 
although the samples were taken from saliva, which does have a density of 
approximately 1 x 104-6 CFU/ml (Deo & Deshmukh, 2015; Pannu et al., 2013). The results 
in this thesis appear to be similar to the above. 
It is known from the literature that chlorhexidine is a very potent antibacterial agent. 
Comparing it with polylysine gave an insight as to how much more potent chlorhexidine 
was and with some early tests it was shown that chlorhexidine could be as much as forty 
times more potent than polylysine. However, the limitations of chlorhexidine have been 
discussed in chapter 1.3.3. Even at the lowest inoculum density tested, 5x105 CFU/ml, 
the MIC of EPL was still high at 500 μg/ml. Further research is needed to establish 
MIC/MBC in air at different inoculum concentrations as well as different environments. 
Investigating more S. mutans isolates, especially wild strains, would provide more 
information on their resistance to antibacterials such as EPL and CHX. When 
microorganisms grow in natural conditions, they become organised into multicellular 
communities that are better protected against the harmful environment. This multicellular 
existence allows the bacteria to differentiate and develop specific properties which will 
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benefit the whole community. Moving into a laboratory the bacteria can grow under more 
favourable conditions, which result into the suppression of some of their protective 
mechanisms. Organism that have been lab grown for a long time may therefore exhibit 
very different behaviour compared to their wild counterparts  (Palková, 2004). 
 
6.2 Novel composite formulations with added polylysine 
Polylysine has been added to dental composites in previous research conducted at the 
UCL Eastman dental institute (Panpisut et al., 2016; Khan, 2015; Walters (a), 2016), but 
reports on the optimum concentration have not been made. An increased amount of EPL 
in the composite will have a negative effect on the mechanical properties of the material, 
so the minimum amount to cause inhibition of bacteria would need to be used.  
The first series of formulations used constant monomer and constant glass with added 
MCPM, TCP and EPL. Composites with EPL inhibited the growth of S. mutans and even 
reduced bacterial numbers as the concentration increased. Overall a comparison 
between formulations with 0% and 2% EPL showed that the difference in bacterial counts 
was 6 logs over 24 hours. Generally, a 3-log reduction (99.9%) can be regarded as 
significant and that is also seen when statistical analysis is done where the p value is 
<0.05. At 6 hours, there was small difference between all the composites, which showed 
that the EPL level is insufficient until after the first few hours. This was further looked at 
when EPL release experiment was done. 
Some of the components of the formulations were changed for the second series of 
composites. TEGDMA was replaced with PPGDMA and HEMA, DMAEMA were 
removed. As discussed in chapter 1.4.6, MCPM is usually combined with another 
calcium phosphate due to its release of phosphoric acid which can be cytotoxic in high 
concentrations. When TCP is added, it allows for the acid released from MCPM to be 
neutralised as TCP is basic. Additionally, as MCPM is hydrophilic there were concerns 
of high release, which would make the composite porous, and hence affect the 
mechanical properties. However, research done at UCL showed that MCPM reacts 
rapidly after initial polymerisation and does not necessarily require TCP (Dakkouri, 
2015). As described above CQ usually required an amine, i.e. DMAEMA, to initiate 
polymerisation of the monomers. However, it has been shown that if monomers with high 
conversion rates are used, then DMAEMA is not required. PPGDMA and UDMA both 
have high conversion rates and as a result DMAEMA is not required. By removing 
DMAEMA, 4META also had to be reduced to allow it to dissolve. Without the amine, up 
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to 3% 4META can be included in the formulations as that is the highest concentration 
that will dissolve (Dakkouri, 2015). 
The formulations from series 2 and later were adjusted due to the above findings. There 
was no significant difference in the antibacterial properties when adding PPGDMA to the 
liquid phase and when adding MCPM to the powder phase. MCPM was expected to have 
minimal effect as its main role is that of remineralising. Increasing the concentration of 
Polylysine from 2% to 5% did not produce any further antibacterial effect. At the inoculum 
density of 104 and 105, the 2% polylysine was enough to cause inhibition of growth of S. 
mutans in air conditions. Finally, Z250, the commercial composite by 3M showed a 
statistically significant increase in viable counts after 24 hours of approximately 4 log10. 
This was similar to the control composite which did not have any Polylysine. 
Z250 was used as a control as it is a very common commercial composite used for 
posterior and anterior restorations. It does not have any antibacterial properties.  As a 
result, when caries is left behind, these materials only rely on the bond with the tooth and 
for that reason the margins of the cavity have to be caries free.  
In the third series of formulations, the inoculum density was further increased to 
approximately 5x106 CFU/ml, 1 log more than in the previous set and formulations with 
PLR 3 were used. The conditions of the experiment were also changed. It was done in 
air at 37oC while being shaken as before and then in an air enriched with 5% CO2 
incubator at 37oC non-shaken. By changing the PLR from 5 to 3 the monomer/powder 
percentage was reduced from 83% to 75%. As a results EPL and MCPM (which were 
both present in the powder phase) would be less in the PLR 3 formulations.  
Reducing the PLR to 3 and increasing the inoculum density but using a 2% EPL 
composite (B2) still produced an antibacterial effect in air conditions, a 7 log10 decrease 
in bacterial counts compared to control at 24 hours. In this series of composites FUJI IX 
and FUJI II were also tested. These glass ionomer cements contain fluoride which, as 
discussed in chapter 1.2.2. and 1.3.2, is known for its antibacterial properties. The 
antibacterial properties of fluoride are not well understood. The two glass ionomer 
cements saw an increase in bacterial counts after 24 hours consistent with the inoculum 
and with the commercial composite (Z250). There did not seem to be any antibacterial 
effect of the glass ionomer cements. Although there may not be any antibacterial activity, 
GIC’s do have remineralisation properties and when placed in a carious cavity they may 
aid in the arrest of caries. 
When the conditions changed and air enriched with 5% CO2 was added the results were 
completely different. At the inoculum density of 7x106 CFU/ml of S. mutans all the 
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formulations showed an increase in viable counts after 24 hours. The control, Z250 as 
well as the C2, C3 (2% EPL) show a 2 log10 increase in viable counts compared to 
inoculum at 0 hours. The 5% EPL formulations C4, C5 did also show an increase but 
less than 1 log, so there likely was some bacterial inhibition present at this level of 
polylysine. When comparing C4, C5 with inoculum at 24 hours there is a statistically 
significant difference in the viable counts. It is clear that the different environment is more 
favourable for the growth of S. mutans and as a result polylysine if far less effective and 
can only inhibit the growth of the bacteria at high concentrations. This can also be 
demonstrated in the MIC/MBC where this thesis experiments were done in air enriched 
with 5% CO2 where the MIC/MBC was high, compared to previous UCL research (Dr A. 
Day) where the MIC/MBC was done in air and the results were much lower as the 
polylysine was far more effective in these favourable conditions. Additionally, when 
looking at Confocal images, the difference in growth of bacteria on the discs can be 
correlated with the viable counts experiment and the different conditions tested.   
In the fourth series of formulations the aim was to use even lower concentrations of 
polylysine as well as re-test whether MCPM had any antibacterial effect. The experiment 
was also done at two different concentrations, in air, to assess how the inoculum density 
affects the antibacterial properties. The inoculums used were 8x105 CFU/ml and 8x106 
CFU/ml. In this series of composites MCPM was added to the control. The 10% MCPM 
did not affect the antibacterial properties and the resultant density after 24 hours was 
similar to the control which did not contain any polylysine or MCPM. It was clear that 
there was a critical density of the inoculum where the polylysine stops being as effective. 
This was seen in this experiment, were the 1% polylysine inhibited growth at 8x105 
CFU/ml but was ineffective at 8x106 CFU/ml inoculum density. Similarly, the 2% 
polylysine reduced bacterial counts at 5x106 CFU/ml (tested in third series of 
formulations) but when the density increased it only inhibited bacterial growth at 8x106 
CFU/ml. In these conditions, if the growth of S. mutans has already been inhibited, 
increasing the concentration further would reduce the viable bacterial counts. This is 
because the inhibitory concentration is always equal or less than the bactericidal 
concentration.  A further increase in polylysine concentration would not have any 
additional effect. It did seem then that through these experiments the 2% polylysine 
always had some antibacterial effect even at higher densities of inoculum and that is the 
critical concentration of polylysine required when tested under air conditions. 
The aim of this experiment was to see if the addition of polylysine to the novel composite 
formulation would affect bacterial growth in a simulated environment where the discs 
were constantly shaken at 200rpm at 37oC in air condition or non-shaken in air enriched 
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with 5% CO2. This may simulate the restoration in the oral cavity where the tooth 
constantly being flushed with saliva/food/toothpaste and the interface below the 
restoration. Shaking also prevents the formation of a biofilm. Biofilm is very important for 
the growth of Streptococcus mutans. When the experiment was done in air enriched with 
5% CO2 conditions and sucrose, S. mutans grew very quickly as the conditions would 
be very optimum for its growth. This was shown with the third series of composites were 
the same formulations with the same inoculum showed very different properties in air 
and in air enriched with 5% CO2. S. mutans is far better at proliferating in the presence 
of CO2 and for that reason composite discs with polylysine were far less effective at 
inhibiting its growth. Additionally, due to the formation of a biofilm it was much more 
difficult for polylysine to penetrate through the biofilm and inhibit growth. However, as the 
composite/dentine interface underneath the restorations has reduced oxygen, there is 
an argument for also testing the composite discs in air enriched with 5% CO2. All the 
commercial materials, Z250, FUJI II LC, FUJI IX, saw an increase in bacterial counts 
after 24 hours. This was all done under the same conditions.  
Handling of materials 
Manual handling of materials for preparation of composite discs showed that 
formulations without diluent monomer (PPGDMA, TEGDMA) and PLR of 5 proved to be 
very difficult to handle. In a clinical scenario, these formulations would not be used. The 
addition of PPGDMA improves the handling and flowability significantly and as a result 
this was similar to commercial materials such as Z250 when the PLR is 5. Formulations 
with a PLR of 3 were quite flowable and as a result they were difficult to handle with 
instruments due to the stickiness. However, when used with a delivery system to place 
directly on the tooth their handling was much improved. Their flowability was similar to 
FUJI II LC. Using a PLR 3 would be more suitable for a cavity which has not been 
excavated and caries has been left behind. This is because the flour of the cavity will be 
uneven and the composite will flow better on it. Only the presence of a diluent monomer 
and the PLR affected the handling properties. Other components such as polylysine and 
MCPM did not have affect the handling of the materials. 
Limitations 
In this thesis, bacterial counts were done from the suspension were the composite discs 
were placed. When the discs were kept in air for 24 hours there was no biofilm formed 
and only planktonic bacteria were present on the disc (as seen in the Confocal/SEM). As 
a result, bacterial counts from the suspension also represented the number of bacteria 
on the composite discs. However, when the discs were placed in CO2 with added sucrose 
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a biofilm was formed. When a biofilm had formed there would be a number of bacteria 
attached to the disc, which were not counted. Attempts to remove a three-day biofilm 
and count the bacteria proved to be unreliable in this research. The discs were gently 
washed and placed in a sterilin tube with 1ml of BHI, then 2 glass beads were added and 
the tube was vortexed for 10 seconds. Bacterial counts done after the above procedure 
were not reliable and the results were inconsistent. As a result this technique was not 
used. In other studies a similar technique, whereby a 2-day biofilm of human saliva on a 
composite disc was harvested by sonication and vertexing was employed, seemed to be 
reproducible (Wu et al., 2015; Zhang et al., 2015). In this study, removing the biofilm 
after 2 days was not attempted. Additionally, staining the discs with Crystal violet (CV) 
stain was attempted, however this didn’t provide reproducible results either. The reason 
was that addition of alcohol to attempt to remove the CV from within the cells was 
unsuccessful, likely due to the dense biofilm that had formed on the discs. 
As discussed before this experiment was only done under certain conditions and only 
with one bacterium, S. mutans. Although the results are conclusive, a more clinical 
scenario would be to test composite discs placed into tooth cavities and then immersion 
in a suspension of saliva. This experiment would represent the oral cavity much closer. 
 
6.3 Confocal microscopy 
The aim of using Confocal was to visualise the bacterial growth on the composite discs. 
It is understood that bacteria do not only exist in a planktonic state, where they float and 
swim in a liquid medium but also can attach to the composite discs and possibly form a 
biofilm. As discussed in chapter 1.1.5 S. mutans requires sucrose to synthesize 
polysaccharides that will form a biofilm matrix and allow it to attach to surfaces as well 
to each other. For that reason, 1% sucrose was added to the suspension of S. mutans 
to not only allow it to replicate faster but also to attach to the discs and form a biofilm. 
Additionally, materials were tested under different conditions attempting to mimic the 
aerobic conditions in the oral cavity as well as the anaerobic conditions in the composite 
tooth interface. Growth under air enriched with 5% CO2 conditions was expected to be 
greater due to S. mutans being a facultative anaerobe. A biofilm was only formed under 
these conditions and only on the control and the commercial materials. What could be 
seen on both experiments was a greater proportion of dead bacteria as the concentration 
of EPL increased. It was also evident that as the environment changed the results for 
the same material under different conditions changed significantly. The control only 
seemed to have planktonic bacteria on the disc under air but when 5% CO2 was 
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introduced there was a biofilm with almost all the disc covered with bacterial colonies. 
The composite discs with 2% EPL reduced bacterial counts under oxygen but when 
under carbon dioxide conditions there was almost a 50% split between live and dead 
bacteria. The result was the same for the composite discs with 5% EPL formulations. 
What was the most interesting observation of this experiment was the vast increase of 
bacteria on the discs on the commercial materials compared to the composite discs 5% 
EPL composite formulation under anaerobic conditions.  
 
6.4 Scanning Electron Microscopy 
Scanning Electron Microscopy was also used to visualise biofilm formation on different 
composite discs incubated in different conditions. The aim was to investigate under what 
conditions a biofilm could be formed on the composite discs and whether there was any 
effect of the added polylysine to the formation of a biofilm. SEM was used on the discs 
following three days incubation in air or in air enriched with 5% CO2 in an inoculum 
density of 5x106 CFU/ml. Only planktonic bacteria were visible when incubated in air, and 
in occasions there were no bacteria visible at all. Under air enriched with 5% CO2, growth 
of what appeared to be a biofilm on the discs had completely covered the composite 
discs. Bacteria adhered to each other and formed a three-dimensional structure 
surrounded by polysaccharides. It appeared that by using Confocal which only ‘sees’ at 
one plane it was not possible to visualise the full depth of the biofilm when that had 
grown. At the same time, having a biofilm formed did not mean that some of the bacteria 
on it were not dead. On the other hand, under air conditions only scattered planktonic 
bacteria were seen on the discs.  
When trying to relate the SEM with the Confocal images it seemed that under air there 
was always going to be a similar number of planktonic bacteria on the discs, but whether 
these were alive or dead depended on the amount of polylysine used. Under air enriched 
with 5% CO2 and 1% sucrose all the discs had what appeared to be a biofilm formed but 
when comparing with the confocal the bacteria were not as dense on the 2% and 5% 
polylysine formulations. This could be explained by the fact that only one plane of 
bacteria was seen with Confocal and this plane is usually the most superficial. At this 





6.5 Mass and Volume change  
Dental restorations are exposed to fluids from the oral cavity continuously. Any dental 
composite will have micro voids after the setting reaction has taken place. When 
immersed in solution (i.e. deionised water) over time the water will be absorbed by the 
voids in the composite and the mass will increase. The volume however will remain the 
same. Water will also be absorbed by the disc and cause swelling which will as a result 
increase the volume and the mass.  The expanded through water sorption polymer 
network results in reduction in mechanical and physical properties (Sideridou et al., 
2007). Water sorption is however required for components to be released (Zhang et al., 
2016). The composite disc will be releasing components, mainly calcium phosphate and 
polylysine leading to a decrease in mass with the volume again remaining unchanged. 
Due to the differences in density of the components the mass and volume change will 
also be proportionately different as water has a density of 1g/cm3 whereas the composite 
disc will have density of approximately 2g/cm3. For that reason, if water replaced 
components release from the composite discs, the volume change of the samples is 
expected to be approximately double of that of the mass change. 
The dissolution of MCPM produces phosphoric acid and dicalcium phosphate. 
Phosphoric acid acts as etchant to enhance bonding and dicalcium phosphate will bind 
with water after it precipitates as lower density brushite. 
As MCPM and EPL are both hydrophilic, an increase in mass in the early stages was 
seen as expected, due to the increase in water sorption. 
This thesis studies indicate that an increase in the content of polylysine will have an 
effect on the mass by increasing it. The increase in mass is relatively proportional with 
the increase in polylysine content, with the larger increase seen when 5% polylysine is 
added to the formulations. This suggests that EPL can improve the precipitation as seen 
in previous research (Panpisut et al., 2016). 
The volume of the composites increases through the water expanding the polymerized 
resin matrix (Mehdawi et al., 2013). As seen already, polylysine will affect mass change, 
however its effect on volume is much less evident.  
These results coincide with previous studies and also are similar with other commercial 
composites indicating that temperature may not affect the mass and volume change 
significantly (Panpisut et al., 2016; Wei et al., 2013). In this experiment, the discs were 




6.6 Polylysine Release 
Polylysine is an antibacterial agent that has not been used in dental composites before. 
It is an excellent alternative to chlorhexidine, which has been the most commonly used 
antibacterial agent in composites. It overcomes the issues of chlorhexidine 
hypersensitivity reactions and antibiotic resistance (Pemberton & Gibson, 2012).  
Polylysine is highly soluble in water and for that reason it can in itself encourage water 
sorption. In this thesis experiments, an increase in polylysine release was seen as the 
concentration of polylysine in the formulations increased. Although the percentage 
release remained similar over the different formulations, (between 3.5% and 5.2%) the 
milligrams released where proportionally higher as the polylysine percentage increased. 
This was expected as the more polylysine the composites had the more the release. 
Previous experiments have shown a much higher release over time from a 2.5% EPL 
formulation, approximately 5.5% after 24 hours and 9% at 3 weeks, these however were 
carried out at a different temperature, hence the diffusion coefficient was different. 
Additionally some of the components of the materials were different, the powder phase 
also had TCP and the liquid phase had TEGDMA instead of PPGDMA (Panpisut et al., 
2016).  
However, the conclusion that increasing the polylysine content will increase its release 
can still be made. This will have beneficial effect on the antibacterial activity of the 
composite formulations. In our experiments, up to 2.4% of polylysine was released in the 
first 24 hours when after 3 weeks this had doubled to 5%. This early high release of 
polylysine may be able to inhibit further growth of bacteria in the composite/tooth surface.  
By comparing the three formulations of 2% polylysine, each with 0%,2% and 10% of 
MCPM, it was evident that MCPM aids the release of polylysine. Up to 66% increase of 
polylysine release was seen when 10% MCPM was added to the formulation compared 
to 0%. 
The release of polylysine in the current study can be explained using the modified 
diffusion equation below  




Where ∆𝐸𝑃𝐿; the change in cumulative EPL in the solution, ∆𝐸𝑃𝐿0; early burst release, 
∆𝐸𝑃𝐿∞; maximum change in the solution, D; EPL diffusion coefficient, t; time, d; sample 
thickness.   
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After 24 hours, the D4 (10M 1P) discs had an average (n=3) of 25.2 μg/ml of polylysine 
released and the D5 (10M 2P), D6 (5M 5P) had much higher release (93 μg/ml and 222 
μg/ml respectively) whereas the D3 (10M 0.5P) had only 8.5μg/ml released. This could 
show a correlation between MIC/MBC in air or in 5% CO2 and the percentage of 
polylysine in discs required to inhibit bacterial growth. This thesis MIC/MBC studies were 
done in 5% CO2 with the MIC at 6x106 CFU/ml being 1000 μg/ml. This explains why in 
viable counts experiment in 5% CO2 there is bacterial growth even with the 5% 
formulations as the μg/ml released are far less than 1000 μg/ml. However in the study 
by Najjar et al the MIC at 5x105 CFU/ml in what we assume to be air was only 20 μg/ml 
(Badaoui Najjar et al., 2009). This could explain why the D4, D5, D6 (10M 1P,10M 2P, 
5M 5P) formulations inhibit growth in air conditions as they release more than 20 μg/ml 
of polylysine, where the D3 formulations (10M 0.5P) which released less than 20 μg/ml 
did not inhibit growth. Even at 6 hours composite discs with 2% and 5% EPL had more 
than 20 μg/ml of polylysine released, which explained the inhibition seen in the series 
one and two formulations which were tested at 6 hours and 24 hours. Further work on 
this field is required.  
The conclusion that increasing the polylysine content will increase its release can be 
made. This will have beneficial effect on the antibacterial activity of the composite 
formulations. Additionally, the early release of polylysine may be able to inhibit further 
growth of bacteria in the composite/tooth surface. 
 
6.7 Clinical Relevance 
In the context of caries management as discussed in chapter 1.1.6, materials with 
antibacterial properties may be able to inhibit the growth of dental caries related bacteria 
that have been left behind in the cavity or not removed at all in techniques such as partial 
caries removal or atraumatic restorative technique. These composites may be able to 
prevent bacterial growth at the tooth-composite interface, at the margins of the 
restoration as well as below the restoration. In combination with its remineralising 
properties, this will allow placement of the novel composites in tooth cavities that have 
not been excavated. Additionally, the PLR of these composites is low, increasing its 
flowability and allowing placement in unprepared cavities. Furthermore, as these 
composites do not require the use of ‘etch and bond’, they can be placed in one step, 
which further simplifies the procedure of restoring a tooth. Specifically, in young patients 
were cooperation is limited as well as in primary teeth the application of these composites 
may be ideal. They may be able to replace materials such as resin modified glass 
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ionomer cements, composites and preformed metal crowns in carefully selected cases. 
The novel composites discussed in this thesis have promising characteristics for 
























7. Chapter Seven: Future work and Conclusion 
Future work 
In this thesis, the antibacterial properties of composite formulations containing polyline 
were investigated in vitro. 
Considering the current experiments, changes could be made to the existing methods. 
MIC/MBC should be investigated under air after 24 hours instead of under air enriched 
with 5% C02 after 24 hours. Different bacteria that cause dental caries may be 
investigated such as Streptococcus sobrinus as well as Lactobacillus spp. Additionally 
wild isolates of S. mutans should be looked at. 
The antibacterial properties of composite formulations with polylysine should be 
investigated for other dental caries related bacteria as well as different S. mutans 
isolates. Additionally, human saliva can be used as an inoculum to assess how effective 
polylysine is on the oral microflora. A technique for acquiring human saliva for these tests 
has been described before (Wu et al., 2015; Zhang et al., 2015).  
For microscopy with SEM and Confocal, other caries related bacteria should be 
investigated. Lower densities of S. mutans should be looked at to determine if there is a 
concentration of polylysine that prevents biofilm formation under air enriched with 5% 
CO2 conditions. 
Additionally, further work is required to make a correlation between MIC/MBC, viable 
bacterial counts and polylysine release from discs at different environments and 
inoculum concentrations. All the above will contribute in the decision on the final 
formulation before production.  
Considering further work on the antibacterial properties of the novel composite 
formulations, they should be placed in extracted teeth with carious cavities and these 
should be immersed in suspensions of human saliva. Following that bacterial counts can 
be done similarly to this thesis methods as well as investigation of the tooth/composite 
interface with microscopy. This would give a closer impression to the oral cavity of how 
the composite formulations perform. Finally, once a final formulation has been decided 





Conclusion   
Traditionally dental caries has been managed with complete caries removal and 
restoration. This is a well evidenced and effective way of dealing with dental caries 
(Ricketts et al., 2013). It is however on many occasions impractical to do this in young 
children due to limited cooperation. For that reason, in recent years the focus of dentistry 
has shifted towards preventions and minimally invasive dentistry. The concept of sealing 
caries is now well evidenced (Tellez et al., 2013). 
The goal for our team of researchers is to create a dental composite that will have all the 
mechanical properties of commercial composites but also be able to bond directly to 
enamel/dentine as well as have antibacterial and remineralising properties. This thesis 
focuses on the antibacterial properties. 
This thesis concentrated on Streptococcus mutans, the main bacterium involved in 
dental caries, and polylysine, an antibacterial agent that was used in the composite 
formulations. Through a series of experiments, it was determined what concentration of 
polylysine inhibits bacterial growth in solution (objective1) and when placed in different 
dental composite formulations (objective 2). The experiments were done in different 
density of the inoculum and in different conditions. Addition of MCPM and PPGDMA did 
not affect the antibacterial properties of the composite formulations. It was concluded 
that the addition of 2% polylysine to the novel composite formulations will inhibit bacterial 
growth in air after 24 hours at all inoculum concentrations used. When tested under air 
enriched with 5% CO2 and 10mg/ml sucrose, only composite discs with 5% polylysine 
were able to have some limited antibacterial activity. This is in agreement from the 
experiment in solution where the Minimum Inhibitory Concentration of polylysine on S. 
mutans was 500 μg/ml at 5x105 CFU/ml in 5% CO2 but when tested in air this can be up 
to 25 times less at 20 μg/ml at the same concentration (Badaoui Najjar et al., 2009). The 
commercial materials, Z250, FUJI II, FUJI IX, did not exhibit any antibacterial properties. 
Composite discs were visualised under Confocal after Live/Dead staining and SEM 
(objective 3). With the Confocal, more dead bacteria were seen on the discs as the 
concentration of polylysine in composite discs increased from 0.5% to 5% EPL. With the 
SEM, a formation of what appeared to be a biofilm on the composite discs was seen 
under air enriched with 5% CO2 conditions with added sucrose in all formulations tested. 
In these conditions, there was no difference in the growth of bacteria on all formulations 
and commercial materials. Under air only planktonic bacteria were visible on the discs. 
101 
 
Mass increase over two months at 23oC seemed to be affected by amount of polylysine 
in the formulation whereas volume was not affected. The higher the concentration of 
polylysine the higher the mass change (objective 4). 
There was significantly higher polylysine release in formulations with higher polylysine 
concentration, from 0.05mg to 0.50mg as the polylysine concentration increased from 
0.5% to 5% after three weeks (objective 5). The addition of MCPM allowed for more 
release of polylysine. There was a 66% increase in polylysine release if 10% MCPM was 
added compared to 0%. When 10% was compared with 5%, then there was 33% higher 
release of polylysine. 
The amount released from all formulations was calculated in parts per million and a 
correlation could be made with the Minimum Inhibitory Concentration and viable counts 
experiments. 
Polylysine is an effective antibacterial agent and its use in dental composites shows 
promising results in the experiments of this thesis. Based on this thesis results a 
concentration of between 2% and 5% of polylysine in the novel composite formulations 
would allow for inhibition of bacterial growth. Other studies have shown that adding these 
concentrations of polylysine to the formulations will not significantly affect chemical and 
mechanical properties (Panpisut et al., 2016; Walters (a), 2016).  
The novel composites discussed in this thesis have promising characteristics for 
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Appendix   
Statistics: Univariate Analysis of Variance 
Novel composite formulations with added polylysine 








A1 A2 1.000 .000 
A3 1.000 .000 
A4 .084 .000 
A2 A3 1.000 .097 
A4 .079 .028 
A3 A4 .522 1.000 
 
 
Figure 5-4 - Series 2 results 
 




B3 B4 1.000 1.000 
B2 1.000 1.000 
B1 .002 .000 
B5 .578 .023 
Z250 .011 .000 
B4 B2 1.000 1.000 
B1 .000 .000 
B5 1.000 .87 
 Z250 .000 .000 
B2 B1 .002 0.000 
B5 .576 .002 
Z250 .011 .000 
B1 B2 .002 0.000 
B5 .000 0.000 
Z250 1.000 1.000 







Figure 5-5 – 
Series 3 Results (inoculum 5x106 CFU/ml) 
 
Composition  Composition  p value 




FUJI II .064 
FUJI IX .358 
inoculum 1.000 
Z250 .002 
C2 C3 1.000 
C4 .269 
C5 .384 
FUJI II .000 
FUJI IX .000 
inoculum .000 
Z250 .000 
C3 C4 1.000 
C5 1.000 
FUJI II .000 
FUJI IX .000 
inoculum .000 
Z250 .000 
C4 C5 1.000 
FUJI II .000 
FUJI IX .000 
inoculum .000 
Z250 .000 
C5 FUJI II .000 
FUJI IX .000 
inoculum .000 
Z250 .000 
FUJI II FUJI IX .000 
inoculum .003 
Z250 .000 
FUJI IX inoculum 1.000 
Z250 1.000 
inoculum Z250 .038 
 
 
Figure 5-6 –  
Series 3 results (inoculum 7x106 CFU/ml) 
 
Composition  Composition  p value 




FUJI II 1.000 
inoculum 1.000 
Z250 1.000 
C2 C3 1.000 
C4 .072 
C5 .044 
FUJI II 1.000 
inoculum 1.000 
Z250 1.000 
C3 C4 .752 
C5 .497 
FUJI II 1.000 
inoculum .337 
Z250 1.000 
C4 C5 1.000 
FUJI II .092 
inoculum .000 
Z250 .005 
C5 FUJI II .057 
inoculum .000 
Z250 .003 
FUJI II inoculum 1.000 
Z250 1.000 











Figure 5-7 – 
Series 4 Results (inoculum 8x105 CFU/ml) 
 
Composition  Composition  p value 






















D4 D5  .000 
D6 .000 
Z250 .416 
D5 D6  1.000 
Z250 .000 









Figure 5-8 - 
Series 4 Results (inoculum 8x107 CFU/ml) 
 
Composition  Composition  p value 






















D5 D6 .000 
inoculum .000 
Z250 .000 
D6 inoculum .000 
Z250 .000 










Mass and Volume  
Figure 5-19 – Mass change 
 
 
Composition  Composition  p value 
10M 0.5P 10M 1P .769 
10M 2P .052 
5M 5P .000 
10M 1P 10M 2P .707 
5M 5P .001 
10M 2P 5M 5P .010 
 
Figure 5-22 – Volume change 
 
Composition  Composition  p value 
10M 0.5P 10M 1P 1.000 
10M 2P 1.000 
5M 5P 1.000 
10M 1P 10M 2P 1.000 
5M 5P 1.000 
















Figure 5-24 – 
Polylysine release percentage 
 
Composition Composition p value 
10M 0.5P 10M 1P .115 
10M 2P .915 
5M 5P 1.000 
10M 1P 10M 2P 1.000 
5M 5P .040 
10M 2P 5M 5P .306 
 
Figure 5-26 - 
Polylysine release milligrams 
 
Composition  Composition p value 
10M 0.5P 10M 1P .744 
10M 2P .000 
5M 5P .000 
10M 1P 10M 2P .001 
5M 5P .000 
10M 2P 5M 5P .000 
 
Figure 5-27 - 
Polylysine release percentage 
 
Composition Composition p value 
10M 2P 5M 5P .473 
0M 2P .016 




















Eastman Dental Institute 
















Background: The Intercollegiate Advisory Committee for Sedation in Dentistry 
(IACSD) released new standards in 2015 for the provision of sedation. It is mandatory 
for records of the audit process and outcomes to be maintained and be available for 
inspection. 
Aim: to evaluate the departments inhalation sedation record keeping.  
Objectives: 
• To establish how effectively the department uses the Inhalation Sedation (IS) 
logbook.  
• To assess the outcomes of IS appointments. 
Standard: 100% of treatments and outcomes recorded in the IS logbook 
Methodology: A retrospective audit was done, with the first cycle in July 2015 and the 
second cycle in February 2016.  Data was collected from the IS logbook and the 
appointment records system. 163 patients were assessed on the first cycle and 148 on 
the second. 
Results:  
• Logbook recording increased from 44% to 74% 
• In both cycles 100% of outcomes was recorded  
• Successful treatments remained similar at 93% and 94% 
• In both cycles 42% of treatments were extractions and 38% restorations  
Recommendations and action plan: The results were presented at departmental 
level. An email reminder was send to all staff. Laminated posters were placed in each 
IS room to remind clinicians to fill in the IS logbook. 
Conclusion: This audit highlighted the need for accurate record keeping. Record 
keeping increased significantly in between cycles but did not achieve the gold 
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The level of dental caries in children has dropped significantly over the last few decades. 
A substantial proportion however still has caries and a lot is left untreated. In the UK in 
2013, a third of 5 years old and almost half of 8 year olds had previous decay in the 
primary dentition. Approximately a third of these children had received treatment (Pitts 
and Chadwick, 2013). In the USA almost 50% of 6 year olds had previous decay 
experience and 60% had received treatment (National Centre for Health Statistics, 
1996). Having dental caries can have a detrimental effect on a person. It can lead to 
pain, swelling, loss of teeth and difficulty eating and drinking. There is evidence showing 
that invasive dentistry can create anxiety and young 5 year old children who have had 
pain/invasive dental treatment are more likely to be dentally anxious at the age of 10 
(Oosterink et al., 2008; Raadal et al., 2002). This can lead to avoidance of dentists and 
further problems. This avoidance is usually be associated with high caries rate (Arnrup 
et al., 2003). 
A large proportion of young children with caries are treated under general anaesthetic 
due to the load of treatment as well as being uncooperative. A general anaesthetic 
should however be avoided where possible due to a rare associated risk of death. 
Additionally, general anaesthetic is a costly procedure and requires specialist staff and 
facilities. The alternative is treatment under local anaesthesia, however this is not always 
accepted by children. Behaviour management as well as dental fear proved to be barriers 
to accepting dental treatment. Approximately 10.5% of children between 4 and 11 years 
old have dental fear and behaviour management problems (Klingberg et al., 1994).  
In 1998 the General Dental Council (GDC), the regulatory body for dentistry in the UK, 
changed the guidelines for the provision of general anaesthesia for dental procedures. 
As a result, in July 2000 a document was published for the Department of Health (DoH) 
called A Conscious Decision. This was chaired by the Chief Medical and Chief Dental 
Officers. Following the release of the above document all general anaesthetic services 
for the provision of dentistry were only allowed to be done in a hospital setting. This 
changed the focus to the use of different methods for the control of pain and anxiety.  
This change resulted in a reduction in the use of general anaesthesia and an increase in 
the use of conscious sedation (Pike, 2000; Smith and Thompson, 2007).  
Since the increase of the use of conscious sedation appropriate standards needed to be 
in place. In 2003 the UK standing Dental Advisory Committee published standards for 
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the use of sedation in dentistry with title Conscious Sedation in the Provision of Dental 
Care. This has been superseded a few times with the latest document published in 2015 
by the Intercollegiate Advisory Committee for Sedation in Dentistry (IACSD) with title 
Standards for Conscious Sedation in the Provision of Dental Care. 
These reports make recommendations for practitioners providing conscious sedation. It 
is important to consider alternative methods of pain and anxiety control, and also it is 
vital that theoretical, practical education and training is of high standard and is 
continuously updated. Additionally auditing the dental team as part of clinical governance 
to ensure high quality of care is required. Finally the team must maintain appropriate 
equipment and drugs and ensure these are well maintained (Pike, 2000; Farnfield, 2003). 
IACSD also recommended the ages at which sedation can be used. The main 
recommendation is a cut off at 12 years of age for the use of intravenous sedation. There 
is no minimum age for the use of inhalation sedation. 
Behaviour management is divided into two categories: pharmacological and non-
pharmacological. Non-pharmacological behaviour management (NPBM) involves 
techniques employed by dentists to reduce anxiety of patients, with the aim of completing 
treatment with the least distress possible. Common NPBM techniques include empathy, 
distraction, positive reinforcement and tell, show, do. These techniques when used 
effectively can shape the behaviour of a child and allow the treatment to be completed. 
However, many children may still find it difficult to tolerate dental treatment. 
Pharmacological behaviour management is subdivided into two categories, general 
anaesthetic and conscious sedation, inhalation or intravenous. Different countries will 
have different definitions for what conscious sedation constitutes. This is because some 
sedation drugs are also used in different doses to induce general anaesthesia. The ideal 
sedative drug should reduce anxiety to the level that the patient allows treatment. It 
should be used safely in primary care and have a wide margin of safety. The drugs used 
in conscious sedation are benzodiazepines, mainly midazolam for intravenous/oral/rectal 
and nitrous oxide for inhalation.  
According the general dental council and the UK department of health, conscious 
sedation is ‘’A technique in which the use of a drug or drugs produces a state of 
depression of the central nervous system enabling treatment to be carried out, but during 
which verbal contact with the patient is maintained throughout the period of sedation. 
The drugs and techniques used to provide conscious sedation for dental treatment 
should carry a margin of safety wide enough to render loss of consciousness unlikely’’. 
In the USA the definition of conscious sedation is very similar but the American academy 
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of Paediatrics also separates sedation to conscious and deep, where in deep sedation 
the patient is not easily aroused.  
All children should be able to expect painless high-quality care. Although behaviour 
management may need to be used in conjunction with conscious sedation, 
pharmacological agents should not substitute effective communication and the 
management abilities of the operator. In 2002 the British society of paediatric dentistry 
released national guidelines for the use of conscious sedation in paediatric dentistry 
(Hosey, 2002). High risk sedative techniques such as polypharmacy are not indicated 
for the primary dental care, certainly in the UK, but also in parts of the world where deep 
sedation is more common. Inhalation sedation remains the preferred technique of 
pharmacological management for anxious paediatric patients. Restraining devices (such 
as the papoose board) and deep sedation techniques (where the patient is sedated more 
than what the definition of the GDC implies) are not acceptable in the UK. In the 2002 
guidelines the indications and contraindications for inhalation sedation (IS) are outlined 
along with the evidence that supports it. Briefly, IS is indicated for children with mild to 
moderate anxiety to allow them to cope with multiple appointments and accept treatment 
but should not be used in isolation from the support given by the dentist. It can be used 
to facilitate extractions, and specifically it is indicated over a general anaesthetic for 
orthodontic premolar extractions. It is a weak analgesic and has minimal effect on the 
cardiovascular and respiratory systems. Contraindications are few and include first 
trimester of pregnancy, common cold, nasal blockage, bleomycin chemotherapy and pre-
cooperative children (Hosey, 2002). 
A Cochrane review in 2012 concluded that there is weak but consistent evidence that 
oral midazolam is effective in reducing anxiety compared to placebo with few minor 
adverse effects. Additionally there is weak evidence that inhalation sedation with nitrous 
oxide is more effective than placebo with no adverse effects (Lourenço-Matharu, Ashley 
and Furness, 2012). There is little evidence to show which age group is inhalation 
sedation most effective and appropriate. When prescribing drugs to children the British 
National Formulary (BNF) divides children in three groups, 1-6 years, 6-12 years and 
over 12 years of age. Based on the above, consideration should be given as to why 
sedation is provided. In pre-co-operative children (under 6) the intention is often to get 
the treatment done and the sedation may be the tipping point which enables the 
treatment to be done. In older children, for example over 12, the intention may be to 
make the treatment more pleasurable and as a result reducing anxiety for further visits. 
Additionally, sedation can aid significantly when more complex treatments are required. 
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The outcome of dental treatment has been shown to have an effect on how acceptable 
it is. Treatments that had positive outcomes have been rated as more acceptable 
compared to the ones with negative outcome (Newton, Naidu and Sturmey, 2003). 
Multiple studies have been previously completed about the acceptability of inhalation 
sedation and success rates range are good ranging from 83% to 100% (Crawford, 1990; 
Shaw et al, 1996; Bryan, 2002).  
Nitrous oxide 
Nitrous oxide is a colourless and odourless gas with a faint, sweet smell. It is an analgesic 
and anxiolytic agent which causes central nervous system depression and euphoria with 
negligible effect on the respiratory system. Nitrous oxide works in two different ways. The 
analgesic effect is introduced by release of endogenous opioid peptides. This is followed 
by activation of opioid receptors, descending Gamma-aminobutyric acid type A (GABAA) 
receptors and noradrenergic pathways that modulate processing at the spinal level 
(Emmanouil and Quock, 2007).  Anxiolysis occurs by the activation of the GABAA 
receptor either directly or indirectly through the benzodiazepine binding site. Nitrous 
oxide is absorbed very quickly, which leads to quick uptake from the lung alveoli. Nitrous 
oxide is quite insoluble, and can pass down a gradient into other tissues and cells in the 
body. It is excreted quickly from the lungs. As nitrous oxide is 34 times more soluble than 
nitrogen in blood, diffusion hypoxia may happen. Children desaturate more rapidly than 
adolescents, and giving 100 percent oxygen to the patient once the nitrous oxide has 
been replaced is crucial (Patel et al., 1994). 
Nitrous oxide is absorbed quickly, allowing for a fast onset and recovery which can be 
as quick as two minutes. It causes negligible impairment of any reflexes, hence the 
cough reflex is protected (Paterson and Tahmassebi, 2003). It is very safe with no 
recorded deaths or cases of serious morbidity when used correctly (Nathan, 1989). 
Studies have concluded that negative outcomes may be linked with use of nitrous oxide 
in a greater than 50 percent concentration and as an anaesthetic during major surgery 
(Schmitt and Baum, 2008). Although uncommon, silent regurgitation and subsequent 
aspiration need to be taken into account with nitrous oxide/oxygen sedation. The problem 
lies as to whether pharyngeal-laryngeal reflexes remain intact. This issue can be avoided 
by ensuring the patient does not go into an unconscious state (Hogue, Ternisky and 
Iranpour, 1971). 
Nitrous oxide has been linked with environmental concerns because of its role in the 
greenhouse effect. It is produced naturally by bacteria in soils and oceans. Humans 
produce it by burning fossil fuels and forests and through the agricultural practices of soil 
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cultivation and nitrogen fertilization. Nitrous oxide is responsible for about five percent of 
the greenhouse effect. Dental and medical practice contribute for less than two percent 
of this (Levering and Welie, 2011). 
Adverse effects  
Nitrous oxide is a safe drug to use to provide anxiolysis to young children. When used 
by trained dentists on patients that have been carefully selected and fall under the criteria 
discussed before, nitrous oxide is an effective and safe drug for providing 
pharmacological behaviour management in children. Adverse effects, acute or chronic, 
are rare (Donaldson and Meechan, 1995). Vomiting and nausea are considered the 
commonest side effects of inhalation sedation, occurring in about 0.5 percent of patients 
(Kupietzky et al., 2008). Fasting is not necessary for children having inhalation sedation. 
However it recommended that only a light meal is consumed in the two hours before the 
appointment (Hosey, 2002).  Diffusion hypoxia can happen following rapid release of 
nitrous oxide from the blood stream into the alveoli, thereby diluting the concentration of 
oxygen. This can cause headaches and disorientation and can easily be avoided by 
administering 100 percent oxygen for 3-5 minutes after nitrous oxide has stopped 
(Paterson and Tahmassebi, 2003). For the dental team, it has been reported in the 
literature that long term exposure can be linked with bone marrow suppression and 
reproductive organ disturbances (Lehmberg et al., 2008). Most of these reports were 
made when nitrous oxide was used as a general anaesthetic and active scavenging was 
not available. It is now recommended to minimise exposure by using effective 
scavenging and ensuring all equipment is maintained properly (AAPD Clinical Affairs 
Committee and AAPD Council on Clinical Affairs, 2009). 
Sedation scoring 
The patients level of consciousness during sedation and treatment can be assessed 
through their response to commands, verbal or physical. During dental procedures, the 
patient must be observed clinically at all times. The observations should include colour, 
respiratory rate and responsiveness. If a patient can speak, this indicates that they are 
breathing (American Society of Anesthesiologists Task Force on Sedation and Analgesia 
by Non-Anesthesiologists, 2002). 
The airway becomes increasingly compromised and the likelihood of respiratory and 
cardiovascular depression increase as the depth of sedation progresses from light to 
deep. It is important that the dentist uses a universally accepted system to evaluate and 
record the level of sedation. Additionally, the accurate recoding of the sedation scoring 
is important from a medicolegal point of view. There are three widely used sedation 
128 
 
scoring systems, the Ramsay sedation scale (RSS), the modified Observers Assessment 
of Alertness/Sedation scale (OAA/S) and the Wilson sedation score, also known as the 
University of Michigan scoring system (UMSS).  The RSS defines the conscious state 
from a level 1, where the patient is anxious, agitated or restless, through to a level 6, 
where the patient is completely unresponsive. The OAA/S is a six-point scale ranging 
from 5 to 0 that involves creating a response to an intense stimulus that begins with 
speaking with a normal voice to prodding and finally to a painful stimulus. Finally, the 
UMSS is a sedation scale that was originally developed for children but has also been 
adopted for use in adult sedation. It assesses level of consciousness objectively over 
five different points. The UMSS is an observational tool that scores the patients 
responsiveness to stimuli. This sedation scoring tool has been previously tested for inter-
rater and test-retest reliability, and its validity in children of 6 months to 12 years is high, 
supporting its use in procedural sedation (Malviya et al., 2002; McDermot et al., 2003). 
Furthermore the UMSS scores of 0-1 have been shown to be sensitive and specific in 
determining whether the patient has returned to baseline level of alertness and how 
ready he is to be discharged after sedation (Malviya et al., 2004). 
Apart from sedation scoring the dentist needs to assess the operating conditions. 
Depending on levels of anxiety, patient cooperation and level of sedation the conditions 
may be good, fair, poor or impossible. The patient may be fully cooperative with optimum 
degree of sedation, there may be minimal interference from the patient due to over/under 
sedation, the operation may be difficult due to over/under sedation and finally, the 
operation may be impossible. Operating conditions indicate whether a treatment has 
been successful, but not whether the sedation has been effective. 
The final part of sedation record keeping is recovery. Recovery from inhalation sedation 
is rapid and only a few minutes of recovery need to be monitored. Recovery can be 
normal, within the timescale expected, rapid or prolonged. As part of record keeping, 
sedation scoring, operating conditions as well as recovery must be recorded and be 
available for inspection. 
Audit guidelines 
Any procedure that involves conscious sedation must be subject to regular audit and 
review. The members of the dental team should take part in this. This should involve the 
analysis of outcomes as well as the recording of procedures. All these documents will be 
part of a record and should be available for inspection. 
Regular auditing of conscious sedation practice is essential and is considered to be a 
core requirement for those undertaking conscious sedation practice for patients (Dental 
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Faculties of the Royal College of Surgeons and the Royal College of Anaesthetists, 
2015). 
Conscious sedation procedures have to be the topic of regular audit in which all of the 
team must take part. Auditing should be an ongoing assessment of procedures and 
processes with review of outcomes and changes made to techniques and procedures as 
required. Records of the audit procedure and results from them must be kept and be 
accessible for review. Auditing of conscious sedation practice falls under the record 
keeping umbrella. Accurate record keeping in relation to dental care and inhalation 
sedation is necessary to ensure appropriate flow of treatment. It is also essential for 
medicolegal reasons. Information on the records is personal to a patient and is therefore 
confidential and encompassed by the Data Protection Act 1998 (Dental Faculties of the 
Royal College of Surgeons and the Royal College of Anaesthetists, 2015). 
All sedation teams must have a clinical log which is be kept together with clinical records. 
Each clinical team must have contemporaneous and continuous records of the number 
and types of sedation treatments done together with the amount of any complications 
that may have happened (Dental Faculties of the Royal College of Surgeons and the 
Royal College of Anaesthetists, 2015). 
Before the administration of nitrous oxide/oxygen, informed consent should be taken 
from the parent, ideally in a separate appointment, and recorded in the patient’s record. 
The dentist should provide instructions to the parent regarding instructions before 
treatment if needed. Additionally, the patient’s record should include the reason for use 
of nitrous oxide, the dosage used, including percentage of the mixture and flow, how long 
the procedure lasted, and recovery after treatment. (American Academy of Pediatric 










In 2015 the new guidelines of the Intercollegiate Advisory Committee for Sedation in 
dentistry were released. It is mandatory that records of the audit process and outcomes 
from them must be maintained and be available for inspection. The aim of this audit was 
to evaluate the department’s inhalation sedation record keeping. The objectives were to 
establish how effectively the department uses the inhalation sedation (IS) logbook and 
to assess the outcomes of IS appointments. 
Standards  
The standard was set to 100% as this was mainly a record keeping audit. 100% of 
treatment and outcomes should be recorded in the IS logbook and be available for 
inspection. 
Methods and data source 
The audit was carried out retrospectively. It was done in two cycles. The first cycle was 
in July 2015 and the second cycle in February 2016. The data was collected from three 
different sources. Initially all the appointments booked were recorded. The reception staff 
hold an Excel spreadsheet with the appointments booked. This is not updated with the 
daily changes to the appointments. However, the spreadsheet contains all the 
information regarding number of patients booked, date, time and patient details are 
recorded. From this spreadsheet, the initial number of patients booked was recorded. 
The second source of data was the outcome forms that were completed every time an 
appointment was completed. These forms are always completed and they include the 
treatment done. From the completed outcome forms information regarding type of 
treatment was also collected. The different types of treatment included restorations, 
restorations with preformed metal crowns, root canal treatment, extractions, surgical 
treatments, fissures sealants and other. These forms were not completed if the patient 
attended but did not have inhalation sedation in their appointment. As a result, by getting 
access to the outcome forms it was possible to find which patients attended and what 
treatment they had. Patients that attended but did not have IS treatment done had their 
status changed on the booking system to a normal appointment. Patients that did not 
attend or cancelled did not have an outcome form completed and did not have their 
appointment status changed to a normal appointment. Finally, the IS logbook was 
assessed and a comparison was made between which patients had an outcome form 




With the above method, it was possible to collect all the data regarding 
• patients booked 
• patients who attended and had IS appointment 
• patients who attended but had a normal appointment 
• patients who did not attend or cancelled 
• number of patients who had IS appointment recorded in the IS logbook 
• types of treatment completed 
The remaining data was collected from the IS logbook. For the purposes of this audit 
only the outcome of the inhalation sedation appointment was recorded. Additional 
information in the logbook includes a patient identifier, type of sedation used, percentage 
of nitrous oxide and oxygen used, sedation scoring, recovery and signatures from the 
clinician and the dental nurse. In the cases were treatment had failed, the notes were 
retrieved to check what was the outcome of this appointment. Failed appointments would 
usually result in a new appointment for IS given, an appointment for use of intravenous 
sedation if the patient is over 12 or an appointment for a general anaesthetic if it was 
though that the patient wouldn’t cope with another IS appointment. 
All the data collected was inserted into an excel spreadsheet which included the patient 
identifier, date of appointment, whether it was completed or not and what treatment the 
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Table 4: Example of data collection sheet 
Below is the table used to record treatment in the IS logbook. for the purposes of this 
































The results of this audit were presented in the departmental monthly meeting as well as 
a poster in a national sedation meeting. The poster for the national meeting also included 
data of the same audit done for intravenous sedation.  
First cycle 
Below are the results of the first cycle which were recorded between the 22-06-2015 and 
22-07-2015. 
 














Figure 30: Booked, completed and recorded appointments – First cycle 
 
 
Figure 31: Successful appointments – First cycle 
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• IS excel spreadsheet
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Total appointments 163 
Completed  104         64% 
No IS used 18           11% 
DNA/Cancel 41           25% 
  
Logbook 46/104     44% 
Successful  43/46       93% 
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At the end of the first cycle there were two major points which would require attention. 
Firstly the high ‘did not attend’ rate which was 25% and secondly the poor record 
keeping with only 44% of appointments recorded in the IS logbook.  
Recommendations 
The results were presented in the monthly departmental meeting and 
recommendations were made regarding the poor record keeping. These were to:  
• circulate an email to all staff to ensure the logbook is been always completed 
• place laminated posters in the two IS rooms to remind staff to complete the 
logbook 
Following the above a plan was made to repeat the audit approximately six months 
later. 
Second cycle 
Below are the results of the second cycle which were recorded between the 01-02-2016 
and 30-02-2016. 
 














Figure 34: Booked, completed and recorded appointments – Second cycle 
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July 2015 February 2016 
Total appointments 163 148 
Completed  104         64% 104        71% 
No IS used 18           11% 17          11% 
DNA/Cancel 41           25% 27          18% 
   
Logbook 46/104     44% 77/104    74% 
Successful  43/46       93% 73/77      94% 
Table 7: Result from both cycles 
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The second cycle was completed in February 2016. Further to the recommendations 
after the first cycle a significant improvement in record keeping was noted. This 
increased from 44% to 74%. The diversity of treatments completed remained similar with 
restorations (including PMC) and extractions accounting for approximately 78% of all 
treatments provided. There were eight failed treatments in the two cycles. Out of these 
four were failed extractions and in the other four the patients wouldn’t allow treatment to 
commence. Four of these patients went on to have a general anaesthetic, three had 
treatment under IV sedation and one patient reattended for further treatment under IS. 
Discussion 
Inhalation sedation is used routinely in the department of paediatric dentistry as seen by 
the high numbers of appointments in the two cycles of the audit where approximately 
155 appointments per month are booked. It is important that records of these 
appointments are appropriately kept and that these are audited regularly. The reason for 
that is to ensure a high standard of record keeping is maintained and also a high standard 
of inhalation sedation service is provided. 
The departments high success rate of 95% is in accordance with previous research as 
discussed before where success rates can be between 83% and 100%. This is however 
one of the limitations of this audit, where failed treatment was recorded, not failed 
inhalation sedation. For example, an extraction could have been completed deeming the 
treatment successful but that does not necessarily mean that the patient was adequately 
sedated. It is crucial that in future audits both the outcome of treatment and outcome of 
sedation is recorded, as it is likely that successful sedation based on the sedation scoring 
will be lower than successful treatments. All the failed appointments were either failed 
extractions or appointments were although sedation commenced treatment did not 
commence at all.  
The ‘’did not attend’’ rate of 25% in the first cycle can be considered high. Although not 
part of this audit a telephone service was introduced between the audit cycles to remind 
patients of all sedation appointments. The results of this were significant and the DNAs 
were reduced from 25% to 18% in only a few months. 
As expected the breakdown of different treatments remained the same over the two 
cycles, with the majority (>1/3) of treatments completed under inhalation sedation being 
dental extractions. Dental extractions are regarded amongst the most stressful 




One of the biggest improvements in between the two cycles (which was also the reason 
for this audit) is the significant increase in recording of sedation appointments in the 
logbook. This was initially very low at 44%. When an entry was made in the logbook, the 
outcome was always recorded too, hence recording of outcomes was 100% for both 
cycles. Because logbook recording was so low, it was not possible to fully assess 
success rates and complications in the first cycle as only 44% of the records was 
available for inspection. There are multiple reasons why record keeping was so low. Staff 
change continuously in the department and training is only limited to a few days. New 
staff may not be aware of sedation logbooks until after a few weeks into the job. A 
suggestion for this aspect is for dental nurses to also be responsible for the logbook. 
Dental nurses trained for sedation are usually more senior and do not change position 
often. On the other hand, new dentists come in the department every few months, many 
without any prior inhalation sedation experience. Record keeping advice should be part 
of the induction of new dentists.  
After the first cycle when the poor record keeping was noted, actions were taken, mainly 
an email reminder, a staff meeting presentation and posters in both sedation rooms. 
These actions were enough to ensure all staff remembered to put an entry in the logbook 
at the end of each sedation appointment. Record keeping increased to 74%. This not 
only enabled compliance with record keeping standards set out by the General Dental 
Council but also ensured that records can be accessible for auditing. 
As part of this audit the outcomes of sedation were not recorded apart from operating 
conditions. Future audits should also comment on sedation scoring and recovery, the 
two aspects that were not included in this audit. Additionally, the percentage of nitrous 
oxide given should be recorded as well as the American Society of Anaesthesiologists 
score. 
Conclusion  
This audit highlighted the need for contemporaneous and complete record keeping for 
inhalation sedation appointments. Record keeping was below standard at the end of the 
first cycle and this improved significantly following the multiple actions taken to address 
that. After the second cycle record keeping was still not perfect and this warrants the 
need for further auditing as well as regular reminders to all staff to ensure record keeping 
is of high standard in the department of paediatric dentistry.  
The results of this audit, together with results of the same audit for intravenous sedation, 
were presented at national level in the UK, which ensured that the findings and 
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CASE SUMMARY  
 
 
AJ is a fit and well young girl referred by her GDP regarding dental caries affecting 
her primary dentition. She has no previous pain from her teeth. 
She presented with caries in 6 of her primary teeth. AJ was introduced to dental 
treatment gradually. A combination of composite fillings, conventional crowns, 
extraction, as well as fissure sealants and fluoride varnish application was carried out. 
Treatment was carried out using non pharmacological behaviour management and 
inhalation sedation. 
Cooperation was difficult in the beginning but improved over time. 










Age at start of treatment: 5 years and 10 months 
 





HISTORY OF PRESENTING PATIENT’S COMPLAINT 
• Mother and dentist noticed caries on multiple teeth.  
• No history of pain, swelling or use of antibiotics. 
 
RELEVANT MEDICAL HISTORY 
• Delivered full term. 
• No known allergies, no medical conditions and up to date vaccinations. 
 
DENTAL HISTORY 






• Lives with parents and six siblings.  
• Year one at school. Attends with her mother. 
 
DIET 
• Breast fed until 12 months old. Bottle fed until 2 years old.  
• Has fruit juice and biscuits regularly. 
 
ORAL HYGIENE 
























• No facial asymmetry 
• No lymphadenopathy 
• No TMJ abnormalities 
• Normal height/weight 
• Very shy, allowed examination 
INTRA-ORAL EXAMINATION 
• Soft tissues – healthy appearance 
• Oral hygiene – fair with some plaque deposits present 
o Simplified plaque index – 28%  (OHI-S) (Greene and Vermillion 1964) 
• Hard tissues 
o Teeth present    
 
 




• Occlusion  
o Class I deciduous molar occlusion 
o Early mixed dentition 
o Anterior openbite 
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GENERAL RADIOGRAPHIC EXAMINATION 
 
Radiographs taken 
• Right and left bimolars 








Figure 4 and 5: Bimolar radiographs (26-1-2015) 
 
 
Radiographic findings  
• Periapical radiolucency associated with LLD 
• Caries see on LLE, LLD, URE, LRE  










• Poor oral hygiene 
• Dental caries affecting six primary teeth secondary to diet 
• Periapical pathology LLD 
• Dental anxiety 
 
AIMS AND OBJECTIVES OF TREATMENT 
 
 
• Improve oral hygiene through instructions, fluoride advice, and dietary education 
• Restore oral health  
• Manage anxiety and promote positive attitude towards dentistry 





1. Acclimatisation and prevention 
• Establish a preventive regimen consistent with the Department of Health 
preventive toolkit 
• Use of non-pharmacological behaviour management (NPBM) and inhalation 
sedation as a pharmacological behaviour management technique 
 
2. Quadrant dentistry 
• Maxillary right quadrant 
i. URE composite restoration 
• Maxillary left quadrant 
i. ULE composite restoration 
• Mandibular right quadrant 
i. LLE PMC 
ii. LLD extraction 
• Mandibular left quadrant  
i. LRE PMC 
ii. LRD PMC 
 
3. Fissure sealant of all first permanent molars once erupted 
 
4. Maintenance and follow up 
• Monitor restorations 
• Radiographic review 














TABLE OF MATERIALS USED 
 
 
 Material used Description 
A Topical Anaesthesia Topical Anaesthetic Gel/Liquid – 20% Benzocaine, 
Dentsply, Milford, DE, USA 
 
B Local Anaesthesia 
(LA) 
 
Lignocaine Special, 2.2 ml (2% Lidocaine, 1 
:80000 
epinephrine); Septodont, Saint –Maur-des-Fosses, 
France 
 
C Composite Material Filtek Supreme XTE, 3M Espe, USA 
D Fissure sealant Fissure Sealant Delton; Dentsply, Australia  
 
E Acid etch Phosphoric Acid Gel Etchant 37.5%; Kerr 
Corporation, USA 
F Bonding agent Opti bond Solo plus, single component, Total etch 
bonding agent, Kerr Co., California, USA 
G Preformed metal crowns 
(PMCs) 
Stainless steel primary crowns; 3MTM ESPETM, 
St Paul, Minn, USA 
H Glass Ionomer Luting cement Aquacem®; Dentsply, Milford, DE, USA 
I Duraphat® Colgate Duraphat Varnish 50mg/ml dental 
suspension; Colgate Oral Pharmaceuticals, New 


































Visit 1 (26-1-15) 
• Patient attended all the appointments with her mother 
• Complete history taken 
• Clinical and radiographic examination 
• Clinical photographs 
• Treatment plan formulated 
• Discussion about Inhalation Sedation (IS) and leaflet given 
• Written consent for IS obtained 
• Oral hygiene instruction (OHI) given according to the DoH toolkit for prevention 1  
• Plaque score: 27% (OHI-S) 
 
Visit 2 (31-3-15) 
• No signs and symptoms, oral hygiene reinforced 
• URE 
o Inhalation sedation (30% Nitrous oxide and 70% Oxygen, titrated) 
o Topical anaesthetic and 1.8ml 2% lidocaine with adrenaline 1/80000  
o Rubber dam isolation 
o URE occlusal caries removed, 3 cavities 
o Restored with A1 composite  
o 100% Oxygen for 5 minutes and post-operative instructions given (POIG) 
• Patient was moving a lot during procedure and needed positive verbal instructions  
• Duraphat® fluoride varnish 22600ppm applied to all teeth  






Visit 3 (28-4-15) 
• No signs or symptoms, improved oral hygiene 
• ULE 
o Inhalation sedation, topical and local anaesthesia as described before 
o Rubber dam isolation 
o Occlusal caries removed ULE 
o Restored ULE composite A1 
o POIG 









Visit 4 (5-5-15) 
• No signs or symptoms 
• LRD, E 
o Inhalation sedation, topical and local anaesthesia as described before 
o LRD,E proximal and occlusal preparation done for Preformed metal crown 
(PMC) 
o Partial caries removal on LRE, distal caries on LRD removed during 
preparation 
o Cemented LRD size 4 and LRE size 5 PMC with Aquacem® 
o Good occlusion 
o POIG 
• Cooperation improved 
• Treasure card updated 
 
Visit 5 (16-6-15) 
• No signs or symptoms, Oral hygiene improved  
• LLD, E 
o Inhalation sedation, topical and local anaesthesia as described before 
o LLE proximal and occlusal preparation done for PMC 
o Partial caries removal on LLE 
o Cemented LLE size 5 PMC with Aquacem® 
o Extracted LLD intact using elevators and forceps 
o Good occlusion 
o Haemostasis 
o POIG 
• Good cooperation today 
• Duraphat® fluoride varnish 22600ppm applied to all teeth  




Visit 6 27-1-16 
• No signs or symptoms, Oral hygiene improved 
• Plaque score: 11% (OHI-S) 
• New bitewings and clinical photos done today  
• Duraphat® fluoride varnish 22600ppm applied to all teeth  













Figure 6: Anterior view 27-1-2016 
 
 
Figure 7: Upper occlusal view 27-1-2016 
 
 













• No recurrent caries 
• No signs of periapical pathology 
 
 
LONG TERM TREATMENT PLAN AND FUTURE CONSIDERATIONS 
 
AJ has been discharged back to her GDP who will continue to offer prevention and apply 


















DISCUSSION AND REFLECTION ABOUT CASE PRESENTED 
 
The case was overall successful. It can be difficult to manage a young child who 
presents with caries affecting multiple teeth and when they have had no previous 
exposure to dentistry. Treatment has to happen in stages, efficiently and effectively 
and aim to maintain cooperation. In this case the treatment was completed chairside 
and a general anaesthetic was avoided. This not only ensured the treatment was 
carried out safely but also by completing the treatment a positive attitude towards 
dentistry was achieved. 
 
Prevention 
Prevention was given according to the ‘Delivering better oral health: an evidence 
based toolkit for prevention’ from the Department of Health (3rd edition)1. The mother 
was advised to use a toothpaste with fluoride concentration of 1450ppm and brush 
twice daily with spiting and not rinsing. A pea size amount of toothpaste should be 
used. Tooth brushing instructions were given using the modified bass technique. Diet 
advice was given with the aim of reducing sugar attacks during the day. Finally, as 
fluoride varnish of 22600ppm should be applied four times per year, a recall interval 
was set to 3 months as AJ is high caries risk2. AJ’s oral hygiene improved over the 
course of treatment. On the second visit a simplified plaque index was done and oral 
hygiene was poor with a score of 27% (OHI-S, Greene and Vermillion, 1964) and in 
the last visit 11% so a marked improvement but not perfect. 
 
Behaviour management 
Inhalation sedation (IS) was used as a pharmacological behaviour management with 
AJ. A combination of IS and non-pharmacological behaviour management techniques 
made the treatment possible. IS has a favourable outcome when treating children with 
mild to moderate anxiety3. Tell show do was used effectively and AJ was interested to 
know how everything worked before treatment started. We managed to complete all 
the treatment without losing cooperation and promoted a good attitude towards 
dentistry for the future. The facial image scale was used to assess the anxiety of AJ. 
Although she was quite nervous for the first visit, this anxiety reduced over the course 
of the treatment and at the last appointment she was much more relaxed. The facial 







Considering the sequence of treatment, when AJ first presented she had a periapical 
pathology present on the radiograph of the LLD. However, she was not in any pain. At 
the time AJ was 5 years old and had never had treatment before. The decision was 
made to postpone the extraction towards the end of the treatment as there was a 
chance of losing cooperation by attempting the extraction at the beginning. If there was 
pain on presentation the treatment plan would have been different. The mother was 
happy that if the LLD became symptomatic we would plan to extract it straight away.  
We decided to use conventional crowns instead of the Hall technique due to the extent 
of caries on the lower second primary molars. We knew that although the cavities were 
large on the lower second molars there was no pathology radiographically and there 
were no signs of infection clinically. Partial caries removal was done before sealing the 
cavities with preformed metal crowns. The same happened for both second molars but 
not for the LRD which had a smaller distal cavity. This was only prepared mesially and 
distally to create space as both crowns on the lower right quadrant were cemented on 
the same day. Preformed metal crowns with conventional preparation have an 
excellent prognosis with success rates of 97% after 5 years5. Similarly Hall crowns 
have a success rate of 97% after 5 years6.  
Overall this was a successful case made possible using behaviour 




• Prevention advice and its importance 
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AH is a 10 year old fit and well boy. He sustained trauma to the maxillary central 
incisors while playing Karate in April 2015. This resulted in enamel dentine pulp 
fracture of the maxillary central incisors.  
AH presented five months after the initial injury for assessment. He was a very 
anxious young boy. The maxillary central incisors were built up with direct composite 
and root canal treatment was completed on both maxillary central incisors. Inside 
outside bleaching was undertaken. 







Age at start of treatment: 10 years old 




HISTORY OF PRESENTING PATIENT’S COMPLAINT 
• History of trauma 
o The maxillary incisors were fractured during a karate lesson. AH was 
 accidentally elbowed. The injury was witnessed. There was no loss of 
consciousness. 
o The patient went to A&E and was cleared of head injury.  
o Subsequently the dentist extirpated the maxillary central incisors and placed 
temporary restorations.  
o No history of antibiotic use or swelling associated with the maxillary incisors. 
 
RELEVANT MEDICAL HISTORY 
• Fit and well with no known allergies. 
 
DENTAL HISTORY 
• Regular attender and after the accident attended the GDP a few times.  
• Previously had local anaesthetic for the extirpation of the maxillary incisors. 
• Very bad experience which left him very nervous of dental treatment. 
 
SOCIAL HISTORY 
• AH is in year 5 at school and has one sibling. He leaves with his parents. 
 
DIET 
• Diet is low in sugar. He likes to snack on olives and mainly drinks water. 
 
ORAL HYGIENE 






EXTRA ORAL EXAMINATION 
• No facial asymmetry 
• No lymphadenopathy 
• No TMJ abnormalities 
 
INTRA ORAL EXAMINATION 
• Soft tissues – healthy appearance 
• Oral hygiene – good with minimal plaque deposits present.  
• Simplified plaque index – 11% (OHI-S) (Greene and Vermillion 1964) 
• BPE -  
 
• Hard tissues  
• Mixed dentition 




• Enamel Dentine Pulp (EDP) fracture of UR1, UL1 
• UR1 GIC and UL1 Zinc Oxide-Eugenol temporary restorations 
• No abnormal mobility 
• Maxillary canines palpable 
• Occlusion 
• Class I molar relationship 
• Mandibular midline shift to the right 
• 4mm Overjet and 3mm Overbite 
 
• Trauma assessment 
Test UR2 UR1 UL1 UL2 
EPT 58 - 41 41 
Ethyl Chloride +ve -ve -ve +ve 
TTP - - - - 
Colour - discoloured - - 
Sinus - - - - 
Table 1: Vitality assessment 
0 1 0 
0 0 0 
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Figure 5: Anterior view (22-9-2015) 
Figure 6: Maxillary occlusal view (22-9-2015) 
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GENERAL RADIOGRAPHIC EXAMINATION 
 
Radiographs taken 
• Long Cone Periapical radiograph of maxillary central incisors 









• Periapical radiolucencies associated with the UR1, UL1  
• Enamel Dentine Pulp fractures with restorations on UR1, UL1 
• UR1, UL1 have almost closed apices 












• Enamel Dentine Pulp fracture of maxillary central incisors leading to loss of  
vitality 
• Dental anxiety 
 
AIMS AND OBJECTIVES OF TREATMENT 
 
• Manage anxiety and promote positive attitude towards dental treatment 
• Maxillary central incisors 
• Complete endodontic treatment 
• Restore with direct composite 
• Non vital inside outside bleaching  




• Behaviour management  
• Due to AH’s anxiety it was decided treatment should be completed under 
inhalation sedation  
 
• Initial treatment 
• Dress root canals of the maxillary central incisors 
• Composite build-up of maxillary central incisors 
• Prevention according to the Department of Health Toolkit 
 
• Long term treatment  
• Obturation of maxillary central incisors 
• Inside outside bleaching 
 
• Follow up and maintenance 
• Clinical review every 6 months and radiographic review every 6-12  
• months 
• Reinforce OHI 




TABLE OF MATERIALS USED 
 
 
 Material used Description 
A Electric pulp test Kerr; Analytic Technology Corp, Redmond, WA 
B Ethyl chloride test Endo cold spray, Henry Schein, UK 
C Topical Anaesthesia Topical Anaesthetic Gel/Liquid – 
20% Benzocaine, Dentsply, Milford, DE, USA 
 
D Local Anaesthesia 
(LA) 
 
Lignocaine Special, 2.2 ml (2% Lidocaine, 1 :80000 
epinephrine); Septodont, Saint –Maur-des-Fosses, 
France 
 
E Composite Material Filtek Supreme XTE, 3M Espe, USA 
F Sodium Hypochlorite 
Ca(OH)2  
2.5% Sodium Hypochlorite, Milton; Procter & 
Gamble 
Australia, Parramatta, NSW 
 
G Non-setting Calcium 
Hydroxide 
 





IRM; Dentsply, Milford, DE, USA 
 
I Gutta Percha (GP) Densply, Maillefer, Ballaigues, Switzerland 
















Visit 1 (22-9-2015)  
• AH attended all the visits with his mother 
• Full clinical and radiographic examination 
• Provisional treatment plan agreed 
• The maxillary incisors were fractured, with temporary restorations in situ 
• The patient was not in pain 
 
 
Visit 2 (2-11-15) 
• AH was very nervous on first treatment visit, due to a previous painful  
experience at the dentist 
• Vitality tests completed  
• UR1 endodontic treatment 
o Inhalation sedation (30% Nitrous oxide and 70% Oxygen, titrated) 
o Topical and 1.8ml 2% lidocaine with adrenaline 1:80000 
o Rubber dam isolation  
o UR1 access cavity 
o Removal of necrotic pulp tissue 
o Sodium Hypochlorite irrigation 
o Working length radiograph (UR1=21mm) 
o Ca(OH)2 to 21mm and GIC temporary restoration 
• NPBM and Inhalations sedation helped the patient accept  
the treatment 
• Frankl: 2 
 
 
Visit 3 (8-12-15) 
• No complaints 
• Redone vitality tests – inconclusive results  
Test UR2 UR1 UL1 UL2 
EPT 27 - 46 59 
Ethyl Chloride +ve -ve -ve +ve 
TTP - - - - 
Colour - v. dark - - 
 
• UL1 endodontic investigation 
o Inhalation sedation 
o Local anaesthetic and rubber dam placed as explained above 
o Removed GDPs restoration – into pulp chamber 
o No pulp tissue, no bleeding, no odour or exudate 
o Working Length at 21mm using apex locator 
o Sodium Hypochlorite irrigation 
Figure 8: Working 
length radiograph 
UR1  (2-11-2015) 
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o Ca(OH)2 dressing to 21mm and GIC liner  
o Composite build-up with crown form and A1B shade 
• Unable to complete polishing due to patients challenging behaviour 
• Frankl: 2 
 
 
Visit 4 (3-2-16) 
• No signs or symptoms 
• Composite Build-up of UR1 
o Inhalation sedation 
o Local anaesthetic and rubber dam used  
o Composite build-up with crown form and A1B shade 
o Polished 
• Frankl: 3 
 
 
Visit 5 (25-2-16) 
• UL1 mild TTP, no other complaints 
• Ca(OH)2 change UR1, UL1 
o Inhalation sedation and local anaesthetic 
o Rubber dam used 
o Access cavities opened on both UL1, UR1 
o Working length after composite build ups 
(UR1,UL1=24.5mm). Confirmed with apex locator. 
o Sodium Hypochlorite irrigation  
o Dried and Ca(OH)2 dressing to 24.5mm 
• Frankl: 3 
 
 
Visit 6 (22-3-2016) 
• UL1 is still tender, decision not to obturate today 
• UR1 obturation 
o Inhalation sedation and local anaesthetic  
o Access cavity opened on UR1 
o Canal irrigated, dried, apical stop present 
o UR1 obturated with cold lateral condensation GP and root canal sealer 
o Post operative radiograph shows good obturation 















Visit 7 (28-6-2016) 
• No complaints, UL1 symptoms have settled, UR1 no SOS 
• UL1 obturation 
o Inhalation sedation and local anaesthetic 
o Access cavity opened on UR1 
o Canal irrigated, dried, apical stop present 
o UL1 obturated with cold lateral condensation GP and root 
canal sealer 
o Post op radiograph shows good obturation 
• Plan for whitening both UR1/UL1 
• Impression for whitening tray done 
• Frankl: 4 
 
 
Visit 8 (18-10-16) 
• Rubber dam isolation 
• UR1,UL1 prepared for inside outside bleaching 
• Reduced GP to below CEJ, GIC lining placed 
• Preoperative photographs and shade taken 
• Carbamide peroxide 10% provided with instructions 
• Four month review radiograph taken 
• Frankl: 4 
 
Visit 9 (25-10-16) 
• Both patient and mother happy with bleaching result 






















Figure 10: Obturation 

























Figure 13: Four month review radiograph (18-10-2016) 
Radiographic findings 
• Well condensed root canal treatment on maxillary central incisors 
• Some calcium hydroxide extruded on UR1 
• No signs of root resorption 
 
 
LONG TERM TREATMENT PLAN AND FUTURE CONSIDERATIONS 
 
• Clinical and radiographic review 
• Prevention 











DISCUSSION AND REFLECTION ABOUT CASE PRESENTED 
 
AH sustained an enamel dentine pulp (EDP) fracture on both the maxillary central 
incisors. 
These injuries are common and studies quote an estimated 5.3-21% of children will 
have dental trauma, with the most affected group being 7-12 year old1,2.  
 
Behaviour management 
AH’s previous bad experience made behaviour management challenging. The case 
demonstrates how the use of NPBMT together with inhalation sedation helped in 
completing the treatment and provided a positive dental experience3. In the final 
appointments, AH was able to accept treatment without inhalation sedation. 
 
Enamel dentine pulp fracture 
The principle of early restoration on EDP fractures is to preserve pulp vitality. In this 
case the maxillary central incisors were non vital on presentation hence endodontic 
treatment was the only option. 
 
Implications of possible additional periodontal injury 
Although we are not certain what the periodontal injury was due to the late 
presentation, it can be assumed that either a concussion or a subluxation occurred as 
the teeth had not moved position. These two periodontal injuries are the most 
common. If this was an injury involving only the periodontium the prognosis would be 
very good with over 80% of teeth remaining vital4. However, as the injury also involved 
an EDP fracture vitality was lost on both maxillary central incisors. The absence of 
any root resorption indicates that the trauma to the periodontium was minimal. 
Therefore it appears that the loss of vitality was primarily due to the crown fracture. 
 
Treatment  
The patient presented five months after the initial injury. The teeth were non vital. On 
the first visit baseline radiographs and vitality tests were done5. The treatment plan 
was to build up the maxillary incisors with composite to improve aesthetics and 
provide an effective seal for the endodontic treatment. The aim of early restoration is 
also to provide a consistent reference point for diagnosis of the working length. This 
was achieved radiographically and using an apex locator. The UR1 and UL1 were 
extirpated and built up over two separate appointments as the patient had limited 
cooperation. As both teeth do not appear fully developed apically, apexification was 
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achieved using calcium hydroxide before obturation. Prolonged use of Ca(OH)2 as 
intracanal dressing has been shown to weaken the tooth structure and in such cases 
an apical barrier can be formed with the use of MTA. In our case the apices were 
almost closed and for that reason, after three months of Ca(OH)2 dressing, the UR1 
was ready for obturation with cold lateral condensation. Due to recurrent infection the 
UL1 obturation was delayed for a further 3 months. 
Overall the case has been successful, we have build up the confidence of AH, as well 
as restored the maxillary central incisors.  
LESSON LEARNED 
• Successful outcomes following dental trauma depend on prompt and appropriate 
management 
• Management of dental trauma maybe the patients first experience of dentistry. Use of 
NPBM and inhalation sedation can aid successful outcomes. 
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Case Number 3 
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UO is a 10-year-old fit and well girl who was referred by her community dentist for 
management of enamel defects. 
Clinically there was generalized hypoplasia affecting all the teeth and no post eruptive 
breakdown was seen. There also was caries affecting multiple teeth. 
A diagnosis of Hypoplastic Amelogenesis Imperfecta and dental caries was made 
based on the clinical and radiographic findings. 
Treatment included preformed metal crowns (PMCs) on all the first permanent molars, 
composite restoration of multiple teeth and extraction of UL7. Restorations were 







Age at start of treatment: 10 years 




HISTORY OF PRESENTING COMPLAINT 
UO was referred by the community dentist for the management of the affected 
Permanent teeth. UO had no pain or sensitivity on presentation, but was concerned  
about the appearance. 
 
RELEVANT MEDICAL HISTORY 




UO was a regular attender at the community dental service for checkups and treatment.  
She previously had restorations under local anaesthetic. 
 
FAMILY HISTORY 
Lives with her mother, father and three sisters. Somalian origin. No other family  
members with dental anomalies. 
 
SOCIAL HISTORY 
Year 6 at school. 
 
DIET 
Good eater, has fruit and vegetables regularly. 
 
ORAL HYGIENE 










• No facial asymmetry 
• No lymphadenopathy 
• No TMJ abnormalities 
INTRA-ORAL EXAMINATION 
• Soft tissues – healthy appearance 
• Oral hygiene – fair with some plaque deposits present 
o Simplified plaque index – 1.00 (OHI-S) (Greene and Vermillion 1964) 
o BPE  
 
 
• Hard tissues 




o Carious teeth 
 
o Existing amalgam restorations on first molars and composite  
restoration on maxillary incisors 
• Occlusion  
o Class I occlusion 
o Posterior crossbite UR5,UR6 
o Mandibular midline shift to the right 
o Well aligned arches with no crowding 
 
• Amelogenesis imperfecta 
o The hypoplastic phenotype affecting all the teeth in the permanent  
dentition has a characteristic concave appearance on the mandibular 
incisors and a generalized rough and pitted appearance on all the teeth. 
An element of hypomineralisation may also be present due to the white 
chalky enamel present which lacks translucency. 
 
1 1 1 
1 1 1 
7 6 5 4 3 2 1 1 2 3 4 5 6 7 
7 6 5 4 3 2 1 1 2 3 4 5 6 7 
 6  4       4 5 6 7 










































GENERAL RADIOGRAPHIC EXAMINATION 
 
Radiographs taken: 
• Bitewings  
• Orthopantomogram 
 
Figure 4: Orthopantomogram 19-4-2016 
 
 
Figure 5: Horizontal Bitewing Radiographs 18-6-2015 
Radiographic findings: 
• OPG 
o All permanent teeth present 
o Typical appearance of Amelogenesis Imperfecta  
• Bitewings 
o Secondary caries under amalgam restorations on mandibular first molars 







• Hypoplastic Amelogenesis Imperfecta  
• Dental caries 
 
AIMS AND OBJECTIVES OF TREATMENT 
 
• Restore dental caries 
• Maintain dentition  
• Improve aesthetics 





o As outlined in the Department of Health Evidence based toolkit 
• Behaviour management  
o Acclimatise and use NPBM to complete treatment 
• Restorations  
o Composite build-up of the premolars and second molars  
o PMCs on the first molars 
o Extraction of the UL7 
o Re-restore maxillary anteriors  
• Follow up and maintenance 
o Clinical review every 6 months 
o Reinforce OHI 












TABLE OF MATERIALS USED 
 
 
 Material used Description 
A Topical Anaesthesia Topical Anaesthetic Gel/Liquid – 20% Benzocaine, 
Dentsply, Milford, DE, USA 
 
B Local Anaesthesia 
(LA) 
 
Lignocaine Special, 2.2 ml (2% Lidocaine, 1 :80000 
epinephrine); Septodont, Saint –Maur-des-Fosses, 
France 
 
C Composite Material Filtek Supreme XTE, 3M Espe, USA 
D Fissure sealant Fissure Sealant Delton; Dentsply, Australia  
 
E Acid etch Phosphoric Acid Gel Etchant 37.5%; Kerr 
Corporation, USA 
F Bonding agent Opti bond Solo plus, single component, Total etch 
bonding agent, Kerr Co., California, USA 
G Preformed metal 
crowns (PMCs) 
Stainless steel crowns; 3MTM ESPETM, St Paul, 
Minn, USA 
H Luting cement Aquacem®; Dentsply, Milford, DE, USA 
I Duraphat® Colgate Duraphat Varnish 50mg/ml dental 
suspension; Colgate Oral Pharmaceuticals, New 
York City, USA 
j Resin Modified Glass 
Ionomer Cement 
(GIC) 
























Visit 1 (18-6-15)  
• UO was referred by the community dental service for treatment of her 
hypoplastic teeth.  
• She attended with her father for all the appointments  
• Clinical and radiographic examination  
o Permanent dentition 
o Amelogenesis Imperfecta hypoplastic phenotype 
o Dental caries as charted  
 
Visit 2 (20-10-15)  
• Bitewing radiographs were taken to assess for caries. 
• LL4, LL5, LR4, LR5 
o Cotton roll isolation, cleaned with pumice 
o For all composite restorations these steps were followed: 
▪ Brushed with pumice, etch, bond and A1B Filtek  
supreme XTE composite used  
o Restored the occlusal surfaces of all lower premolars 
o Occlusion was checked 
• Behaviour was good 
• OH poor with plaque index - 1.00 (OHI-S) 
• Oral hygiene instruction (OHI) given according to the DoH toolkit  
(Public Health England 2014) 
• Prescribed Duraphat® 2800ppm toothpaste 
• Duraphat® fluoride varnish applied to all teeth 
 
Visit 3 (17-2-16)  
• No complaints 
• UR4 
o Topical anaesthetic and local anaesthetic 2% lidocaine with  
adrenaline 1/80000  
o Rubber dam placed 
o Occlusal caries removed UR4, Composite A1 used to restore 
o Polished and occlusion checked 
• Behaviour was good  
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Visit 4 (19-4-16) 
• No complaints 
• UL4 ,UL5, UL7 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam placed 
o Occlusal caries removed UL4,5,7 
o A1 composite used to restore UL4,5 
o Polished and occlusion checked 
o RMGIC placed occlusally on UL7 
• OPG taken to assess condition of first molars before crowning 
• Clinical photographs done 
• Agreed that UL7 was unrestorable and LL6 seems to have a very deep  
restoration but will restore with PMC. 
 
Visit 5 (21-4-16) 
• Emergency appointment  
o Extraoral swelling left cheek extending infraorbitally, but not close  
to eye 
o Erythema around the diffuse swelling 
o Tenderness extraorally 
o Trismus 
o Temperature 38.5OC 
• After clinical and radiographic examination a diagnosis of dental abscess  
UL7 was made 
o Prescribed antibiotics Amoxicillin 500mg and Metronidazole 200mg  
orally. We were unable to do extraction due to trismus. 
• Instructions given to attend A&E if swelling increases 
• Review the next day 
 
Visit 6 (22-4-16) 
• Feels better than previous visit 
• Has eaten 
• Swelling remained similar after 3 doses of antibiotics 





Visit 7 (27-4-16) 
• Swelling and pain resolved two days ago  
• XLA UL7 
o Topical anaesthetic and local anaesthetic as above 
o UL7 Elevated and extracted intact 
o Post-operative instructions given and Haemostasis achieved 
• Patient did very well – praised 
 
Visit 8 (24-5-16) 
• Attends with father  
• No complaints, however amalgam filling LL6 has come out 
• PMC on UL6  
o Topical anaesthetic and local anaesthetic as above 
o LL6 caries removed with excavator 
o Size 4 PMC cemented on UL6 using aquacem 
o LL6 temporized with RMGIC FUJI II 
• Duraphat® fluoride varnish applied to all teeth 
 
Visit 9 (8-6-2016) 
• Attends with father 
• No complaints 
• PMC on LR6 and composite on LR7 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam isolation 
o Caries removed from LR7 
o Composite occlusal restoration A1B LR7 
o Amalgam restoration and occlusal caries removed from LR6, GIC  
lining placed 










Visit 10 (11-10-2016) 
• No complaints 
• PMC LL6 and composite on LL7 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam isolation 
o All caries removed from LL7 
o Composite occlusal restoration A1B LL7 
o Polished 
o Distal preparation LL6 for PMC, GIC lining placed and size 2  
PMC cemented with Aquacem 
 
Visit 11 (18-10-2016) 
• No complaints 
• PMC UR6 and fissure sealant on UR7 
o Topical anaesthetic and local anaesthetic as above 
o All caries removed from UR6 
o Fissure sealant placed on UR7 
o Size 3 PMC cemented on UR6 with Aquacem 
• Prescribed Duraphat 2800ppm toothpaste 
• Duraphat® fluoride varnish applied to all teeth 
• Oral hygiene improved with plaque index at 0.66 (OHI-S)  
• Review in 3 months 
 
Visit 12 (17-12-2016) 
• No complaints 
• UR1, UL1 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam placed 
o Old restorations removed from UL1, UR1, Composite A1B used  
to restore with crown form 








Visit 13 (23-01-2017) 
• No complaints 
• UR2, UL2 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam placed 
o Old restorations removed from UL2, UR2, Composite A1B used to  
restore with crown form 
o Polished and occlusion checked 
 
Visit 14 (01-02-2017) 
• No complaints 
• UR3, UL3 
o Topical anaesthetic and local anaesthetic as above 
o Rubber dam placed 
o Old restorations removed from UL3, UR3, Composite A1B used 
to restore with crown form 
o Polished and occlusion checked 
• Very happy with result 






















Figure 6: Anterior view 1-2-2017 
 
Figure 7: Maxillary occlusal view 1-2-2017 
 






LONG TERM TREATMENT PLAN AND FUTURE CONSIDERATIONS 
 
• Review every 6 months 
• Prevention 
• Fluoride varnish every three months 
 
 
DISCUSSION AND REFLECTION ABOUT CASE PRESENTED 
 
Amelogenesis imperfecta (AI) represents a group of conditions which affect the 
structure and appearance of enamel. It affects 1:700 to 1:14000 people (Crawford et 
al. 2007).  
The classification of Winter and Brook in 1975 is one of the most accepted ones 
(Crawford et al. 2007). UO had a hypoplastic type of AI which presented with random 
pits and was also rough. UO seems to be the first in her family with a dental anomaly, 
so we were unable to do a pedigree chart. 
When considering the diagnosis it is important to consider the differentials. 
Chronological hypoplasia is the main differential diagnosis in our case, however this 
can be excluded as all the teeth have erupted. As part of the diagnosis the radiographic 
examination may be of value. In our case the OPG radiograph showed the typical 
appearance of AI, with taurodontism on the lower second molars. 
The reasons for restoring the teeth are to improve aesthetics on the anteriors, 
to maintain posterior teeth and to improve the anatomy for more effective cleaning. 
When development has ceased heavily restored first molars can be restored with full 
coverage restorations (Pousette Lundgren et al. 2015). 
It is important to make a correct diagnosis of hypomineralized or hypoplastic AI. As 
hypoplastic enamel is fully mineralized it does not break down and often no 
restorations are required. Also bonding is equally effective to a non AI tooth. On the 
other hand on a hypomineralized tooth, enamel is more prone to breakdown. UO had 
a hypoplastic type of AI and there was no sensitivity. However due to multiple early 
interventions and failure of prevention UO had a lot of caries in the posterior teeth. 
This is partly because of the abnormal shape of teeth as well as poor oral hygiene and 
diet. The anatomy of the teeth makes them more prone to caries and restorations may 
allow improved cleaning. Additionally the restorations on the anterior teeth were 
breaking down and were unaesthetic. Although the teeth were predominantly 
hypoplastic an element of hypomineralisation was also possibly present due to the 
chalky appearance enamel which chipped off easily. 
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UO’s oral hygiene improved overall but was still not perfect. A preventive 
regime was formulated according to the Deparment of Health Toolkit (Public Health 
England 2014). 
Overall we have succeeded in managing UO well and maintaining her dentition apart 
from the loss of the UL7 due to unrestorable caries. She has also been educated 
towards better oral hygiene habits.  
 
LESSONS LEARNED 
• Amelogenesis imperfecta is a complex condition to treat  




Crawford, P.J. et al., 2007. Amelogenesis imperfecta. Orphanet Journal of Rare 
Diseases, 2(1), p.17. 
Pousette Lundgren, G. et al., 2015. A Randomized Controlled Trial of Crown 
Therapy in Young Individuals with Amelogenesis Imperfecta. Journal of Dental 
Research, 94(8), pp.1041–1047. 
Public Health England, 2014. Delivering better oral health : an evidence-based toolkit 





































Case Number 4 
 








Eastman Dental Institute 











HHL was an 8 years old boy who was referred by the orthodontist to the Eastman 
Dental Hospital for management of his malocclusion and missing teeth. 
The diagnosis of hypodontia was made as well infraoccluded primary teeth on a class 
III malocclusion. 
HHL was medically fit and well. He did not have any complaints regarding his teeth. 
HHL had a class III malocclusion on a mild Class III skeletal base. Intraorally he was 
in the mixed dentition with fair oral hygiene. The lower arch had mild crowding and the 
lower right first primary molar and lower second primary molars were severely 
infraoccluded. The upper arch also had mild crowding. 
The OPG demonstrated the congenital absence of all four second premolars and the 
lower right first premolar. In addition, it showed resorption of the distal roots of the 
upper second deciduous molars by the upper first permanent molars. 
After the orthodontic/paediatric meeting it was decided that HHL would benefit from 
interceptive orthodontics. This would involve correction of the anterior local crossbite 
and extraction of the retained upper second deciduous molars to allow for the eruption 
of permanent molars. In addition, the infraoccluded lower deciduous molars would be 
build up with composite into the occlusion. 
Treatment was carried mainly using non–pharmacological behaviour management 
(NPBM) techniques. Treatment provided: 
• Prevention and acclimatization 
• Oral hygiene instructions (OHIs). 
• Dietary advice. 
• Upper removable appliance to correct the crossbite by the orthodontic department 
• Restorations: 
➢ Composite build ups of the lower right primary molars and the lower left 

















Age: 9 years on presentation 
Sex: Male 
First attended: 13/10/2015 
REASON FOR ATTENDANCE 
Referred by orthodontist to manage the infraoccluded primary teeth. 
CHIEF COMPLAINT 
HHL is aware that he was missing teeth but is not concerned about it. 
MEDICAL HISTORY 
Fit and well, no know allergies and not on any medication. There is a history of 
tonsillectomy and adenoidectomy. 
DENTAL HISTORY 
Regular attender to GDP every 6 months. Has never had local anaesthetic or any 
restorations. 
FAMILY AND SOCIAL HISTORY 
HHL is adopted and has no siblings. He attends school and is currently in year 4. No 
information was known about hypodontia of the parents. 
DIET 
Good eater, drinks water mainly and as snacks usually has cheese and toast. 
ORAL HYGIENE 










• No facial asymmetry 
• No lymphadenopathy 
• No TMJ abnormalities 
INTRA-ORAL 
• Soft tissues – health appearance 
• Oral hygiene – good with no minimal plaque deposits present.  
o Simplified plaque index – 12% (Greene and Vermillion 1964) 
• Hard tissues  
o Mixed dentition 
o LRE,D, LLE severely infraoccluded  





• Occlusion  
o Class III malocclusion with increased vertical proportions 
o Posterior bilateral crossbite and anterior localized crossbite of UL1 
 
Radiographically there are five permanent teeth missing, including all the second  
premolars and the lower right first premolar. 
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• Absence of all four second premolars and the lower right first premolar 
• Resorption in the distal roots of the upper second deciduous molars  































DIAGNOSIS AND TREATMENT PLANNING 
DIAGNOSIS 
1. Dentition  
• Hypodontia, infraocclusion of LRD,E LLE 
• Orthodontic  
• Class III malocclusion on class III skeletal base 
• Upper and lower arch mild crowding 
• Posterior and anterior crossbite 
TREATMENT OBJECTIVES 
• Align dentition  
• Build up and maintain infraoccluded primary teeth 
• Correct crossbites 
PROVISIONAL TREATMENT PLAN 
1. Prevention 
• OHI 
• Fluoride varnish application twice yearly 
2. Behaviour management  
• Acclimatise and use NPBM to complete treatment 
3. Restorations  
• Composite build-up of the lower right primary molars and the lower left 
second primary molar 
4. Orthodontic  
• Orthodontic department to provide upper removable appliance to 
correct crossbite 
5. Follow up and maintenance 
• Clinical review every 6 months 
• Reinforce OHI 






































Vertical bitewings (10/6/16) 
 
 
• Composite buildups to occlusal plane LRE, LRD, LLE 
• Root resorption present on LLE, LRE, LRD 
• ULD, URD close to exfoliation 
• Absent LR5,LR4,LL5 
















TREATMENT PROGRESS AND DENTAL MANAGEMENT 
9-3-15 Visit 1  
HHL was referred from his local orthodontist to our orthodontics department. He 
attended with his foster mother. He was assessed and a treatment plan was 
formulated. This was to: 
• GDP to extract the upper retained Es 
• Paediatric dental department to build up infraoccluded lower Es and Ds 
• URA to correct crossbite 
• Reassessment 
13-10-15 Visit 2 (first visit to paediatric deparment) 
• HHL attended with his foster mother.  
• He was fit and well with no known drug allergies and no medical conditions.  
• A new patient assessment was done on the day and a below are the findings: 
o UL1 in crossbite 
o Class III malocclusion 
o LRD,E, LLE severely infraoccluded 
o Small area of hypomineralisation on LR6 
o Small white spot UL1 incisally 
o OH good with PI at 12% 
• The initial referral plan by orthodontics was to build up all lower Es and Ds but 
on examination the LLD was not infraoccluded and a permanent successor 
was present. Hence we agreed to build up the lower Es and the LRD.  
• Options were discussed for the treatment and it was decided to attempt a 
technique were the build up is done with chemical cure composite under a 
preformed metal crown and then the PMC is removed. 
 
9-3-16 Visit 3 
HHL attended with his foster father. There were no complaints. 
The general dental practitioner had extracted the Upper Es.  
He was wearing a URA provided by our orthodontic deparment. 
Plan to do build up the LRD with composite  
• LRD composite build up 
• Cotton roll isolation 
• Size 2 crown chosen 
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• Core build up of LRD with A1 Filtek composite 
• Cemented PMC with chemical cure composite 
• Waiting time of four minutes 
• Crown sectioned mesiocclusally 
• Polished composite 
• Separators placed interproximally for crowns on the Lower Es at the next visit 
• Good cooperation 
• OHI and TBI done 
 
23-3-16 Visit 4 
HHL attended with his foster father. There were no complaints and the crown on the 
LRD was intact. 
Plan to do build up with composite the lower Es 
• Separators removed 
• Cotton roll isolation 
• Size 2 crown chosen 
• Core build up of lower Es with A1 Filtek composite 
• Cemented PMC with chemical cure composite 
• Waiting time of four minutes 
• Crown sectioned mesiocclusally 
• Final finishing done and occlusion checked. Patient and father very happy with 
final appearance. 
• Good cooperation 
Following the completed treatment, the lower Es and LRD were on the same 
occlusal level as the remaining teeth and in occlusion with the upper teeth. 
10-6-16 Visit 5 
HHL attended with his foster father. There were no complaints and all the crowns 
were intact. He was still continuing with the URA.  
• Clinical examination showed the intact crowns present 
• Oral hygiene was good with PI at 12% 
• Clinical photographs done  
• Post op vertical bitewing radiographs done  




APPRAISAL AND DISCUSSION 
 
Infraocclusion is a frequent clinical finding having a prevalence of 1.3% to 8.9% in 
primary molars. In 17% to 25% of the cases, they are associated with missing 
permanent premolars (Kennedy, 2012; McGeown & O’Connell). Clinicians treating 
patients with infraocclusion need to make a decision whether to follow an extraction 
or retention plan.  
In the majority of cases where infraocclusion is not associated with hypodontia the 
primary molar will be left to exfoliate or extracted. There are however cases where the 
severity of infraocclusion, the position and resorption rate of the root, the number of 
missing teeth and the overall orthodontic evaluation will lead to a treatment plan which 
requires retention of the primary teeth. 
Hypodontia is the term used for the congenital absence of teeth. It is common affecting 
3.5-6.5% of the population in the permanent dentition and 0.1-0.9% in the primary 
dentition(Brook, 1974; Thilander & Myrberg, 1973). It has been described as 
hypodontia when 1-5 teeth are missing, oligodontia when 6 or more teeth are missing 
and anodontia when all teeth are missing. The third molars are not included in the 
above. Furthermore, hypodontia can be as part of a syndrome or non-syndromic. The 
main syndrome associated with hypodontia is Ectodermal Dysplasia, but also Oro-
Facial Digital syndrome, Down’s syndrome and syndromes associated with oral cleft. 
Non syndromic is usually autosomal dominant inheritance and some genes such as 
MSX1, PAX9 have been associated with hypodontia. In our case HHL did not have 
any features of ED or any other syndrome. Taken into account that he is adopted the 
foster parents did not have any information of parental hypodontia, however we 
assume that this a case of non-syndromic hypodontia with five missing permanent 
teeth. 
There are many different ways of classifying infraocclusion. It can be classified 
radiographically, clinically or through study models. Here we have chosen to use the 
simple clinical classification of Brearley and Mc Kibben from 1973 (Brearley & 
McKibben, n.d.). This is a commonly used system and includes the following 
categories: 
• Slight – occlusal surface located approximately 1 mm below the expected 
occlusal plane for the tooth. 
• Moderate – occlusal surface approximately level with the contact point of one 
or both adjacent tooth surfaces. 
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• Severe – occlusal surfaces level with or below the interproximal gingival tissue 
of one or both adjacent tooth surfaces. 
Looking into the treatment options, in our case the 3 missing permanent lower 
premolars and the occlusal and skeletal profile resulted in a treatment plan requiring 
retention of the infraoccluded primary molars. All three of the primary lower retained 
molars were severely infraoccluded. 
Long term studies have shown that infraoccluded primary teeth may have very slow 
exfoliation rates and after the age of 20 only a few teeth are lost (Bjerklin & Bennett, 
2000). It is very difficult to estimate how long HHL teeth will last as there is already 
resorption of the roots, however once these are back in occlusion this may slow down. 
Multiple different approaches have been reported in the literature for the treatment of 
infraoccluded primary teeth. These can be direct composite, indirect composite 
onlays, Preformed Metal Crowns, porcelain crowns and porcelain or gold 
onlays(Bonin, n.d.; Cavanaugh & Croll, 1994; Gulati & Welbury, 1998; Kennedy, 
2012). All of the above have been successfully used with good results. The main 
advantage of the clinical approach in our case is that it enables the clinician to easily 
create an aesthetic crown in one appointment using materials and instruments readily 
available in the clinical practice and without the use of a laboratory. A previous study 
has shown good very good result following a 12 month review (Lygidakis, 
Chatzidimitriou, & Lygidakis, 2015).  
Overall we were happy with how successful the treatment for HHL was. The three 
crown build ups were done in two visits and the whole procedure was relatively quick 
and easy for the patient. The end result was aesthetically very good and brought the 
teeth back into occlusion. The three-month review appointment showed very good 
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